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ABSTRACT 
The P300 component of the auditory ERP elicited to target stimuli has been 
extensively investigated as a potential psychophysiological marker in schizophrenia. 
Theoretical and empirical evidence is presented, suggesting the earlier components 
(N100, P200) to both target and non-target stimuli may better capture information 
processing deficits currently proposed to be central to schizophrenia. The thesis 
comprises 4 studies. 
Study 1 demonstrated deficits to non-target (reduced N100 amplitude, earlier 
P200 latency), in addition to target stimuli (reduced and earlier N100 amplitude, 
increased P200 amplitude), in schizophrenia (n = 40) compared with matched normal 
controls. The schizophrenia group was also characterised by a lack of differentiation 
between ERPs elicited to target and non-target stimuli, in comparison to the normal 
control group. 
Study 2 confirmed the results of Study 1 in groups of chronic (chronic 
schizophrenia, n = 40) and first episode schizophrenia (FESz, n = 40), and 
additionally established that in normal controls non-target stimuli occurring 
immediately before the target (T-1) generated larger Ni amplitudes than the non-
target after (T+1), a pattern that failed to occur in Chronic schizophrenia and was 
minimal in FESz. N100 amplitude deficits to non-target stimuli were also correlated 
with clinical symptomatology, particularly with higher levels on the disorganisation 
factor. Most importantly, N100 and P200 responses to target and non-target (T+1 & 
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T-1) stimuli, were superior predictors in classifying both first episode and chronic 
schizophrenia patients than were the more commonly employed P300 measures. 
Study 3 examined the effect of certain sequence types on ERPs in FESz 
(n =14) and normal controls (n = 14), in order to ascertain whether P300 and 
other ERP deficits in schizophrenia could be attributed to impairments on 
specific sequence occurrences. Specifically, effects from the discontinuation of a 
long series of repetitions (DR-series) and alternations (DA-series) were 
examined. In general, patients with FESz demonstrated similar ERPs to controls 
to the series examined. 
Study 4 demonstrated that the early (N100 and P200) component deficits 
to target and non-target stimuli were specific for FESz (n = 20), when compared 
to both a clinical (ADHD, n = 20) and normal (n = 20) control group. Finally, a 
stepwise discriminant function analysis (Dfa), demonstrated that measures 
derived from the early components had better sensitivity and specificity values 
(vs. N2, P3) for diagnostic classification when compared with ADHD. 
This thesis provides compelling evidence that N100 and P200 
components to target and non-target stimuli are impaired in both the early and 
chronic manifestations of schizophrenia, and argues that, on account of the 
superior sensitivity and specificity values associated with the early components, 
they may serve as potentially useful biological markers for the disorder. 
ABBREVIATIONS 
Abbreviations used in the text throughout this thesis 
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Abbreviation Term 
ADHD Attention Deficit Hyperactivity Disorder 
ANOVA Analysis of Variance 
ER_P Event related Potential 
cf. Compared with 
CIDI Composite International Diagnostic Interview—Computerised Version 
CRT Choice reaction time task 
CSz Chronic schizophrenia 
CT Computer Tomography 
DfA Discriminant function analysis 
DA Discontinuation of alternations 
DR Discontinuation of repetitions 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th Edition 
FESz FESz 
fMRI functional Magnetic Resonance Imaging 
ISI Inter stimulus interval; 
ITI Inter target interval 
IQ Intelligence Quotient 
MANOVA Multivariate Analysis of Variance 
1VIRI Magnetic Resonance Imaging 
ms Milliseconds 
N Non-target 
n number 
PANSS Positive and Negative Symptom Scale 
PET Positron Emission Tomography 
rCBF regional Cerebral Blood Flow 
RST Response-stimuli interval 
RT Response Time 
SANS Schedule for the assessment of negative symptoms 
SAPS Schedule for the assessment of positive symptoms 
SPECT Single Photon Emission Tomography 
T Target stimuli 
T-1 Non-target stimuli immediately preceding the target stimuli 
T+1 Non-target stimuli immediately following the target stimuli 
TTI Target to target interval 
Note. Abbreviations used in Tables are not given here; all abbreviations will be defined on their first 
use in the text. 
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1  INTRODUCTION 
1.1 RATIONALE FOR AND OVERVIEW OF THE THESIS 
The central importance of cognitive deficits to schizophrenia has been 
proposed for at least a century (Andreasen, Paradiso & O'Leary, 1998; Blueler, 
1950/1911; Braff, 1993; Broadbent, 1958; Frith, 1995; Gray, 1998; Hemsley, 1996; 
Kraeplin, 1989/1919). Although there is little doubt about the existence of a 
cognitive deficit, the nature of this deficit, its interaction with symptoms, stability 
over time, whether it follows a neurodevelopmental or neurodegenerative course, and 
the underlying brain dynamics remain unclear (Andreasen, 2000; Frith, 1992; 
Goldman Rakic, 1994; Gray, 1998). This primary deficit is seen to underlie 
impairments in second order cognitive processes (e.g. attention, memory, language 
emotion) and symptoms of schizophrenia. 
The development of event related potentials (ERPs) has provided a window for 
understanding the neural mechanisms that might underlie this deficit. The 
millisecond resolution generated by ERPs time-locked to stimuli in cognitive 
paradigms and recorded over the entire scalp provides a spatio-temporal map of 
consequent electrical brain activity in the real time of cognition. Understanding the 
psychophysiology of such a cognitive deficit has exciting implications, in particular 
the possibilities of identifying a biological validation of diagnosis, an endophenotype 
for genetic and pharmaceutical research and a biological marker of risk for 
schizophrenia. The results of this thesis which includes first episode and chronic 
14 
schizophrenia participants may also inform treatment intervention and the timing of 
that intervention and contribute to the understanding of the pathology underlying 
schizophrenia. 
The P300 component of the ERP to target stimuli in the auditory oddball 
paradigm is seen to reflect "the processing of incoming information when it is 
incorporated into memory representations of the stimulus and the context in which 
the stimulus occurs" (Polich & Herbst, 2000, p4). Research has demonstrated a 
widely reproducible, reduced P300 amplitude in schizophrenia (Ford, 1999; Jeon & 
Polich, 2000; Pritchard, 1986) which has been suggested as a possible biological 
marker of risk for schizophrenia (Bharath, Gangadhar, & Janakiramaiah, 2000; 
Blackwood, 2000; Freidman & Squires-Wheeler, 1994). It has been argued that this 
reduction represents difficulties in context updating and generation of expectancies 
(Donchin & Coles, 1988). 
There are several limitations in P300 research (see Chapter 2) suggesting the 
need to look beyond the P300 component. Although reduced P300 amplitude is 
sensitive for schizophrenia, it is not specific to schizophrenia. Reduced P300 
amplitude has also been found in other psychiatric and neurological conditions such 
as alcoholism (Pfefferbaum, Ford, White & Mathalon, 1991), depression 
(Pfefferbaum, Wenegrat, Ford, Roth & Koppell, 1984), attention deficit hyperactivity 
disorder (AMID; Barry, Johnstone & Clarke, 2003), borderline-personality disorder 
(Blackwood, Sinclair & Kutcher, 1986); Parkinson's disease (Raudino, Garavaglia, 
Beretta & Pellegrino, 1997) and dementia (Goodin, Squires Henderson & Starr, 
1978). In addition, theoretical and empirical findings provide some support for the 
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notion that a comparator disturbance leading to a failure to make use of context in 
information processing might occur 100-200ms post-stimulus and consequently 
would be better captured in the differentiation between target and non-target ERP 
components, particularly the earlier N100 and P200 components (See Chapter 2.5). 
ERP studies in schizophrenia have focused mainly on the P300 component elicited 
by target stimuli, many restricting their analysis solely to P300. Less attention has 
been given to earlier N100, P200 components to target stimuli and even less to non-
target stimuli (see Chapter 2 for review). Hence, it is theoretically compelling and 
clinically relevant to investigate deficits in earlier components, N100 and P200, to 
both target and non-target stimuli in schizophrenia. To be valuable, such an 
investigation would need to demonstrate the presence of these deficits at onset and 
over longer duration of illness and their improved sensitivity and specificity when 
compared to the P300. 
The thesis is built around four empirical studies and is presented as follows. 
Chapter 1 provides a brief outline of the thesis, presenting the clinical picture, a 
review of the symptom structure and major models of schizophrenia. Chapter 2 
reviews the previous literature on the auditory P300 component in schizophrenia and 
presents arguments for the importance of examining ERPs to non-target stimuli in 
addition to target stimuli. The focus of Chapter 3 (Study 1) is to examine the 
relationship between the ERPs elicited by target and non-target stimuli in an auditory 
oddball paradigm. The critical difference between this Study and previous research is 
the examination of ERP components to non-target in addition to target stimuli, and 
the examination of the difference in ERP responses to non-target and target stimuli 
between the schizophrenia and normal control groups. 
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Chapter 4 reviews and evaluates the literature germane to Study 2, and 
Chapter 5 describes the Study. This Study encompasses several objectives. In order 
to exclude the possibility that the deficits identified in Study 1 were a consequence of 
chronicity, or it's many consequences, this Study examines the presence of these 
deficits in a group of people experiencing their first episode of schizophrenia and 
their matched control group and contrasts these with deficits found in a group with 
chronic schizophrenia and their matched controls. The focus is on a more fine-
grained analysis of deficits in ERPs to target and non-target stimuli, sub-averaging 
ERPs elicited by non-target stimuli, depending on their sequence - the non-target 
occurring immediately preceding (T-1) or following (T+1) the target stimuli. In 
addition, the relationship between key symptom clusters and ERP findings are 
analysed. Although not major objectives of the Study, age and gender effects were 
also briefly examined. The wide age span arising from this design allows for a 
comparison of age effects between schizophrenia and normal control groups. Gender 
differences in schizophrenia have recently gained theoretical relevance and hence 
differential gender effects on ERPs between clinical and control groups are also 
investigated. 
The interpretation of Study 2 results led to questions regarding sequence 
effects on ERPs to target and non-target stimuli in schizophrenia, necessitating the 
development of a different paradigm. These questions were investigated in Study 3 
(Chapter 6). The improved sensitivity for schizophrenia of N100, P200 components 
elicited by target and non-target stimuli versus N200 and P300 to target stimuli also 
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lead to a further investigation of the relative specificity of these components in Study 
4 (Chapter7). 
Chapter 6 introduces and describes Study 3. This Study examined how 
sequence effects on ERPs may contribute to an understanding of difficulties with 
either the independent processing of target and non-target stimuli and/or the 
interrelated processing of these two stimuli in a group with first episode 
schizophrenia. The Study focuses on the effects of the discontinuation of alternation 
sequence on P300 amplitude, latency and RT, as a possible index of associative 
strength. A further aim of this Study was to discriminate between two competing 
hypotheses emerging from the results of Study 2 regarding the absence of sequence 
effects on the non-target N100 amplitude in schizophrenia. 
The final experimental Study (Study 4) is described in Chapter 7 and 
examines whether deficits in N100 and P200 components to target and non-target 
stimuli, observed in chronic and first episode schizophrenia were specific to this 
disorder. As ADHD shares deficits in common cognitive domains (eg. attention, 
working memory and inhibitory dysfunction) with schizophrenia (Chapter 7.1) they 
provide a useful psychiatric control group for exploring the specificity of ERP 
findings in schizophrenia, particularly in a young group with FESz. Hence, Study 4 
examined ERPs to target and non-target stimuli (T-1 & T+1) in FESz in comparison 
to normal and psychiatric (ADHD) control groups. 
Chapter 8 comprises a summary, interpretation and discussion of the four 
studies previously conducted. The theoretical and clinical implications are also 
discussed, as are the limitations of this thesis and suggestions for further research. 
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In summary, this thesis significantly contributes to ERP findings within the 
schizophrenia literature and enhances the theoretical understanding of the 
mechanisms that may contribute to the psychopathology of this clinical condition. 
1.2 SCHIZOPHRENIA - THE CLINICAL PICTURE 
1.2.1  Classification and course  
There is, as yet, no accepted biological validation for the diagnosis of 
schizophrenia, which is a clinical diagnosis based upon the evaluation of reported 
and observed symptoms (Sedvall & Terenius, 2000). Diagnosis is made on the basis 
of characteristic positive (delusions, hallucinations, disorganized speech or 
behaviour) and negative (affective flattening alogia and avolition) symptoms, with 
continuous signs of disturbance for at least six months. These symptoms are 
accompanied by deteriorating personal, social and occupational functioning and are 
not secondary to another disorder e.g. substance abuse (American Psychiatric 
Association, 1994). The peak age of onset is in the twenties, with onset generally a 
little earlier in males than females (Hafner et al., 1998). Schizophrenia is one of the 
most costly mental illnesses in terms of its impact on patients, their families, the 
health system and the economy (Langley-Hawthorne, 1997; Andreasen, 1995). 
Schizophrenia has a range of courses and outcomes (Gaebel & Frommann, 2000). 
Although onset may be abrupt the majority of individuals display some type of pro-
dromal phase which may last a year or more before the onset of overt psychotic 
symptoms. Although Kraeplin (1989/1919) conceived dementia praecox as a 
deteriorating illness, Bleuler (1950/1911) emphasized that the course could be 
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irregular with remissions and intermediate outcomes. Ciompi (1988) suggests the 
course of schizophrenia is not always catastrophic, as almost 30% of patients can get 
well or have a good remission and in 30% a mild residual symptomatology persists. 
DSM IV (American Psychiatric Association, 1994) specifies six main course 
patterns: episodic with interepisode residual symptoms, episodic with no interepisode 
residual symptoms; continuous, single episode in partial remission, single episode in 
full remission and other or unspecified. 
Schizophrenia has a similar clinical presentation and prevalence throughout 
the world, a lifetime and point prevalence of approximately 1 percent (Sartorius, 
Jablensky & Korten, 1986). However, sex differences have been reported with a two 
to three-fold increase in the incidence of schizophrenia in males (Hambrecht et al., 
1994; Timms, 1998). Compared with females males have been found to show poorer 
premorbid adjustment (Childers & Harding, 1990; Salokangas, 1983), younger age at 
onset and at first hospitalization (Hafner et al., 1989; Loranger, 1984; Shtasel, Gur, 
Gallacher, Heimberg, & Gur, 1992), more severe symptoms and course of illness 
(Angermeyer, Kuhn, & Goldstein,1990; Childers & Harding, 1990; Goldstein, 1988; 
Goldstein, Santangelo, Simpson, & Tsuang, 1990; McGlashon & Bardenstein, 1990; 
Salongas,1983) worse social and vocational outcome(Childers & Harding, 1990), 
greater structural brain anomalies (Gur et al., 2000; Harvey et al.,1990; Leong & 
Chue, 2000) and neurological soft signs (Alexander et al., 1994). 
1.2.2 Clinical heterogeneity  
Schizophrenia has been considered a heterogeneous disorder in terms of both 
clinical symptoms and neuropathological findings (Hemsley, 1996). One approach to 
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explore this heterogeneity has been the use of categorical subtypesfor 
example,paranoid/non paranoid (Kremen, Seidman, Goldstein, Faraone & Tsuang, 
1994), thought disorder/no thought disorder (Tallent, Weinberger & Goldberg 2001), 
positive/negative (Crow, 1980) or deficit/non-deficit (Carpenter, Heinrichs, & 
Wagman, 1988). However one problem with this approach is that individual patients 
may have symptoms from more than one category, for example, many patients with 
schizophrenia exhibit both positive and negative symptoms. An alternative approach 
uses factor analysis to reduce the large number of symptoms into factors that can co-
occur in individual patients. 
Many factor analytic studies (Andreasen, Arndt, Miller, Flaum & Nopoulos, 
1995; Liddle, 1987; Loftus, DeLisi, & Crow, 1998) suggest that three primary 
symptom factors account for the interrelationships among the core symptoms of 
schizophrenia. The three factors have been characterised by Liddle (1987) as 
follows: (1) psychomotor poverty - deficit negative symptoms such as affective 
flattening, emotional and social withdrawal, and avolition); (2) reality distortion - 
positive symptoms of hallucinations and delusions; and the (3) disorganisation factor 
- positive and negative aspects of thought disorder and attentional problems. These 
studies have largely limited factor analysis to the core symptoms of schizophrenia as 
measured by the schedule for the assessment of positive symptoms (SAPS), and the 
schedule for the assessment of negative symptoms (SANS, Andreasen, Arndt, Miller, 
Flaum & Nopoulos, 1995) or the positive and negative sections of the positive and 
negative syndrome scale (PANS S, Kay & Opler, 1987). When investigators have 
added symptoms of general psychopathology to the factor analysis (usually the 
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psychopathology section of the PANSS), they have found that five factors, or more, 
are necessary to explain the heterogeneity of symptoms in schizophrenia (Bell, 
Lysaker, Beam-Goulet, Milstein, Lindenmayer, 1994; Lancon, Reine, Llorca, 
Auquier, 1999; Lindenmayer, Grochowski, & Hyman, 1995). In these studies the 
three core factors have largely remained, with the addition of two or more further 
factors, although the exact symptoms that comprise these dimensions differ slightly 
across studies. The two most common additional factors have been characterised as 
excitement and depression/anxiety. Consideration of symptom factors can unlock 
significant associations with brain function that can be obscured through traditional 
group averaging (Harris, Williams, Gordon, Bahramali & Slewa-Younan, 1999; 
Liddle, 1987, 1992; Liddle et al., 1992; Williams, Gordon, Bahramali, Wright & 
Meares, 2000). For example, Harris (2004) found increased alpha 2 and beta power 
associated with reality distortion (divided into psychotic and paranoid domains) 
while finding decreased alpha and beta power associated with the disorganisation 
factor. A review of the relationship between symptom factors and cognitive domains, 
psychophysiology and imaging factors is presented in Chapter 4.4 
1.3 GENETICS 
Evidence from many studies demonstrates that genetic factors contribute 
substantially to the aetiology of schizophrenia (Gottesman, 1991; Moldin & 
Gottsmann, 1997) with epidemiological studies suggesting that additive and 
interactive genes, each with small effects, mediate this genetic vulnerability (Joober, 
Boksa, Benkelfat, & Rouleau, 2002). Genetic research has led to the questioning of 
the usefulness of the DSM IV categorical definition of schizophrenia for genetic 
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investigation, while acknowledging its necessity for clinical purposes. The disorder 
is unlikely to be caused by one gene that is 100% penetrant and the number of people 
that meet the requirements of DSM IV may be only a selected fraction of the total 
occurrence of the phenotype (Clonninger, 1994). Strauss (1969) and others (Claridge, 
1994; Johns & Van Os, 2001) have suggested that psychosis may exist as a 
continuous phenotype in nature. Phenotype incorporates the observable 
characteristics of an organism in contrast with genotype, which is an organism's 
genetic composition 
The most widely accepted model for the transmission of schizophrenia, the 
polygenic threshold model (Gottesman & Moldin, 1997; Gottesman & Shields, 1967) 
proposes that the liability to develop the disorder is normally distributed in the 
population, reflecting the additive effects of several different genes plus 
environmental factors. Thus, only those individuals who exceed a certain threshold 
of liability would develop the disease. Relatives of schizophrenic patients have, on 
average an increased liability compared with the general population because of 
predisposing genetic factors, causing more of these relatives to be beyond the 
threshold for manifesting the disorder. The strongest evidence for the existence of 
schizophrenia susceptibility loci has been found on chromosomes 1, 6, 8, and 13 
(Bailer, et al., 2000; Brzustowicz et al., 2000; Gurling et al., 2001; Schwab et al., 
2000 Shaw et al., 1998 Williams et al., 1999). However, statistical evidence is not 
strong, and the existence of nonreplications demonstrates that these findings are not 
conclusive (National Institute of Mental Health's Genetic workgroup, 1999). 
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The problems surrounding the adequacy of the current diagnostic criteria for 
schizophrenia, and the heterogeneity of individuals currently classified, contribute to 
the importance of identifying biological endophenotypes, as they can identify 
relatives of affected individuals who would be considered unaffected with typical 
diagnostic systems. They can also identify individuals at risk before the development 
of the disease and help to identify a candidate location for illness-susceptibility loci 
(Porjesz et al., 2002). Endophenotypes represent measurable characteristics that 
reflect an underlying genotype that may be more closely related to that genotype than 
the diagnostic category itself. Endophenotypes must be associated with the illness in 
the population, heritable, primarily disorder dependant and co-segregate with illness 
within families (Gottesmann & Gould, 2003). The heritability of P300 amplitude in 
the normal population has been estimated around 60% (van Beijsterveldt & van Baal, 
2002; Wright et al., 2001) with highest heritability (79%) from the Minnesota twin 
sample (Katsanis, Iacono, Mcue & Carlson, 1997). Very few studies have looked at 
the heritability of the N100 and P200 components. Studies which have included 
N100 have found both amplitude and latency heritable (Koutchoubei, 1987 - 
orienting task; O'Connor, Mozerati, & Christian, 1994 - oddball; Surwillow, 1980 - 
oddball). O'Connor et al. also found genetic influences in the waveform shape of 
ERPs to both target and non-target stimuli. There are few studies that link ERPs to 
genetic findings in schizophrenia. Blackwood (2001) has linked P300 amplitude to 
chromosome 1. Preliminary findings about the heritability of target and non-target 
ERP components suggests their potential as endophenotypes is worthy of further 
investigation. 
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1.4 MODELS OF SCHIZOPHRENIA 
The last one hundred years of schizophrenia research has shown a shift from 
viewing schizophrenia as a loosening of association cognitively (Blueler, 1950/1911) 
and a neurodegenerative view of its course (Kraeplin, 1896), to a focus on 
specialised or focal deficits, and then to a biologically driven focus on disconnection 
and a neurodevelopmental hypothesis (Bullmore, Frangou, & Murray, 1997; Friston, 
1998; Peled, 1999). Figure 1 is an attempt to integrate some of the major models 
with a unified cognitive deficit and pathophysiology into a working model of 
schizophrenia. 
Comprehensive models of schizophrenia need to account for multiple 
aetiologies including genetic contribution, the age of onset, its remitting and 
relapsing course, the modulating role of neurotransmitters, the heterogeneity of 
symptoms and the difficulty in finding a pathophysiological marker. The stress-
vulnerability model of schizophrenia (Zubin & Spring, 1977; Nuechterlein & 
Dawson, 1984; Clements & Turpin, 1992) provides insight into the remitting and 
relapsing course of schizophrenia. This model proposes that a predisposition to 
schizophrenia on the basis of genetic vulnerability and ecogenetic effects interacts 
dynamically with psychosocial factors in the individual's life such as family 
environment, social network and substance abuse to establish a threshold, beyond 
which a person may develop schizophrenia or psychosis. This threshold moves as 
protective or destructive factors intersect with the person's vulnerability. 
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Working Model of Schizophrenia 
(A) Etiology: multiple convergent factors 
DNA, gene expression, viruses, toxins, birth injury, psychological experiences 
g ‘Q, g g ‘Q, II 
(B) Neur °developmental contribution 
Dysplasia during second half of gestation (resulting in abnormal asymmetry and 
connectivity of the adult brain); abnormal synaptic pruning at adolescence. 
(C) Anatomic and functional disconnection in neuronal connectivity and 
communication in the mature brain involving the modulation of long-term changes in 
synaptic efficacy by the ascending neurotransmitter systems. 
II 
(D) Impairment in a fundamental cognitive process 
A breakdown in the normal relationship between stored material and current sensory 
input or failure to make use of context in information processing 
(See Chapter2, Table 2.1) 
II 
(E) Impairment in one or more second order Cognitive Processes 
(E.g. attention, memory, language emotion) 
II 
(F) Symptoms of Schizophrenia 
(Reality distortion, psychomotor poverty, disorganisation, excitement and 
depression/anxiety) 
Figure 1. 1 A framework for integrating some of the major models of schizophrenia 
Note. Figure adapted from Andreasen's (2000, p108) working model. Changes to 
Andreasen's model are in blue. Arrows in blue have been made bidirectional to 
reflect the possibility of a two rather than one way interaction. 
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The disconnection model, suggesting that different neuronal systems in the 
brain have become disconnected from each other in schizophrenia (Friston 1998, 
1999) has provided the stress-vulnerability model with a plausible 
pathophysiological mechanism. Research suggests that perhaps the difficulty in 
finding a single pathophysiological marker despite many years of research is because 
the pathology in schizophrenia may involve multi-distributed neural circuits and 
neurotransmitter systems (Andreasen, Paradiso, & O'Leary, 1998; Bullmore, et al., 
1997; Friston, 1999; Goldman Rakic & Selemon, 1998; McGlashen & Hoffman, 
2000; Peled, 1999). Disconnection models have been proposed in different, but 
generally compatible versions by several proponents. 
Friston (1999) proposes a regionally specific disruption of effective 
connectivity within the brain through experience, or activity dependent plasticity in 
systems which would only be functionally expressed in the developed brain, 
involving ascending modulatry neurotransmitters. The reduced neuropil hypothesis 
(Selemon & Goldman-Rakic, 1999) proposes that the reduction of interneuronal 
neuropil in the prefrontal cortex is a prominent feature, and suggests a major role for 
prefrontal regions and their multiple distributed cortical, thalamic and striatal 
connections in schizophrenia. Peled (1999) suggests a disorder of multiple constraint 
organisation with specific symptom factors determined by the site and level of the 
disconnection. Reality distortion is associated with a breakdown in auditory 
unimodal networks and their connections with heteromodal networks, psychomotor 
poverty is associated with disturbances in constraint satisfaction of the networks 
located at the highest levels of the hierarchy, and disorganisation is associated with 
disturbance that encompasses most if not all brain systems. 
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Disconnectivity models can also account for the timing of the onset of 
schizophrenia through neurodevelopmental hypotheses. These hypotheses argue that 
there are two stages in the development of the brain that can be linked to brain 
abnormalities that lead to schizophrenia. The first period, the early 
neurodevelopmental stage, takes place during the pre-natal and neonatal period. It is 
argued that a combination of early brain lesions and environmental factors such as 
pre-natal viral infections, obstetric complications and winter or early spring births 
may combine together to predispose a person to schizophrenia but that frank 
psychosis may not occur until the brain has matured sufficiently. For example, 
Bullmore et al. (1997) present evidence that dysplasia during the second half of 
gestation would result in abnormal asymmetry and connectivity in the adult brain. 
The next period, the late neurodevelopmental stage, is thought to take place 
during brain maturation. Here it is argued that schizophrenia may develop as a 
consequence of abnormal synaptic pruning occurring during adolescence. Loss of 
synaptic density is known to be a feature of neurodevelpomental plasticity, with 
upwards of 60% of synapses being pruned in normal CNS development. This process 
reaches the prefrontal and association areas relatively late in the developmental 
course during mid-adolescence (Huttenlocher & Dabholkar, 1997), at the same time 
as the period of greatest risk for schizophrenia. An acceleration of this process of 
synaptic loss may underlie the expression of schizophrenia at this stage as well as the 
substantial cortical grey matter volume loss in the longitudinal structural magnetic 
resonance imaging (sMRI) studies of recent onset schizophrenia (DeLisi et al., 1997; 
Rapoport et al., 1999; Lieberman et al., 2001). 
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Evidence in support of disconnection models has been found in different 
modalities. Several investigators (Woodruff et al., 1997; Bullmore et al., 1998; 
Wright et al., 1999) argue that areas that share neurodevelopmental influences 
develop in parallel, establishing statistically definable structural interdependencies 
that reflect continued connectivity. Structural MRI studies have identified these 
dependencies in normal controls, however decreased interregional dependencies 
particularly between frontal hippocampal and temporal regions have been found in 
people with schizophrenia (Woodruff et al., 1997 Bullmore et al., 1998; Wright et al., 
1999). Studies have also shown low neuropil levels (Lewis et al., 1999) 
abnormalities in synaptic, dendritic, axonal, and white matter tract organization, and 
abnormalities of glutamatergic neurotransmission, (Garey et al., 1998; Glantz & 
Lewis, 2000; Goldman Rakic & Selemon, 1997) which are consistent with disturbed 
intracortical connectivity. 
It is also possible that disconnectivity is anatomically restricted, rather than 
widespread, with certain cortico-cortical and cortical-subcortical connections 
particularly vulnerable to disruption in schizophrenia. The strongest evidence to date 
has emphasised the disconnectivity between frontal and lateral temporal cortices 
(Frith et al., 1995), between the frontal cortex and the hippocampus (Weinberger 
Berman & Torrey, 1992); and in both fronto-striatal thalamic (Robbins, 1990) and in 
fronto-thalamic-cerebellar (Andreasen et al., 1998) circuits. Gray (1995, 1998) 
proposes a specific disconnection, an anatomic abnormality in the limbic forebrain, 
affecting the hippocampal formation, amygdala and temporal and frontal neocortex, 
leading to a functional neurochemical abnormality, hyperactivity of transmission in 
the ascending mesolimbic doperminergic pathway, that disrupts the comparator 
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process. The comparator "has the general function of predicting, on a moment by 
moment basis, the next perceived state of the world, comparing this to the actual next 
perceived state of the world, and determining whether the predicted and actual states 
match or mismatch" (Gray 1995, p 680). 
The point of entry for this thesis is at level D (see Figure 1.1) the 
psychophysiology of the fundamental cognitive deficit - a breakdown in the normal 
relationship between stored material and current sensory input or the failure to make 
use of context. However, there is also interaction with other levels,for example,E - 
resultant cognitive deficits; F - clinical symptoms; and at levels prior to D, if the 
determined deficits are shown to have potential as biological markers for genetic 
investigation. 
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2 AUDITORY ERPs IN SCHIZOPHRENIA: INTRODUCTION AND 
RATIONALE FOR STUDY 1. 
2.1 ADVANTAGES OF ERPS FOR INVESTIGATING BRAIN DYSFUNCTION IN 
SCHIZOPHRENIA 
Neuroimaging technologies for investigating brain dynamics in schizophrenia 
include electroencephalogram (EEG), event-related potentials (ERP), positive 
emission tomography (PET), functional magnetic resonance imaging (fMRI), and 
single photon emission computerized tomography (SPECT). Although PET, SPECT 
and fMRI, provide good spatial resolution, these methods do not have the temporal 
resolution to investigate cognitive processing in the millisecond domain (Gordon, 
2002). Andreasen, Nopoulos, O'Leary, Miller, Wassink and Flaum (1999) claim that 
"the rapid constant checking and updating of input and output" occurs "at the 
nanosecond level" (p. 911). While the claim for nanoseconds may be taking poetic 
license with the physiology of nerve action potential, it nevertheless points to the 
advantages of a technique such as the event related potential (ERP) which has 
millisecond resolution. 
ERPs provide an index of electrical brain activity time-locked to sensory 
stimuli and provide a spatiotemporal map of consequent neural events. They are also 
able to distinguish processing stages and can clarify the timing, ordering and 
interactions of the intermediate processes that are engaged in specific cognitive 
activities (Hillyard & Kutas, 1983). An advantage of ERPs is that neural responses 
can be measured for all stimuli, regardless of whether an overt response is required. 
This makes ERPs ideally suited for the purpose of this Study as they allow us to 
assess the extent to which non-targets, which do not require a response are processed. 
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In contrast measures of performance such as response time (RT) are less able to 
focus on brain activity to non-target stimuli. Additionally, the analytic requirements 
of NMI i.e. subtraction of the baseline activation, elicited by non-target stimuli 
from the activation elicited by target stimuli also make it difficult to examine and 
contrast early (pre N200 & P300) brain activity to target and non-target stimuli. 
Several studies have shown a robust within subject test-retest reliability for ERP 
components supporting their validity as markers of CNS functioning (Sandman & 
Patterson, 2000; Segalowitz & Barnes, 1993; Sinha & Parsons, 1992; Walhovd & 
Fell, 2002). Results form these studies have indicated that measures of amplitude 
show superior reliability over measures of latency. Other advantages of ERPs are that 
they are accessible and non-invasive. Thus ERPs are well suited to the investigation 
of cognitive deficits in schizophrenia and particularly to the investigation of the 
proposed comparator disturbance. 
2.2 THE FUNDAMENTAL COGNITIVE DEFICIT IN SCHIZOPHRENIA 
While the capacity to ignore task irrelevant stimuli and optimally process 
relevant target information is seminal to normal brain function, early models of 
cognitive disturbance in schizophrenia suggested a global failure of this process, 
commonly associated with filter disturbances (Broadbent, 1958). Recent models 
(Gray, 1998; Gray, Feldon, Rawlins, Hemsley and Smith, 1991; Hemsley, 1996) 
propose a core physiological mechanism underlying this process, namely a 
disturbance of the comparator process. The Gray-Hemsley model proposes that the 
cognitive deficits exhibited by patients with schizophrenia correspond to a 
breakdown in the normal relationship between stored material and current sensory 
input. Thus, people with schizophrenia fail to establish appropriate response biases 
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because they are unable to use stored memories of regularities based on their 
previous experience. This model is consistent with Sokolov's (Sokolov, 1963; 
Sokolov & Vinograda, 1975) neuronal model, and with aspects of the models 
proposed by Andreasen et al. (1998), Frith (1995), and Servan-Schreiber, Cohen, 
and Steingard (1996), suggesting a deficit in the co-ordination and expression of 
information, a disruption in the monitoring of willed intention, and a failure in the 
inhibitory effect of context, respectively. The fundamental cognitive deficit could 
thus be seen as a failure to make use of context in information processing Table 2.1). 
Table 2.1 Failure to make use of context in information processing, differing 
conceptions of a fundamental cognitive deficit. 
"It is a weakening of the influence of stored memories of regularities of previous 
input on current perception" (Hemsley, 1987, p182). "This stored body of knowledge 
normally interacts with the encoding, comprehension and or retrieval of new 
information by guiding attention expectancies, interpretation and memory search." 
(Hemsley, 1996) 
A disturbance of the comparator process which "has the general function of 
predicting, on a moment by moment basis, the next perceived state of the world, 
comparing this to the actual next perceived state of the world, and determining 
whether the predicted and actual states match or fail to do so ("mismatch")". (Gray, 
1995, p 680) 
"Several schizophrenic deficits could be related to a disturbance in a single 
mechanism with pervasive implications for cognition: the representation and 
maintenance of context information". (Servan-Schreiber et al., 1996, p 1105) 
"An impairment of the neural mechanisms by which symbolic representations are 
both retrieved from long-term memory and 'held in mind' to guide behaviour in the 
absence of instructive stimuli in the outside world" (Goldman-Rakic & Seleman, 
1997, p 437-438) 
A disorder of consciousness or self awareness that impairs the ability to think with 
"metarepresentations" (higher order abstract concepts that are representations of 
mental states) (Frith, 1992) 
Cognitive dysmetria "a disruption in the fluid co-ordination of mental activity that is 
the hallmark of normal cognition... The basis of the poor co-ordination may be a 
defect in timing or sequencing the flow of information" (Andreasen et al., 1999, p 
911) 
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2.3 THE ODDBALL PARADIGM 
The auditory oddball paradigm, also called the P300 paradigm, is one of the earliest 
and most extensively researched paradigms for eliciting cognitive ERPs (Ford, 1999; 
Picton, 1992), with a body of evidence on functional and clinical implications. In the 
`oddball' paradigm, a subject detects and responds to an infrequent but task-relevant 
stimulus (target), randomly interspersed among more frequent, standard stimuli (non-
target). These stimuli can be either auditory or visual. Most studies in schizophrenia 
have reported the auditory, rather than the visual P300 (Ford, 1999) as P300 
abnormalities are more consistently observed in auditory paradigms (Egan et al., 
1994; Ford et al., 1994; Pfefferbaum, Ford, White & Roth, 1989). In the auditory 
version of the oddball paradigm, the participant is instructed to listen to a series of 
high and low tones, and to respond (e.g. by button press or counting) to one tone 
designated the target stimuli. There is thus a string of frequently occurring stimuli 
(standards or non-targets) interrupted intermittently by infrequently occurring (rare 
or target) stimuli, making the non-targets the context in which the decision 'target' is 
made. This comparison between target and non-target stimuli has been likened to the 
comparator process (Ford, 1999; Brown, Gonsalvez, Harris, Williams, & Gordon, 
2002). Kok (1997) suggests that the primary function of the neural network involved 
in target identification in the oddball is to compare stimulus attributes with an 
internal representation of the target, or memory-dependant characteristics of the 
target. Although more sophisticated paradigms exist for examining the use of context 
and selective attention, they are often too complex to use in clinical settings. As 
generalised attentional and/or motivational impairments adversely affect 
performance on most cognitive tasks in schizophrenia, it is important to have a task 
that patients are capable of performing and that does not require training. The 
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auditory oddball has the advantage of being a simple task which can be performed by 
most subjects. Thus an ERP deficit elicited by such a task is likely to reflect 
mechanisms implicated in the processing requirements of the task, rather than 
secondary reactions to the level of difficulty or incorrect performance on the task. 
Notably, a disturbance at this level may underpin disturbances found in more 
complex paradigms. A review of P300 findings in schizophrenia, indicates the 
contribution the oddball paradigm has made to our understanding of the cognitive 
disturbance in schizophrenia, along with the limitations of this research, and some 
questions that arise from it. 
2.4 AUDITORY P300 FINDINGS IN SCHIZOPHRENIA 
Roth and Cannon (1972) and Levit, Sutton and Zubin (1973) were the first to 
use the auditory oddball paradigm with people with schizophrenia, both finding 
reduced P300 amplitude to target stimuli. These studies utilised the oddball paradigm 
in the passive condition, where subjects ignore the tones. Most subsequent studies 
have used the attend paradigm, where subjects either count or press a button to 
targets. Roth and Cannon's study is particularly relevant, as it was the only study 
found which examined the non-target before and after the target stimuli separately, in 
schizophrenia, apart from the Studies 2 and 4 in the current thesis. 
The P300 deficit has been reproduced widely (Ford, 1999; Jeon & Polich, 
2000; Pritchard, 1986) making it "perhaps the most replicable biological reflection of 
schizophrenia" (Ford, 1999, p 668). Most oddball studies have concentrated on the 
P300 component to the target stimuli, as the P300 component was seen as 
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endogenous, or sensitive to cognitive determinants. The earlier components, N100 
and P200 which occur in both target and non-target stimuli, were seen to be more 
exogenous, or sensitive to manipulations of sensory characteristics (Van Der Stalt, 
1999). The interpretation of the reduced P300 in schizophrenia has led to a number 
of hypotheses which have generated a large area of research. Important issues 
arising from this research are explored below. 
2.4.1 Neuroleptic medication and P300  
A common limitation of many P300 studies in schizophrenia is the use of 
medicated patients as subjects. As untreated psychosis has undesirable outcomes, 
both in the short and long term, withdrawing a patient from medication or delaying 
the introduction of medication raises important ethical questions. However, the 
possibility that medication may influence ERP findings needs to be considered. As it 
is a variable occurring in the clinical and not in the control group, it is necessary to 
demonstrate that the differences between groups are not attributable to medication. 
This is especially important, as several neuroleptic medications also have 
anticholinergic effects, and specific anticholinergics are used to control 
extrapyramidal symptoms. However, cholinergic suppression has been shown to 
reduce P300 amplitude in healthy individuals (Hammond, Meador, Aung-Din, & 
Wilder, 1987; Meador et al 1987; Meador et al 1988 and Meador et al 1989). 
The possibility that reduced P300 in schizophrenia could be a medication 
artefact has been addressed by several studies which have found reduced P300 in 
patients with schizophrenia who have been withdrawn from neuroleptic medication 
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(Coburn et al., 1998; Ford et al., 1994, Laurent et al., 1999; Ogura et al., 1991) and in 
a neuroleptic—naive sample (Hirayasu et al., 1998). 
More recently, several studies have examined the interaction of medication 
and P300 from the alternative view, the possibility that neuroleptic medicine could 
normalize the P300 reduction in schizophrenia. While traditional antipsychotic 
medications do not appear to increase P300 amplitude in schizophrenic patients 
(Blackwood et al., 1987; Ford et al., 1994), there have been mixed results with the 
atypical antipsychotic medications that target various subtypes of serotonin receptors 
and D4, rather than the D2 dopamine receptors targeted by typical antipsychotic 
medication. Clozapine has been reported to increase P300 amplitude (Umbricht et 
al., 1998), while risperidone had no significant effect on P300 amplitude but 
normalized the latency (Iwanami et al., 2001). Gonul et al. (2003) found that, 
although olanzapine normalized P300 amplitude over the frontal area, the effect was 
unrelated to changes in the patients' clinical symptoms, and P300 amplitude over the 
parietal area remained below normal limits. The salient point here is that reduced 
P300 amplitude in schizophrenia does not appear to be the consequence of 
antipsychotic medication. 
2.4.2 Effects of probability manipulations on P300 deficits in schizophrenia  
Although there is a large body of work on the effects of probability and local 
sequence effects on the P300 in the normal population, this area received little 
attention in schizophrenia research. The bulk of studies on P300 in schizophrenia 
have used low probability targets (Jeon & Polich, 2000). Duncan, Perlstein and 
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Morihasa (1987) varied probability (0.10, 0.30 and 0.50) and found that patients with 
schizophrenia had significantly reduced P300 only to low probability stimuli. 
Mathalon and Ford (2002) varied probability between 0.2 and 0.8 and again found a 
significant reduction in P300 amplitude only to the low probability stimuli in 
schizophrenia. However the results in both these studies could be due to target to 
target interval (TTI) (see Chapter 6 for review of TTI versus probability) rather than 
probability. Sequence effects in schizophrenia have received even less attention, with 
only one study on sequence effects on P300 and RT in schizophrenia (Duncan-
Johnson, Roth and Kopell, 1984). This Study used a choice reaction time task which 
requires a response to all stimuli presented. No studies were found which 
investigated sequence effects on ERPs elicited by the non-target stimulus, or to target 
stimuli which occurred amongst stimuli which did not require a response. There is 
thus a need for further investigation of the effects of stimulus sequence on ERPs 
elicited by target and non-target stimuli in schizophrenia. The literature on sequence 
effects on ERPs is discussed in more detail in Chapter 6 in which Study 3 examines 
sequence effects on ERPs to target and non-target stimuli in FESz. 
2.4.3 Interstimulus Interval (ISI) and P300 in schizophrenia  
ISI is another variable demonstrated to influence the magnitude of P300 
amplitude. Studies have shown that P300 amplitude is not reduced in schizophrenia 
in comparison with normal controls in paradigms with long ISIs (Mathalon & Ford, 
2002; Roth, Goodale & Pfefferbaum, 1991). Mathalon and Ford examined the 
differences between short (1.5 secs) and long (8 sec) ISI and found that with the 
increase in ISI controls showed a slight decrease in P300 amplitude to targets but a 
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marked increase in P300 to standards. In contrast, patients with schizophrenia 
showed no change in the P300 to targets and a relatively small increase in P300 to 
standards with the ISI increase. Relative to the controls, P300 amplitude to targets 
was reduced in the schizophrenic patients with the short but not the long ISI. Without 
non-targets (standards) there is nothing with which to compare the target making 
limited demands on comparative or working memory processes (Donchin and Coles, 
1988). Ford (1999) suggests that whether P300 amplitude differs between 
schizophrenia and normal controls, depends on either the absence of a comparator 
process, i.e. where there is only the target and no non-target, or a very long ISI. 
2.4.4 Skin conductance and P300 in schizophrenia  
Some investigators have attempted to explore the relationship between skin 
conductance and P300. The main difficulty in these attempts was that the P300 is 
recorded in an attend paradigm usually with ISIs of a few seconds, while SCRs, 
which have recoveries over tens of seconds, are usually acquired in an ignore 
paradigm, with much longer ISIs. Roth, Goodale and Pfefferbaum (1991) attempted 
to explore the interaction of P300 and skin conductance in a passive three stimulus 
oddball and an active one stimulus reaction task with interstimulus intervals greater 
than 12 seconds. Not surprisingly, and consistent with findings that the P300 is not 
reduced in schizophrenia with experiments employing longer ISIs (Mathalon & Ford, 
2002), they did not find a reduction in P300 in schizophrenia. The development of a 
program to decompose the overlapped SCRs collected in a short ISI paradigm (Lim 
et al., 1997) allowed the simultaneous collection of SCRs and ERPs in the traditional 
short ISI P300 paradigm. Williams et al. (2003) subaveraged ERPs based on the 
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presence or absence of an SCR defined orienting response (OR), and found that the 
pattern of increased frontal P300 in the with OR' compared to the 'without OR' 
condition present in the control group, was not found in the group with 
schizophrenia. These results indicate that P300 may be modulated by arousal. 
2.4.5 Single trial studies of P300 in schizophrenia  
As P300 amplitude reduction in schizophrenia had been demonstrated in 
ERPs averaged across the experiment, it was possible that the averaging process may 
be obscuring variability within the ERPs elicited by individual targets. Ford, White, 
Lim & Pfefferbaum (1994) applied a P300 screen to all single trial responses to 
target stimuli and found that the schizophrenia group had fewer trials passing the 
P300-screen, smaller P300s on each trial, and P300s that were more variable in 
latency across trials than the normal control group. 
Wagner, Roschke, Fell and Frank (1997) examined the P300 to all single trial 
responses (target and non-target) in groups with depression, schizophrenia and 
normal controls. Amplitude distributions of single trials' maximum positive 
deflections (P300) for both target and non-target stimuli were determined, and served 
as a basis for calculating the discrimination index d'. This index characterised 
differences in the electrophysiological responses to target and non-target stimuli and 
was significantly lower for patients with schizophrenia than for controls and 
depressive subjects. Thus, calculating d' on the basis of single trial analysis 
differentiated between schizophrenics and depressives, while there was no significant 
difference between the two groups on the traditionally averaged P300 component 
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elicited by target stimuli (Roschke & Fell, 1997; Wagner, Roschke, Fell, & Frank, 
1997; Wagner, Roschke, Grozinger, & Mann, 2000). This suggests that it is not only 
necessary to examine the ERPs to target and non-target stimuli, but it is also 
necessary to investigate the relationship between target and non-target ERPs as this 
may be important to the specificity of ERP findings in schizophrenia. Studies 2 and 
4, in the current thesis have investigated the contrast between ERPs elicited by target 
and non-target stimuli. 
2.4.6 Theoretical interpretations of the P300 deficit in schizophrenia 
P300 amplitude has been envisaged as a general index of cognitive 
processing, however its specific meaning continues to be debated. The major 
theoretical interpretation of P300 amplitude is that it is generated by "tasks that are 
required in the maintenance of working memory" (Donchin, Karis, Bashore, Coles 
and Gratton, 1986, p 256). P300 has been demonstrated to follow the decision "target 
or non-target?" as subjects can accurately respond to target stimuli before the peak of 
the P300 component (Ritter, Simson, & Vaughn, 1972; Picton, Hillyard & 
Galambos, 1976). Verleger (1988) suggests that it represents perceptual closure, i.e. 
the P300 is evoked by 'awaited' stimuli when participants deal with repetitive highly 
structured tasks. On the other hand, Donchin and Coles (1988) suggest it may 
represent context updating when stimulus events require that an individual's model 
of the environment must be revised. This refers to the updating of memory after 
incoming information has been evaluated. In addition to stimulus probability, the 
extent to which this updating process is activated depends upon the value, 
significance or relevance of the stimulus (Sutton & Ruchkin, 1984). These authors 
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stress that this is a parietal P300 because of `awaitedness', not 'unexpectedness', i.e. 
P300b reflects suspense and P300a a surprise. Both Verleger and Donchin agree that 
P300 is concerned with expectancy: for Donchin P300 reflects 'expectancy violation' 
whereas Verleger sees the P300 as the result of 'expectancy confirmation'. 
However, there are criticisms of each of these hypotheses. A criticism of 
Donchin's hypothesis of memory updating is that the P300 occurs in situations in 
which one would not think that updating is necessary Picton (1992) suggests that in 
the usual oddball task the brain should quickly develop a memory model that 
incorporates the possibility of an occasional target stimulus. Updating this model 
should not be necessary each time the target occurs. The relationship of P300 to 
expectancy and probability has been challenged by the target to target interval (TTI) 
hypothesis (Gonsalvez et al., 1999; Gonsalvez & Polich, 2002; Croft, Gonsalvez, 
Gabriel & Barry, 2003). The TTI hypothesis proposes that increased P300 amplitude 
could be better explained by target to target interval (TTI) than by expectancy. The 
TTI hypothesis is reviewed in more detail in Chapter 6. Picton et al. (1992) 
hypothesised that P300 reflects the transfer of information from automatic to 
controlled processing or consciousness, yet P300 waves have been recorded in 
patients who are not conscious of the stimuli (Shefrin, Goodin, & Aminoff, 1988). 
Another approach to understanding the meaning of P300 amplitude has been 
to correlate P300 amplitude with neuropsychological measurements. P300 amplitude 
reduction has been correlated with poorer performance on tests of memory (Neiman 
et al., 2002), including the verbal paired-association sub-test of the Weschler 
Memory Scale (Nagasawa et al., 1999), and lower IQ (Shajahan, O'Carroll, Glabus, 
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Ebmeier, & Blackwood, 1997). Prolonged P300 latency has been correlated with 
verbal fluency scores (Souza et al., 1995). P300 amplitude reduction was also 
correlated to measures of disability of daily life (Iwanama, Yamashina, Kazamatsuri, 
& Kamijima, 1999). 
Intracranial recordings describe both P3a and P3b generators for the P300 
elicited to target stimuli (Halgren, Marinkovic & Chauval, 1997). The P3a, related to 
the orientation of attention, is thought to occur in para-limbic and prefrontal 
networks (Halgren et al., 1997; Yamaguchi & Knight, 1991; Yamaguchi & Knight, 
1993). The P3b, associated more with contextural integration, is generated in the 
temporo-frontal region (ventrally), association cortices (temporo-parietal region) and 
the hippocampus (Frodl-Bauch, Bottlender, & Hergerl, 1999 for review; Halgren, 
Squires, Wilson, Rohrbaugh, Babb & Crandall, 1980; Halgren, Marinkovic & 
Chauvel, 1997; Okada, Kaufman, & Williamson, 1983). Functional neuroimaging 
studies indicate that the P300 signal discrimination process engages preferential 
anterior and posterior cingulate, supramarginal gyrus (SMG) and hippocampal 
networks (Clark, Fannon, Lai & Benson, 2001; Kiehl, Laurens, Duty, Foster & 
Liddle, 2001; McCarthy, Luby, Gore & Goldman-Rakic, 1997). 
Research findings on whether: the P300 is a state or trait deficit; ERP 
disturbances are present at onset of illness and/or different from chronic 
schizophrenia; and also the differential effects of non-target sequence effects, age 
and gender on ERPs in schizophrenia compared with normal controls; topography; 
43 
and symptom relationship to ERP deficits are discussed in Chapter 4, and provide the 
rationale for Study 2. 
2.5 BEFORE THE P300: TARGET AND NON-TARGET N100 P200 
2.5.1 Rationale for investigating ERPs to non-target stimuli  
In auditory oddball studies, ERPs elicited by non-target stimuli are 
occasionally presented graphically, but are not usually the focus of investigation or 
analysis. However, recent research suggests that there are both theoretical and 
empirical indications for investigating possible ERP disturbances to non-target 
stimuli in addition to target stimuli in people with schizophrenia. Houghton and 
Tipper's (1996) model of "normal" selective attention proposes that, in addition to 
the excitatory feed back loop elicited by target stimuli, selective attention involves an 
inhibitory feedback loop elicited by non-target stimuli (see Figure 2.1). Thus ERP 
responses to non-target stimuli, would reflect how the brain, when involved in an 
oddball paradigm, processes information which is not task relevant. 
EXTERNAL INPUT 
\ / 
ROPERTY-UNIT 
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Figure 2.1 Model of the response system in selective attention (Houghton and 
Tipper, 1996, p27). 
Evidence of cognitive effects on ERPs to non-targets has come from 
comparisons with ERPs elicited by 'neutral' stimuli, delivered while the subject is 
not involved in any related cognitive task (Desmedt & Tomberg, 1991). Garcia-
Larrea, Lukaszewicz and Mauguiere (1992) compared ERPs to non-target stimuli in 
an active oddball (count response required to target), a passive oddball (no 
instructions given to subjects), and a neutral, ignore condition (only non-target 
stimuli). ERPs elicited by non-target tones during either the passive or active 
oddball, showed consistent differences when compared to ERPs to the neutral 
condition, with N100 and P250 amplitudes enhanced in the two former conditions. 
Notably, the P250 component was not even present in 8 of the10 subjects during the 
neutral runs. There were early and late effects associated with N100 amplitude to 
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non-target stimuli. The early effect found in all three conditions was maximal 
centrally and disappeared with progression of the experiment. This effect was 
interpreted to reflect changes in a vigilance-related component, the disappearance 
seen as progressive optimisation of the alerting state. The later effect was not found 
in the neutral condition and was more important in the active than passive oddball. It 
was predominantly frontal, with higher amplitude over the right hemisphere and 
persisted to the end of the recording session. This effect was thought to be processing 
negativity evoked by active discrimination from relevant target tones. Similarly 
Yordanova, Kolev and Polich (2001) found event-related desynchronisation in the 
alpha band to stimuli when used as non-targets in the auditory oddball but no alpha 
event related desynchronisation when the same stimuli were used for passive 
listening. 
2.5.2 Rationale for examining N100 and P200 components to target and non-target 
stimuli and their differentiation 
As participants can accurately respond to target stimuli before the peak of the 
P300 component (Ritter, Simson, & Vaughn, 1972; Picton, 1992) the decision "target 
or non-target?" may have preceded the process that generates the P300. Goodin, 
Aminoff, and Mantle (1986) suggest that the decision also precedes the N200 
component, based on changes in the EMG prior to the response. Models which 
propose a deficit at the comparator stage (Gray, 1998; Hemsley, 1996) and stress a 
failure in the inhibitory effect of context (Servan-Schreiber, et al., 1996) would thus 
predict an earlier disturbance that perhaps might be reflected in deficits of N100 and 
P200, elicited by both target and non-target stimuli in addition to the P300 deficit. 
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Consistent with some current theories (e.g. Gray, 1998; Hemsley, 1996), 
critical dysfunctions in schizophrenia could relate to mechanisms that are called into 
play when switches from one stimulus to another occur. Such processes may be best 
captured by differential response to target and non-target stimuli rather than by 
studying only target related ERPs. In support of this, in a single trial study of P300 
(Wagner et al., 1997) it was the discrimination index d' that was specific to 
schizophrenia compared to depression (see 2.3.5). There is also evidence that N100 
and P200 components elicited by target and non-target stimuli are sensitive to 
schizophrenia. Boutros et al. (1997) suggest from their data that N100 and P200 
elicited by target and non-target stimuli are helpful in diagnostic classification, and 
Ford, Mathalon, Kalba, Marsh and Pfefferbaum (2001) demonstrated that N100 
amplitude reduction to targets and non-targets is more specific to the "core 
pathophysiology" of schizophrenia than P300 reduction and "deserves more study" 
(p857). The current thesis provides a detailed examination of N100 amplitude to 
target and non-target stimuli. 
There are additional indications of disturbances in earlier components which 
might have later 'flow on' effects on the P300 from studies which have found 
reduced P50 suppression (Yee, Nuechterlein, Morris, & White, 1998) and mismatch 
negativity (MN/IN) in schizophrenia (Javitt, Doneshka, Grochowski, & Ritter, 1995; 
Mitchie et al., 2000; Shelley et al., 1991). MMN is a negative component of the ERP 
elicited by a discriminable change in a repetitive background of auditory stimulation, 
while the subjects attention is directed elsewhere, eg reading a book (Michie, 2001). 
Unlike components elicited to the auditory oddball in this thesis, in which a response 
is required to the deviant (target) stimuli, the MMN does not rely on attention to, or 
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detection of the deviant stimuli. Javitt et al. (1993) suggests MMN reflects 
widespread dysfunction of working memory. However, Michie (2001) suggests that 
it represents an abnormality within the window of temporal integration,that is co-
incident with the early phase of auditory sensory memory. As this thesis focuses on 
the oddball paradigm an in depth review of the MMN is beyond the scope of the 
thesis (for a review of this literature see Michie, 2001). 
2.5.3 N100 component  
N100 is involved in stimulus classification: the decision to further process 
information or ignore them (Fabiani, Gratton, & Coles, 2001; Kok, 1997) Several 
studies have demonstrated correlations between N100 and specific aspects of 
stimulus features (Naitanen & Picton, 1987; Pritchard, 1986), and between N100 
and attention, with N100 amplitude larger with increases in attentional 
requirements (Maclean, Ohman, & Lader, 1975; Pritchard, 1981) whether 
automatic or directed (Ford, Roth, Menon, & Pfefferbaum, 1999). N100 
amplitude is also related to arousal and is enhanced with caffeine (Bruce, Scott, 
Shine, & Lader, 1992) and diminished with alcohol (Pfefferbaum, Roth, 
Tinkleberg, Rosenbloom, & Kopell, 1979). Ford et al. (1994), found that during 
antipsychotic treatment larger N100 amplitude to target and non-target stimuli 
were associated with higher levels of methoxyhydroxyphenylglycol which they 
interpreted to suggest an influence of arousal. 
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N100 amplitude shows a systematic reduction in amplitude when the eliciting 
stimulus is repeated (for both attend and ignore instructions) usually in habituation 
paradigms. Whether this reflects a cognitively relevant process, or a more basic 
neurophysiological process is not clear, i.e. can it be seen as habituation, as defined 
by orienting response theory (Sokolov, 1963), or a process involving the recovery 
cycle or refractory period of the neural generators underlying the N100 (Callaway, 
1973; Naatanen and Picton, 1987). This attenuation has often been reported as 
habituation. However, some studies (Barry, Cocker, Anderson, Gordon, & Rennie, 
1992; Budd, Barry, Gordon, Rennie, & Mitchie, 1998) have challenged this, as there 
is no evidence of dishabituation following the change stimulus. These studies suggest 
support for the view that the N100 decrement is due to refractory periods or recovery 
cycle processes of at least two generators contributing to activity in the N100 peak 
latency range. Recovery cycle or refractory cycle effects reflect the dissipation of a 
state of temporal excitability of the N1 generators following their activation by a 
stimulus (Callaway, 1973; Wastell, 1980). It is generally maintained that closely 
spaced presentations of auditory stimuli do not allow adequate recovery of these 
mechanisms and produce a decline in Ni amplitude (Callaway, 1973; Naatanen and 
Picton, 1987). However in direct contrast to this, N100 amplitudes to frequent tones 
(non-targets) in the oddball paradigm have been found to change across the stimulus 
sequence, with larger amplitudes associated with longer trains of frequent stimuli 
(Hermanutz, Chen, & Sommer, 1981; Hirata & Lehman, 1990, Starr, Aguinado, Roe, 
& Michalewski, 1997). This increase in N100 to non-target stimuli with stimulus 
repetition challenges a recovery cycle explanation. 
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Genetic analysis of ERPs suggests that several regions of the human genome 
contain genetic loci related to the generation of N100, in particular the GABA (A) 
receptor (Porjesz et al., 2002; Uraski, Ogura, Hirano, & Tomori, 1994). Additionally, 
increased levels of GABA may affect N100 by reducing the signal that is recorded 
over the prefrontal area of the brain (Winterer et al., 2000) 
2.5.4 N100 in schizophrenia  
Target stimuli 
Reduced N100 amplitude to target stimuli has been found in both medicated 
and unmedicated patients with schizophrenia (Blackwood et al., 1987; Ford et al., 
1994; Ford et al., 1999; Ogura et al., 1991; Pfefferbaum, Wenegrat, Ford, Roth,& 
Kopell, 1984; Pfefferbaum, Ford, White, & Roth,1989; Pritchard, 1986; Roth, 
Horvath, Pfefferbaum, & Kopell, 1980; Roth, Pfefferbaum, Kelly, Berger, & Kopell, 
1981; Roth Goodale, & Pfefferbaum, 1991; Shagrass, Straumanis, Roemer, & 
Armadeo, 1977; Shagrass, Roemer, Straumanis, & Armadeo,1978). It is thus 
unlikely to be solely related to drug effects, despite reports that neuroleptic 
medication reduces N100 amplitude (Baribeau-Braun, Picton, & Gosselin, 1983; 
Pfefferbaum, Ford, White, & Roth, 1989). N100 latency to target stimuli has either 
been found not to differ (Ford et al., 1994; Boutros et al., 1997 Laurent et al., 1998) 
or to be earlier (Ford et al., 2001) for schizophrenia compared to controls. 
Non-target stimuli 
Reduced N100 amplitude to non—target stimuli has also been found in both 
medicated (Pfefferbaum et al., 1984; Roth & Cannon, 1972) and unmedicated 
(Laurent et al., 1999) patients with schizophrenia. Roth and Cannon (1972) further 
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clarified that N100 amplitude was larger for controls only for either target stimuli or 
non-target stimuli that immediately precede a target, but not for the first or second 
non-target that followed a target stimulus. However this study employed an ignore 
condition, with no response required to target stimuli. Studies 2 and 4 (Chapters 5 & 
7) in the current thesis examine these effects in the more commonly used attend 
paradigm in which the subject is asked to respond to target stimuli. 
Ford et al. (1994) found delayed N100 latency to non-targets. Other studies 
have not found significant differences in N100 latency to non-target stimuli in 
schizophrenia (Boutros et al., 1997, Laurent et al., 1999). 
2.5.5 P200 component  
The P200 component may represent inhibition of sensory input from further 
processing (Hegerl & Juckel, 1993; Schupp, Lutzenberger, Rau, & Birbaumer, 1994) 
and is normally associated with automatic stimulus identification and discrimination 
(Lindholm & Koriath, 1985). Although the topography of N100 amplitude to target 
and non-target stimuli is similar, there are differences in topography between target 
and non-target P200 amplitude. This difference appears to result from the distortion 
introduced by the concurrent negative shift of the N200 (Simson, Vaughan, & Ritter, 
1977). Topographically, P200 to non-target stimuli is maximal centrally (Amenedo 
& Diaz, 1998). 
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2.5.6 P200 component in schizophrenia  
The P200 has been reported to be earlier, or larger in people with 
schizophrenia (Pfefferbaum, Horvath, Roth, Tinklenberg, & Kopell, 1980; Roth, 
Horvath, Pfefferbaum, & Kopell, 1980), decreased in some studies (Faux et al., 
1987), but not different in other studies (Ford et al., 1994). No difference in P200 
amplitude and latency to non-target stimuli was found in studies with unmedicated 
patients (Ford et al., 1994; Laurent et al., 1999). However, Ogura et al. (1991) found 
P200 amplitude increased in patients withdrawn from medication. 
2.6 CONCLUSION 
Most oddball research in schizophrenia has focused on the P300 component, 
however both the theoretical and empirical evidence reviewed in this Chapter 
indicate the need to investigate ERPs to non-targets in addition to targets in 
schizophrenia. This evidence emphasizes the necessity for examination of the 
differences between N100 and P200 components elicited by target and non-target 
stimuli in schizophrenia as compared to normal controls. 
3 STUDY 1: ERP COMPONENTS ELICITED BY TARGET AND NON-
TARGET STIMULI IN SCHIZOPHRENIA AND NORMAL CONTROLS. 
The main resultsof this study have been published (Brown et al., 2000, see Appendix 
2 for a copy of the article). A more complete account of the Study and its results is 
presented below. 
3.1 INTRODUCTION 
The review of the oddball ERP literature in schizophrenia in Chapter 2 indicated a 
focus on the robust P300 defict. However the usefulness of this finding as a 
biological marker for schizophrenia is limited by its lack of specificity. Theoretical 
and empirical findings (see Chapter2, 2.5.1 and 2.5.2) provide some support for the 
notion that a comparator disturbance in schizophrenia, leading to a failure to make 
use of context in information processing, might occur 100-200ms post-stimulus and 
consequently would be better captured in the differentiation between target and non-
target ERP components, particularly the earlier N100 and P200 components. ERP 
studies in schizophrenia have focused mainly on the P300 component elicited by 
target stimuli, many restricting their analysis solely to P300. Less attention has been 
given to earlier N100, P200 components to target stimuli and even less to non-target 
stimuli (see Chapter 2, 2.5.4 and 2.5.6). This study investigated deficits in earlier 
components, N100 and P200, to both target and non-target stimuli in schizophrenia, 
in addition to the later components N200 and P300. 
3.2 HYPOTHESES 
a) Between groups, Non-targets 
1. The N100 to non-target stimuli will be reduced and occur later in the 
schizophrenia group. 
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2. P200 amplitude will be reduced or not differ and P200 latency will be earlier, 
to non-target stimuli in the schizophrenia group. 
b) Between Groups, Targets 
1. N100 will be reduced and earlier to target stimuli in the schizophrenia group. 
2. P200 will be increased and delayed to target stimuli in the schizophrenia 
group. 
3. N200 will be reduced and delayed to target stimuli in the schizophrenia 
group. 
4. P300 will be decreased and delayed to target stimuli in the schizophrenia 
group. 
c) Group by Stimulus Contrasts 
1. N100 will be increased and delayed to target compared with non-target 
stimulus in the control but not the schizophrenia group. 
2. P200 amplitude will be increased and prolonged to non-target compared with 
target stimulus in the control but not the schizophrenia group. 
3.3 MET HOD 
3.3.1 Participants  
Forty participants with Schizophrenia (11 females and 29 males; mean age 
35.45 years, range 20 to 53 years) were recruited from hospitals and community 
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centres in Sydney. Each participant was interviewed with Sections G (Schizophrenia 
and other psychotic disorders), M (Organic mental disorders), and P (interviewer 
observations) from the Composite International Diagnostic Interview (CIDI) (World 
Health Organisation, 1992a), resulting in a DSM-IV (American Psychiatric 
Association, 1994) and ICD10 (World Health Organisation, 1992b) diagnosis of 
schizophrenia. Exclusion criteria for both this group and for the normal control group 
were a recent history of substance abuse, epilepsy or other neurological disorders, 
and mental retardation or head injury, assessed using section M from the Composite 
International Diagnostic Interview (World Health Organisation, 1992a) and the 
Westmead Hospital Clinical Information Base questionnaire. After interview, 
schizophrenic symptoms were rated by the participating psychiatrist, using the 
Positive and Negative Syndrome Scale (PANNS) (Kay and Opler, 1987). The mean 
chlorpromazine equivalent for medication in the participants with schizophrenia was 
660.5 ± 636.6 mg. 
Forty control participants (mean age 36.7 years, range 20 to 54 years) were 
drawn from the general population and were age and gender matched to within 5 
years with the schizophrenia group. Control participants were screened for history of 
psychiatric illness (themselves or first degree relative). The Westmead Hospital 
Clinical Information Base questionnaire was also used to obtain demographic 
information for both groups. 
3.3.2 Data Acquisition Procedure 
All participants were asked to refrain from drinking caffeine or smoking for 
at least three hours prior to their recording. Participants were seated in a reclining 
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chair in a quiet, dimly lit laboratory; facing a video screen and wearing a pair of 
headphones (see Figure 3.1). To reduce eye blinks, participants were instructed to 
look at a small dot on a computer screen placed 60 cm in front of them during the 
task. The Study was approved by Western Area Health Service and University of 
Wollongong ethics' committees. 
A conventional auditory oddball paradigm was employed, consisting of 40 
target tones (1500 Hz with 15% probability and 247 non-target (1000 Hz) tones both 
lasting 50ms (with 10ms rise and fall). The tone intensity was 60 dB SPL and the 
interstimulus interval (IR) was 1.3 s. Participants were asked to ignore the low 
pitched (non-target) tones and press two reaction time buttons (with the index finger 
of each hand, to control for possible lateralised effects of motor responding) when 
they identified a high pitched (target) tone. Speed and accuracy of response were 
emphasised equally. EEGs were recorded on a DC based system (Synamps equipped 
with a 16-bit AID converter) from 19 scalp sites (Fp 1, Fp2, Fz, F3, F4, F7, F8,C3, 
C4, Cz, T3, T4, T5, T6, P3, P4, Pz, 01, 02) according to the 10-20 International 
system (Bloom, 1982) in reference to linked-ear electrodes. In this Study analysis 
was restricted to midline sites, while full topography is analysed in Study 2. The 
sampling rate was 250 Hz. A low pass filter was applied to the signals prior to 
digitization. The cut-off of this filter was 50 Hz, with attenuation being 40dB/decade 
above 50 Hz. In addition, a 50Hz notch filter was applied to eliminate 50Hz AC 
mains power supply interference. Horizontal eye movement potentials were recorded 
using two electrodes, placed 1 cm lateral to the outer canthus of each eye. Vertical 
eye movement potentials were recorded using two electrodes, placed on the middle 
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of the supraorbital and infraorbital regions of the left eye. Impedance for all 
electrodes was less than 5 kOhms. 
EOG correction was carried out off line using a standard procedure (Gratton, 
Coles, & Donchin, 1983). Only correctly identified target epochs for which a button 
press response was obtained within one second of the target tone were analysed. 
Averaged ERPs to target stimuli were computed and N100, P200, N200 and P300 
peaks were measured relative to a prestimulus (200ms) baseline by an automated 
system based on the detection of a consistent change in the sign of the gradient of the 
wave form. Thus a change from a consistently positive to a consistently negative 
gradient was identified as a positive peak, and vice versa for a negative peak (Haig, 
Gordon, Rogers, & Anderson, 1995) with the criteria that N100 occurred between 80 
-140ms, P200 between 150-240ms, N200 between 200-280ms and P300 between 
250-500 ms. Peaks thus identified were then verified through visual inspection. N100 
and P200 peaks in averaged ERPs to non-targets before and after were ascertained 
according to the same method. 
Figure 3.1 Picture of a participant, fitted with the electrocap, in the laboratory. 
3.3.3 Analysis  
N100 and P200 amplitudes and latencies were submitted separately to a 3 
way ANOVA repeated measures design, incorporating group (schizophrenia vs. 
controls) by stimuli (target vs. non-target) by electrode site (Fz, Cz, Pz), with 
repeated measures for stimulus and site factors. For the site factor, linear and 
quadratic contrasts were examined, the linear contrast purporting to examine reduced 
amplitudes at parietal sites (Fz vs. Pz) and the quadratic contrast purporting to test 
the frequently observed maximal amplitudes at central sites (Cz vs. Fz + Pz). N200 
and P300 components were reliably observed only to the target stimulus and were, 
therefore, subjected to a two way ANOVA, incorporating group (schizophrenia vs. 
controls) and electrode site (Fz, Cz, Pz) with repeated measures for the site factor. 
Similar linear and quadratic contrasts as above were carried out for the site factor. 
Only results form midline sites are included in this Study, full topography is 
examined in the second Study (Chapter 5). 
3.4 RESULTS 
Average ERPs for midline sites are presented in Figure 3.2 (between-groups) 
and Figure 3.3 (within group). Means and standard deviations for each component 
amplitude and latency appear in Table 3.1. A small percentage (between 1% and 
2.5% in each group) of ERP measures were identified as outliers (greater or less than 
one and a half the interquartile range from the upper and lower quartile). Because 
57 
Tar gets Non-targets 
N100 
P200 
-----Ail i.. --------.... 
—  Control —  Schizophrenia 
-511V 
Fz 
P300 
58 
results remained unchanged following removal of outliers only results based on 
entire dataset (with outliers) is presented here. 
-100 100 300 500 -100 100 300 500 
+5juV +5[±V Milliseconds 
Figure 3.2 Between-Group ERP differences for target and non-target stimuli. 
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Figure 3.3 Within-group ERP differences for target and non-target stimuli. 
Table 3.1 Component means and standard deviations (SD) for control and 
schizophrenia groups to target and non-target stimuli. 
Target Non-target 
Control 
Mean SD 
Schizophrenia 
Mean SD 
Control 
Mean SD 
Schizophrenia 
Mean SD 
N100 Fz -10.01 3.06 -7.11 3.10 -7.99 2.80 -5.35 2.65 
amplitude Cz -11.57 3.68 -7.34 3.36 -9.42 3.41 -5.88 2.61 
Pz -6.48 2.73 -3.74 2.44 -5.41 2.45 -3.33 1.45 
N100 Fz 108.60 13.61 102.70 17.60 100.60 13.24 103.28 13.73 
latency Cz 105.80 10.55 98.78 11.28 99.00 9.26 99.25 8.03 
Pz 103.30 10.57 94.55 13.36 99.40 8.09 99.00 13.01 
P200 Fz 1.17 4.27 2.86 4.61 3.97 3.00 3.33 2.73 
amplitude Cz 0.10 4.28 5.41 5.35 6.45 3.70 5.59 2.74 
Pz 1.93 3.79 4.61 4.03 3.70 3.09 3.40 2.10 
P200 Fz 171.14 16.19 173.35 19.05 204.50 31.02 184.20 24.13 
latency Cz 164.42 15.11 173.88 21.64 209.03 31.27 182.65 21.56 
Pz 161.26 20.38 169.22 33.29 198.63 39.72 179.00 27.82 
N200 Fz -5.28 3.72 -5.08 4.94 
amplitude Cz -7.62 6.52 -2.40 6.46 
Pz -2.62 5.24 0.20 5.76 
N200 Fz 215.85 19.12 227.93 35.50 
latency Cz 210.15 19.29 226.15 40.55 
Pz 202.57 22.50 223.39 40.47 
P300 Fz 9.92 6.45 5.00 5.79 
amplitude Cz 11.18 8.15 10.35 7.13 
Pz 17.38 7.59 15.01 7.14 
P300 Fz 323.33 25.20 327.28 34.23 
latency Cz 322.69 29.21 327.98 49.64 
Pz 334.83 37.50 350.38 48.03 
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3.4.1 N100  
Amplitude 
Main effects were significant for group, F(1,78) = 30.8, p<.001, with the 
schizophrenia group showing reduced N100 amplitude compared with controls, and 
for stimulus, F(1,78) = 58, p<.001, with N100 amplitude for non-target stimuli 
reduced compared to target stimuli. Significant linear, F(1,78) = 130.56, p< .001 and 
quadratic, F(1,78) = 259.51, p<.001 contrasts for the site factor indicated N100 
amplitude was maximal fronto-centrally. The main effect for group was qualified by 
a significant quadratic contrast for Group X Site, F(1,78) = 5.97, p<.01, as the 
between-group difference was maximal at the vertex compared with frontal and 
parietal sites. Significant linear F(1,78) = 21.45, p<.001 and quadratic F(1,78) = 
25.02, p<.001 contrasts, for Stimulus X Site arose as the reduction to non-target 
compared with target N100 amplitude was maximal at fronto-central sites. 
Control  —N— Schizophrenia 
 
Target Non-target 
 
Figure 3.4 N100 amplitude for control and schizophrenia groups, across stimuli, at 
midline sites (left). N100 amplitude to target and non-target stimuli, across group, at 
midline sites 
Latency 
The main effect for group was not significant, F (1,78) = 2.9, p = .09, 
however there was a Stimuli X Group interaction, F(1,78) = 9.8, p<.01, as N100 
latency was significantly delayed for target compared to non-target stimuli for the 
control but not the schizophrenia group (see Figure 3.4). There was a significant 
linear contrast for site, F(1,78) = 16.20, p<.001, with N100 latency prolonged at Fz. 
110 
Control  —N—  Schizophrenia 
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Figure 3.5 N100 latency to target and non-target stimuli, across sites. 
3.4.2 P200 
Amplitude 
Main effects were significant for group, F(1,78) = 5.3, p < .05, with the 
schizophrenia group showing increased P200 amplitude overall, and for stimulus, 
F(1,78) = 16.3, p <.001, with P200 reduced to target compared with non-target 
5- 
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stimuli. There was a quadratic contrast for site, with P200 maximal at Cz compared 
with Fz and Pz. These main effects were further qualified by a significant Group X 
Stimulus, F(1,78) = 19.8, p < .001, Group X Site (quadratic contrast), F(1,78) = 10.0, 
p<.01 and Group X Stimulus X Site (quadratic contrast), F(1,78) = 22.69, p<.001, 
interactions. Whereas the schizophrenia group responded similarly to target and non-
target stimuli, normal controls responded differentially with decreased P200 to target 
compared with non-target stimuli, with this difference most marked at Cz (see Figure 
3.6). 
Control 7 Schizophrenia 
6- 
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Tar get Non-tar get Tar get Non-tar get 
Figure 3.6 P200 amplitude to target and non-target stimuli. 
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Latency 
Main effects were significant for group, F(1,78) = 5.2, p<.05 with the 
schizophrenia group demonstrating earlier P200 latency overall; for stimulus, F(1,78) 
= 53.2, p<.001, with a delay to non-target stimuli compared with target stimuli; and 
for site with a significant linear contrast, F(1,78) = 6.34, p<.05, which was maximal 
fronto-centrally. The Group X Stimuli interaction, F(1,78) = 18.77, p<.001, for P200 
latency, arose because there was a pattern of prolonged P200 latency for non-target 
compared with target stimuli for the control but not the schizophrenia group, which 
resulted in an earlier P200 latency to the non-target stimulus for the schizophrenia 
compared with controls (see Figure 3.7). 
220 - Control  —N—  Schizophrenia 
210 - 
  
200 - 
190 - U 
170 - 
  
   
160 - 
Target Non-target 
Stimulus 
Figure 3.7 P200 latency to target and non-target stimuli. 
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3.4.3 N200  
Amplitude 
The main effect for group was significant, F(1,78) = 6.9, p = .01, with N200 
amplitude reduced for the schizophrenia group. Significant linear, F(1,78) = 39.5, p 
< .001, and quadratic, F(1,78) = 18.12, p < .001, contrasts for site, indicated a fronto-
central maximum for N200 amplitude. These main effects were further qualified by 
significant Group X Site linear, F(1,78) = 4.29, p<.05, and quadratic F(1,78) = 18.97, 
p<.001, contrasts. In sum, as compared with the normal controls, the schizophrenia 
group produced reduced N200 amplitudes, with this reduction being specific to 
central and parietal sites. 
Latency 
The main effect for group was significant, F(1,78) = 7.2, p<.01, for N200 
latency, with the schizophrenia group delayed overall. A significant linear contrast 
for site, F(1,78) = 7.55, p<.01, indicated that N200 latency was prolonged at Fz 
compared with Pz for all subjects. 
3.4.4 P300  
Amplitude 
The main effect for group was significant, F(1,77) = 4.4, p<.05, with P300 
amplitude reduced overall in the schizophrenia group. There were also significant 
linear, F(1,77) = 119.4, p<.001, and quadratic, F(1,77) = 7.87, p<.01, contrasts for 
site, with P300 amplitude maximal at centro-parietal sites for all subjects. These 
main effects were further qualified by a Group X Site quadratic contrast, F(1,77) = 
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13.03, p‹.001, as the reduction in P300 amplitude for the schizophrenia group was 
maximal frontally and parietally compared with the vertex (See Figure 3.8). 
Control —N— Schizophrenia 
Figure 3.8 P300 amplitude for schizophrenia and control groups at midline sites. 
Latency 
Effects were not significant for group. For site, there were significant linear, 
F(1,77) = 11.68, p<.001, and quadratic, F(1,77) = 5.68, p‹.05, contrasts 
demonstrating prolonged latencies at parietal compared with fronto-central sites for 
both groups. 
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3.4.5 Response Time  
The schizophrenia group had a mean RT of 384ms (SD = 90ms) which was 
significantly slower, t (1,76) = -4.43, p <.001, than the control group, with a mean 
RT of 309ms (SD = 50ms). 
3.5 DISCUSSION 
Few studies have examined ERPs to non-target stimuli or systematically 
focused on components prior to the P300 complex. This Study was primarily 
designed to examine differences in ERP components to target and non-target stimuli 
in patients with schizophrenia and age and sex matched controls. The results indicate 
significant group differences in early components to target and non-target stimuli 
validating this approach. Earlier components may not be as conspicuous as the larger 
P300, nevertheless reliable differences between groups emerged. The Study of ERPs 
elicited by target and non-target stimuli together has an additional advantage, as 
relational and interactive mechanisms between the two categories of stimulus can be 
examined. As hypothesised, the schizophrenia group responded similarly to the two 
stimuli, in comparison to the normal controls, who differentiated between the two 
stimuli on the N100 and P200 components. 
The N100 amplitude deficit to non-target stimuli, across midline sites, in the 
schizophrenia compared to the control group, is consistent with previous studies with 
attend (Pfefferbaum, 1984; Laurant et al., 1999) and ignore (Roth & Cannon, 1972) 
instructions. The schizophrenia group also demonstrated earlier P200 latency to non-
target stimuli, across midline sites, compared to controls as hypothesised. The 
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hypothesised decrease in P200 amplitude to non-target stimuli in the schizophrenia 
compared with control group was not found. 
Consistent with previous literature (see Chapter 2), that focused on processing 
task relevant target stimuli, the patient group showed a decreased and earlier N100 
amplitude (associated with attention) to target stimuli across midline sites, increased 
P200 amplitude to target stimuli maximal at the vertex, (associated with decision 
making), reduced and delayed N200 latency centro-parietally (associated with 
response selection) and diminished P300 amplitude frontally and 
parietally(associated with the context of information processing) which was also 
delayed parietally. The relational and interactive mechanisms between target and 
non-target stimuli are best reflected in the group by stimulus analyses. With the 
exception of N100 amplitude, the schizophrenia group did not differ in the way they 
responded to target and non-target stimuli. The normal controls, however, did 
differentiate, with delayed N100 latency and an earlier and reduced P200 to target 
compared to non-target stimuli. In the schizophrenia group N100 latency and P200 
amplitude and latency to both target and non-target stimuli resembled the control 
group's response to non-target stimuli. The hypothesised group difference for within 
group N100 amplitude effects was not found as both groups showed reduced N100 
amplitude to non-target compared to target stimuli. 
The pattern of ERP response in the patient group therefore, was firstly 
diminished N100 to both non-target and target stimuli, reflecting globally diminished 
aspects of attention. Secondly, the earlier P200 response to non-target stimuli in 
patients, was enhanced in amplitude and delayed when processing target stimuli. 
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This may suggest that for nontarget stimuli there was a premature closure of decision 
making (reflected in earlier P200 latency), whereas for target stimuli there was an 
increased network activation (reflected in increased amplitude) and a consequent 
delayed speed of processing (reflected in P200 latency) in the patient group. 
However, it is difficult to disentangle target P200 amplitude and latency differences 
from the influence of the overlapping N200 component, and it is possible that these 
between-group P200 changes are influenced by differential N200 responses to the 
target stimuli. 
This disturbance in the processing of target and non-target information is 
consistent with single trial P300 findings (Ford et al. 1994; Roschke et al., 1996), 
and with the Gray-Hemsley model, in which misattributions in the 
"match:mismatching" are proposed to underlie the positive symptoms in 
schizophrenia. Precisely how this misattribution effects subsequent information 
processing is not known. However, it may modulate the delay in N200 latency, and 
the decrease in processing the context of target information (as reflected in this Study 
and numerous other studies by decreased P300 amplitude). This would be consistent 
with Broadbent's (1958) suggestion that early stages of processing may lead to later 
dysfunctions. 
This potential disturbance in selective processing of relatively relevant and 
irrelevant information is also consistent with an entirely different body of research. 
Positron emission tomography (PET) studies suggest that the anatomical circuitry 
involved in extracting relevant and filtering irrelevant information, particularly 
involves the pulvinar nucleus of the thalamus (Posner and Dehaene, 1994), and there 
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is some evidence that these circuits may be impaired in schizophrenia (Andreasen et 
al., 1994). These networks overlap with those suggested by Gray (1998), where 
familiar non-targets (match) and novel targets (mismatch) engage the reticular 
nucleus of the thalamus, but, thereafter, familiar stimuli activate ongoing processes 
in the basal ganglia, whereas novel stimuli activate the cingulate and exploratory 
processing networks. 
These psychophysiological findings may also be linked to disturbances in 
neurochemistry. For example, there is a body of evidence linking dopamine 
hyperactivity to schizophrenia (Gray, 1991). Dopamine is thought to suppress 
spontaneous neural firing while enhancing the capacity of neural systems to increase 
activity in response to a specific stimulus or task (Foote and Morrison, 1986; Cohen 
and Servan-Schreiber, 1993). In addition, dextroamphetamine (indirect monoamine 
agonist) has been found to 'focus' neural activity that is specific for a particular task 
(Mattay et al. 1996). 
However, these results are preliminary and raise several issues which need to 
be clarified. Firstly, this Study averaged all non-target stimuli together, however, 
there is evidence that non-target stimuli immediately before the target stimuli (T-1), 
and non-target stimuli immediately following the target stimuli (T+1), are processed 
differently (Hirata & Lehman, 1990) and that this process may be disturbed in 
schizophrenia (Roth and Cannon, 1972). It would be important to investigate these 
results with non-target stimuli subaveraged for T-1 and T+1 stimulus, as differences 
between N100 amplitude to target and non-target stimuli may have been obscured by 
averaging in this Study. Computing averaged ERPs to non-target and target stimuli 
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regardless of their sequential position (e.g. number of preceding target or non-target 
stimuli) obscures systematic ERP effects that may be observed when sequences are 
sorted and averaged separately (e.g., non-target following a target stimuli versus non-
target preceding a target stimuli) according to their sequential position Secondly, the 
duration of illness ranging from 1 to 33 years, for patients in this Study, may have 
obscured changes in deficits with age and chronicity. It would be important to 
establish that these deficits are present at onset of illness, and are not a product of 
chronicity. Several other factors which could interact with these results and would 
also be important to investigate are the interaction of ERP results with symptom 
factors, the differential effects of aging and gender on ERPs in schizophrenia and 
normal controls, and an extension of analysis from midline sites to full topography. 
The sensitivity and specificity to schizophrenia of N100 and P200 to target and non-
target stimuli in comparison with P300 amplitude also need to be demonstrated. 
These issues are explored in the following Chapters. Chapter 4 evaluates the existing 
literature and Study 2 (Chapter 5) is an empirical investigation (with the exception of 
specificity which is explored in Study 4 [Chapter 7]) of these issues. 
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4 BACKGROUND AND RATIONALE TO STUDY 2 
4.1 ERPs AT FIRST ONSET OF ILLNESS VERSUS CHRONIC SCHIZOPHRENIA 
Although numerous studies have found deficits in the ERPs of patients with 
schizophrenia to target stimuli, and in a smaller number of studies to non-target 
stimuli (reviewed in Chapter 2), most of these studies investigated ERPs in chronic 
patients. An important emerging issue is whether these deficits are trait-like, and 
therefore present at the onset and throughout the developmental course of illness, or 
whether they are markers of chronicity (Salisbury et al., 1998; Ford, 1999; Frodl-
Bauch, Meisenzahl, Galinat, Hegerl, & Moller, 1998; Mathalon, Ford, & 
Pfefferbaum, 2000; Blackwood, 2000), This is significant because ERP deficits 
observed in patients with chronic schizophrenia may be secondary to chronic 
morbidity, neuroleptic medication, or other effects associated with chronic mental 
illness such as hospitalisation. If established as a trait, ERP deficits would be most 
useful in identifying "at risk" individuals, in addition to providing potential for the 
implementation of preventative strategies, and provide a useful endophenotype for 
genetic investigation. 
There is some evidence suggesting that reduced P300 amplitude is a stable trait 
marker in schizophrenia (Mathalon et al., 2000; Blackwood, 2000), with findings of 
genetic association (Blackwood et al., 2001; Weisbrod, Hill, Niethammer, & Sauer, 
1999). However, other results have not been consistent with these findings. For 
example, in one study, P300 amplitude reduction wasn't found in undiagnosed 
family members of people diagnosed with schizophrenia (Friedman, Cornblatt, 
Vaughan, & Erlenmeyer-Kimmling, 1988) nor was it found to be predictive of 
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subsequent schizophrenic breakdowns (Squires-Wheeler, Friedman, Skodol, & 
Erlenmeyer-Kimmling, 1993). Because of the relatively low incidence of 
schizophrenia, even among relatives of those diagnosed with schizophrenia, in the 
Squires-Wheeler et al. study, as might be expected, there were no more than 6 
participants classified as having a schizophrenia-like breakdown and only one met all 
criteria for schizophrenia (this participant's P300 amplitude was reduced one and a 
half standard deviations below the mean for the normal group). These findings 
highlight the need for further confirmation, and for alternative methods to determine 
whether ERP deficits observed among chronic schizophrenics are trait-like. One such 
method, included in Study 2 (Chapter 5) comprises a cross-sectional comparison of 
ERP deficits early (at first presentation) and late (chronic schizophrenia) in the 
developmental course of schizophrenia. 
There have been few studies investigating auditory oddball ERP deficits in 
people with FESz. Two studies specifically investigated patients at first admission 
(Demiralp et al., 2002; Salisbury et al., 1998) and a further study (Hirayasu et al., 
1998) also included patients whose schizophrenia illness had occurred within one 
year. All three studies found reduced P300 amplitude, however there were 
topographical differences between their results. Salisbury et al. found reduced left 
temporal P300, while Hirayasu et al. and Demiralp et al. found a marked frontal and 
modest parietal P300 reduction. Of these studies, two (Demrilap et al. & Hirayasu et 
al.) also examined the N200 component and found both N200 and P300 latencies 
prolonged in the FESz participants compared to normal controls. Medication status 
and electrode sites are two factors which may have influenced the different 
topographical findings. Participants in the Salisbury et al., study were medicated 
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while participants in the other two studies were unmedicated. The Hirayasu et al. 
study used T5/T6 electrode sites for their lateral comparison instead of the T3/T4 or 
TCP1/TCP2 at which left lateralised deficits are usually found (see 4.4). Although 
the nature of the response required to the target is often considered to affect 
topography, with the left lateralised deficit more commonly found in the count, than 
button press response (see 4.4), it is unlikely that response was a confounding factor 
in this case as all three studies used count rather than button press responses to the 
target. Other task parameters such as ISI and probability were also consistent across 
studies and therefore unlikely to affect responses. 
Two of these studies did not have large samples, Salisbury et al. with 14 
medicated and Demrilap et al., with 12 unmedicated FESz participants, and all three 
restricted analysis, either to P300 alone (Salisbury et al.) or to N200 and P300 
(Demrilap et al. & Hirayasu et al.). 
The limitation of these studies to N200 and P300 components, combined with 
the N100 and P200 component deficits to target and non-target stimuli, found in 
Study 1 (Chapter3) highlight the need for further investigation of ERPs in FESz. 
Notably, no studies have examined ERPs to non-target stimuli in FESz. A direct 
comparison of ERPs in first episode and chronic schizophrenia in a substantial 
sample, as in Study 2, provides an opportunity to investigate the differences between 
ERPs at different time points during the course of schizophrenia, i.e. at onset and 
when illness has become chronic. 
75 
The conceptualisation of schizophrenia as a neurodevelopmental disorder and 
the notion that ERPs might be a biological marker for the condition, suggests that the 
normal ontogeny of the ERP will be distorted in subjects with schizophrenia. In 
Study 2, this question of predominantly neurodevelopmental, as against later 
neurodegenerative change in the cortex, is examined by two methods. The first 
method is to compare ERP components between both a FESz group and their age and 
sex matched controls and a chronic schizophrenia group with their controls, to 
determine if the pattern of deficits found in chronic schizophrenia is present at first 
onset. The second combines the first episode and chronic groups into one 
schizophrenia group spanning adolescence to late middle age and similarly combines 
the younger and older control groups. ERP components from each group are 
correlated with age, to see if the patterns of age effects differ in the schizophrenia 
group compared to the control group. This will point to whether changes in ERPs are 
completed at the time of first presentation, thereby providing some support for the 
neurodevelopmental hypothesis, or continue to change over time, providing support 
for a neurodegenerative hypothesis. 
4.1.1 Age effects on target and non-traget ERP components  
The effects of age on the auditory oddball ERP in the normal population have 
been explored in a number of studies discussed below. 
N100 component 
Amplitude 
Reports of the effect of age on N100 amplitude have been inconsistent. The 
relationship between N100 and age appears to vary depending upon the stimulus, 
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with age effects maximal for non-target compared to target stimulus. In a number of 
studies no relationship between age and N100 amplitude to target stimulus has been 
found in younger people aged 7-20 years (Johnson,1989), 4-21 years (Fuchigami et 
al., 1993) and 11-18 years (Friedman, Brown, Vaughan, & Erlenmeyer-Kimling, 
1984). However, in another study, N100 amplitude to targets was found to increase 
with age in a group 5-19 years (Ladish & Polich, 1989). In adult populations, N100 
amplitude to target stimuli has also generally been unchanged in groups aged 18-70 
(Bahramali et al., 1998) and 20-79 (Picton, Stuss, Champagne, & Nelson, 1984). 
Decreased N100 amplitude with age was found in a group aged 18-85 years 
(Syndulko et al., 1982). 
In contrast to target stimuli, N100 amplitude to non-target stimuli has 
generally been found to increase with age (Anderer, Semlitsh, & Saletu, 1996; Ford 
& Pfefferbaum, 1991 Pfefferbaum, Ford, Wenegrat, Roth, & Koppell, 1984), 
although one study reported no effect of age a group 18-82 years (Iragui et al., 1993). 
Several studies (Anderer, Semlitsh, & Saletu, 1996; Ford & Pfefferbaum, 
1991 Pfefferbaum, Ford, Wenegrat, Roth, & Koppell, 1984; Iragui et al., 1993; 
Picton et al., 1984) have examined the effects of age on N100 amplitude topography. 
These studies have indicated that topography remained stable over age. 
Latency 
N100 latency appears to become earlier with increasing age in the child and 
adolescent age range, but not in the adult age range. N100 latency to target stimuli 
has been reported to be earlier with age in groups 4-21 years (Fuchigami et al., 
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1993), 8-16 years (Tonnquist-Uhlen, Borg, & Spens, 1995) and 5-19 years (Ladish & 
Polich, 1989). In adults, N100 latency to target stimulus does not show any 
significant age effects for 17-80 years (Coyle, Gordon, Howson, & Meares, 1991) 
15-80 years (Brown, Marsh, & La Rue, 1983) and 18-70 years (Bahramali et al., 
1999). 
Despite one study to the contrary (Amenado and Diaz, 1998), N100 latency 
to non-target stimuli, on the other hand, has generally been reported to increase with 
age in a group aged 18-82 (Iragui et al., 1993) or to show increase at temporal, but 
not central sites in a group aged 20-88 years (Anderer et al., 1996). 
P200 component 
Amplitude 
Age changes in P200 amplitude to target stimuli have generally not been 
found in child or adult groups. P200 amplitude showed no significant change with 
age for subjects aged 7-20 years (Johnson, 1989), 11-18 years (Freidman et al., 
1984), 18-70 years (Baharamali et al., 1999) and 20-79 years (Picton et al., 1984). 
However, a reduction in amplitude has been reported for ages 18-80 (Smith, 
Michalewski, Brent, & Thompson, 1980) and for ages18-85 (Syndulko et al.1982). 
In contrast to target stimuli, P200 amplitude to non-target stimuli has been 
found to increase with age in ages 20-80 (Anderer, Semlitsh, & Saletu, 1996) and 20-
86 (Amenedo and Diaz, 1998). Topographic distribution changes evident include 
higher amplitudes in parietal compared to frontal regions in young subjects, whereas 
in the elderly the reverse was evident (Anderer et al.). Both these studies had large 
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sample sizes, with 172 subjects (Anderer et al.) and 73 (Amendeo & Diaz). However 
no effect of age was reported from 18-82 years in both target and non-target stimuli 
by Iragui et al. (1993) with a sample size of 71. 
Latency 
P200 latency to target stimuli has been found to decrease with increasing age 
in young people aged 5-19 years (Ladish & Polich, 1989), but to either increase with 
age to non-target stimuli in adult groups (Goodin, Squires, Henderson, & Starr, 1978; 
Polich et al., 1995) or show no difference (Brown et al., 1983) with age. Anderer et 
al. (1996) have suggested that the delay may depend on the site, occurring at anterior 
but not posterior sites because in his study found that P200 was earliest at Fz in the 
elderly but was delayed at Fz in the young group. 
N200 component 
Amplitude 
N200 amplitude to target stimuli has been found to decrease with increasing 
age in young groups 5-19 years (Ladish & Polich, 1989) and 4-16 years (Enoki et al., 
1993). However, Fuchigami et al. (1993) failed to find a decrease in a group 4-21 
years. The amplitude of N200 has also been reported to be decreased in adults aged 
18-82 years (Iragui et al., 1993), and 20-88 years (Anderer et al., 1996) or unchanged 
(Amenedo et al., 1998; Brown et al., 1993; Picton et al., 1984) with age. 
Latency 
N200 latency has been reported to decrease with age in groups 4-21 years 
(Fuchigami et al. 1993) and 5-19 years (Ladish & Polich, 1989). Enoki et al., (1993) 
reported a significant decrease in children and adolescents (9.03 msec/year) reaching 
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its minimum latency at age 16, and then changing to a slight but significant increase 
in latency with age (0.97ms/year) through to 77 years. In adult groups N200 latency 
has been found to be prolonged with age in many studies; with an increase in latency 
of .065msec/year from 20-79 years (Picton et al., 1984); 0.8msecs/year from 16-76 
years (Goodin et al., 1978), 0.58 msec/year (Iragui et al.), 0.25msec/year from20-88 
(Anderer et al., 1996). 
P300 component 
Amplitude 
The relationship between age and P300 amplitude has been inconsistent in 
studies with young people, which may reflect the possibility that changes in 
probability and other task demands may interact with age to affect results. For 
example, a decrease in P300 amplitude at Pz from 7-20 years (1.11 µv/year) has been 
found in a reaction-time version of the oddball task, but not in the count version of 
the oddball task (Johnson, 1989). P300 amplitude increased from 4-20 years at Fz 
(4.6 µv/year, Cz (2.6 µv/year) and Pz (4.1 µv/year) in a low probability condition 
(10% target) and at Pz only (8.4 liv/year) in a high probability condition (30% target) 
in a study using finger movement to respond to the target stimulus (Polich, Ladish, & 
Bums, 1990). No age effects on P300 amplitude were found in a group aged from 4-
21 years using a button press response (Fuchigami et al., 1993) 
In studies with adults, decreases in P300 amplitude with increasing age have 
been found in a number of studies. For example, a decrease of 0.18 µv/year from 20-
79 years (Picton et al., 1984); 0.15 jay/year from 15-80 years (Brown et al., 1983); 
0.1 jay/year from 18-82 years, (Iragui et al., 1993); and 0.47 V from 20-88 years 
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(Anderer et al., 1996). This relationship may also interact with gender as Amendio 
and Diaz (1998) found that age affected P300 amplitude in men, but not in women. 
P300 amplitude has also been found to be more frontally oriented with age in some 
studies (Anderer et al., 1996; Ford & Pfefferbaum, 1991; Picton et al., 1984). 
Latency 
P300 latency has been consistently found to increase with age. This effect has 
been found amongst studies that included young (6-15 years, Goodin et al., 1978; 6-
23 years, Martin, Barajas, & Fernandez, 1988), or adult (Iragui et al., 1983; Picton et 
al., 1984) subjects only, and in studies including both young and adult populations 
(5-86 years Polich, Howard, & Starr, 1985). With regard to this slowing of P300 
among adults, delays from 0.53 to 2.45 msec/year have been found as follows: for 
example, an increase of 1.36 msec/year from 20-79 years (Picton et al., 1984), 1.8 
msec/year from 16-76 (Goodin et al., 1978), 2.45 msec/year from 18-90 years 
(Pfefferbaum et al., 1984), 0.53 msec/year for subjects over 45 years (Brown et al., 
1983), 0.80 msec/year from 18-82 years (Iragui et al., 1993), 0.92 msec/year from 20 
-88 years (Anderer et al.,1996) and 0.82 msec/year from 20-86 (Amenedo & Diaz, 
1998) . Accelerated rates of slowing have also been reported in elderly subjects aged 
from 70-88 years and also in subjects 63 years of age and over (Gordon, Kraiuhin, 
Stanfield, Meares et al., 1986). 
Summary of age effects on ERPs 
To summarise, the effects of increasing age on ERPs to non-target stimuli are: 
an increase and delay in N100 amplitude and an increase in P200 amplitude. The 
effects of increasing age on ERPs to target stimuli are: earlier P200 latency to target 
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stimuli, an initial decrease in childhood, till around 16 years, and then decrease in 
adulthood of N200 amplitude; a prolongation of N200 latency; and a decrease and 
delay in P300. 
4.1.2 Gender effects on ERPs to target and non-target stimuli  
Attempts to explain and integrate the heterogeneity of research findings in 
schizophrenia have mostly focussed on symptom factors (see Chapter 4.2). An 
additional approach is the examination of gender differences (See Chapter 1.2.1) 
suggesting that men and women are prone to different subtypes (Castle & Murray, 
1993; Goldstein, Santangelo, Simpson, & Tsuang, 1990; Murray, O'Callahan, Castle, 
& Lewis, 1992). 
Few studies have examined gender effects on ERPs in schizophrenia. ERP 
studies (Hirayasu et al., 1998; Josiassen, Roemer, Johnson, & Shagrass, 1990; 
Turetsky, Colbath and Gur, 1998) which have found gender differences, suggest that 
it may not be sufficient to control for gender by matching control and patient 
participants, as the effects of gender may be different in schizophrenia. For this 
reason, Study two has examined the gender differences found in control and 
schizophrenia groups to see if there is a different pattern in the schizophrenia group 
compared to the control group. Turestsky et al., for example, found differences in the 
profile and severity of P300 deficits for men and women with schizophrenia, with 
women showing greater left temporal and frontal P300 deficits while men had 
greater right parietal P3 deficits. This pattern of gender differences was not found in 
the control group. Hirayasu et al. included gender as a factor in the analysis of N200, 
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P300 components, and found earlier N200 latency in females compared to males in 
the control and medicated schizophrenia group, but not in a neuroleptic naïve group. 
In addition, increased P300 amplitude in females compared to males in both clinical 
and control groups was evident. Even in normal groups, ERP gender differences 
have not been clearly explicated. Again the focus has been on gender effects on the 
P300 component, with males having a reduced (Deldin, Duncan, & Miller, 1994; 
Hoffman & Polich, 1999; Polich & Geissler, 1991 although see Shelton, Hartmen, & 
Allen, 2002) and prolonged (Deldin et al., Golgeli et al., 1999; Polich, Burns, & 
Bloom, 1988; Shelton et al., 2002) P300 component compared to females. These 
findings highlight the need to explore the modulatory effects that gender may have 
on ERPs in first episode and chronic schizophrenia 
4.2 EFFECTS OF SEQUENTIAL POSITION OF NON-TARGETS ON ERPs. 
ERPs are averaged to increase the signal to noise ratio of small stimulus 
related responses from the background EEG activity. The underlying assumption is 
that the response elicited by all occurrences of an event (e.g., either target or non-
target stimuli) are identical or of little consequence. However, this assumption has 
been challenged by findings of systematic trial to trial variations in response to both 
target and non-target stimuli (Squires, Wickens, Squires, & Donchin, 1976; 
Hermanutz, et al., 1981). Typical analyses of ERPs elicited by target and non-target 
stimuli averages obscure these variations. Study 2 will examine the relationship 
between certain specific sequence effects and non-target stimuli and Study 3 
(Chapter 6) will examine the sequence effect of preceding stimuli on ERPs elicited 
by targets. 
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In non-target sequence studies the non-target immediately before and after 
the target stimuli are referred to with various nomenclatures. For simplicity of 
expression the terminology used by Starr, Sandroni and Michalewski, (1995) will be 
followed in this thesis, with the non-target immediately preceding the target referred 
to as T-I and the non-target immediately following the target referred to as T+I. 
ERPs may be influenced by the momentary brain state at stimulus presentation 
(Ban-y, de Pascalis, Hodder, Clarke, & Johnstone, 2003; Basar, Basar-Eroglu, Rosen, 
& Schutt, 1984), which in turn may be affected by the category of the previous 
stimuli (target or non-target, match or mismatch). For example, the processing of a 
target stimulus may activate additional, transient neural processes that operate on 
T+1 stimuli (Hirata & Lehman, 1990). There is also the possibility of a difference in 
preparedness associated with the predictability of the T+1 stimulus, in those oddball 
designs in which a target stimulus is always followed by a non-target stimulus, either 
by constraint or by nature of the low probability of target stimuli. In this case 
efficient information processing would involve reduced allocation of attention to a 
stimulus known to occur at a particular position, T+1, while there would be more 
active processing of the more salient T-1 stimulus which could be either a target or 
non-target stimulus. 
Non-target sequence effects have also been investigated according to the 
number of preceding non-target stimuli (Hermaneutz et al., 1981) with results 
showing that N100 amplitude increases with an increasing number of preceding non-
targets. This is an intriguing finding when contrasted with habituation findings in 
N100 amplitude (Budd, Barry, Gordon, Rennie, & Mitchie, 1998; Fruhstorfer, 1971; 
Ritter, Vaughan, & Costa, 1968). However, whereas habituation studies generally 
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have task instructions to ignore the stimuli, the non-target sequence results have been 
found with paradigms in which a response to target stimuli is required. The 
increasing N100 amplitude with the number of preceding non-targets could thus 
reflect progressively increasing vigilance for the target stimulus. 
In Study 2, ERPs to both T-1 and T+1 stimuli are averaged seperately. The 
Gray-Hemsley model and other conceptualisations of schizophrenia as a failure to 
make use of context in information processing (Chapter 1) would suggest that the 
preparedness for the T+1 stimulus would be impaired in participants with 
schizophrenia, as they would fail to make use of previous regularities, i.e. that a 
target is always be followed by a non-target to make redundancies in information 
processing. 
Empirically, in the few studies in which ERPs to non-target stimuli have been 
sub-averaged according to their temporal position to the target stimuli (immediately 
preceding or immediately following) significant differences have been found in 
normal samples (Hirata & Lehman, 1989; Roth & Cannon,1972; Starr, Sandroni, & 
Michalewski, 1995; Starr, Aquinaldo, Roe and Michalewski,1997). In each of these 
studies the target stimulus was always followed by a non-target stimulus. These 
studies found N100 amplitude (or its equivalent maximal potential range in the 
Hirata and Lehman study) reduced to T+1 compared to T-1 stimuli in normal 
subjects. However the Starr, Aguinaldo et al. study only found N100 reduced to T+1 
in button press, but not count response condition; while Hirata & Lehman found a 
reduction with mental count. However, this reduction was not present in a 
schizophrenia group (Roth & Cannon) or in a group with Alzheimer's disease or 
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their elderly controls (mean age 66.3 1.6; Golob & Starr, 2000). The N100 
component to T+1 was also delayed in latency, and decreased in global field power 
and current source density compared with the T-1 N100 (Hirata & Lehman). 
Compared to the T+1 stimulus, the T-1 P200 component was reduced in 
amplitude (Starr, Aguinaldo et al., 1997) and occurred earlier. Starr, Sandroni et al. 
(1995) found a pre-stimulus negative shift (RP) and P300 component to T-1 stimuli, 
which were both absent to T+1 stimuli and T-1 P50 amplitude was reduced 
compared to T+1 stimuli. Hirata and Lehman (1990) concluded that an average of all 
non-target stimuli should be avoided as they involved distinctly different ERP 
characteristics, which the authors interpreted as manifestations of different brain 
states. 
The reduction in N100 amplitude to T+1 compared with T-1 stimulus in 
normal subjects was consistent across studies, despite differences in task instructions 
and analyses. For example, in the Roth & Cannon study the instructions were to 
ignore the stimuli as much as possible while the remaining studies all required a 
response to the target stimuli, Starr et al. (1995,97) compared two response 
conditions (button press and count) and the Hirata & Lehman (1990) study used a 
mental count response. 
4.3 SENSITIVITY OF ERP DEFICITS FOR SCHIZOPHRENIA 
Research has demonstrated a widely reproducible, reduced P300 amplitude in 
schizophrenia (Ford, 1999; Jeon & Polich, 2000; Pritchard, 1986). Previous 
literature has focused on the sensitivity of the P300 component in schizophrenia, the 
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classification of patients with schizophrenia from normal controls. For example, 
Ford, Pfefferbaum & Roth (1992) established criterion P300 amplitude, above which 
a diagnosis of schizophrenia may be excluded. Most have focused on P300 amplitude 
to the target stimulus. Boutros et al. (1997) however, found that non-target N100 and 
P200 components were also sensitive measures and recently Ford (2001) proposed 
that N100 amplitude reduction to target and non-target stimuli may not only be 
sensitive for schizophrenia, but may also have greater specificity (i.e. the extent to 
which this deficit is not present in persons without schizophrenia, in including those 
with non-schizophrenic psychiatric disorders) for schizophrenia than P300 reduction. 
In that study, while P300 amplitude was sensitive to schizophrenia-like symptoms 
found both in schizophrenic and in epileptic patients with interictal chronic 
schizophrenia-like features, only N100 amplitude reduction was specific to those 
symptoms in schizophrenia. 
Study 2 investigates the sensitivity of the N100 and P200 components elicited 
by non-targets and targets and compares this to the P300 component to targets in 
discriminating chronic schizophrenia and FESz groups from their respective normal 
control groups. It can be seen that the rationale for examining whether discriminant 
function analysis of N100 and P200 components to target stimuli and non-target 
stimuli, separately to T-1 and T+1 stimuli shows greater sensitivity for schizophrenia 
than P300 amplitude includes both theoretical and empirical reasons. The results of 
Studyl (see Chapter 3) indicate that there is a reduced difference between target and 
non-target N100 and P200 scores in a schizophrenia group. The results of Roth and 
Cannon's early study demonstrated reductions in N100 amplitude to T+1 compared 
with T-1 stimuli in normal control subjects but not in schizophrenia. There is also a 
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theoretically based prediction that there would be reduced processing of T+1 
compared withT-1 stimuli in normal controls but not in schizophrenia. 
4.4 ERP TOPOGRAPHY IN SCHIZOPHRNEIA 
Topographical variations in ERP component measures in schizophrenia may 
have diagnostic (Gruzelier et al., 1999; Maurer, Riederer, Heinsen, & Beckmann, 
1989; Salisbury, Shenton & McCarley, 1999; Weir, Fiaschi & Machin, 1998) and 
pathophysiologic (McCarley et al., 1989, 1993,; O'Donnell et al., 1995, 1999) 
significance. Most studies of ERP topography in schizophrenia have restricted their 
investigation to the topography of the P300 component with several studies showing 
a left lateralised amplitude reduction in schizophrenia compared to normal controls 
(e.g., Faux et al., 1990, 1993; Faux, Torello, McCarley, Shenton, & Duffy, 1988; 
Morstyn, Duffy, & McCarley, 1983; Potts, Hirayasu, O'Donnell, Shenton & 
McCarley, 1998; Salisbury, Shenton, & McCarley, 1999). This has also been found 
to be present at first onset by some studies (Demiralp et al., 2002; Salisbury et al., 
1998). However, the robustness of these findings is challenged by other studies 
which have not found this difference (Ford et al., 1994; 2000; Hirayasu et al., 1998; 
Iwanama et al., 2002; Pfefferbaum, Ford, White, & Roth, 1989). 
There are several possible explanations for the variable findings. A meta-
analysis of 11 topographic studies of P300 amplitude elicited by the auditory oddball, 
in schizophrenia, indicated the importance of electrode site placement with greater 
effect sizes found using TCP1/TCP2 sites than T3/T4 (Jeon &Polich, 2001). Task 
requirements have also been found to influence results with inter-hemispheric 
differences more prevalent in tasks requiring silent counting of targets compared to 
button press. However, investigations comparing button press and count in the same 
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schizophrenia and normal control groups have been conflicting. For example, Ford, 
Mathalon, White and Pfefferbaum (2000) did not find smaller P300s over the left 
(T3) than over the right (T4) lateral scalp in the schizophrenia group, in both button 
press and silent count, while Salisbury, Rutherford, Shenton , McCarley (2001) 
found left lateralised deficit in the silent count condition, but not in the button press 
condition in another schizophrenia group. Turetsky et al. (1998) demonstrated a left 
temporal deficit in schizophrenia, using the button press. Stimulus discriminability 
has also been found to influence topographical results, with asymmetrical findings in 
schizophrenia associated with easier discrimination of pitch tone (Salisbury et al., 
1994; Weisbrod et al., 1997). It is also possible that patient differences, for example, 
variable structural deficits, may have contributed to the conflicting results. 
Potts et al. (1998) also investigated the topography of N100 amplitude and 
found no topographic difference between the schizophrenia and control groups. 
Study 2 investigates laterality and anterior/posterior differences in topography of all 
target and non-target ERP components in first episode and chronic schizophrenia 
groups compared to normal controls. 
4.5 SYMPTOM INTERACTIONS WITH ERPs 
Consideration of symptom factors can reveal significant associations with 
brain function that can be obscured through averaging across subgroups of the 
disorder (Harris et al., 2001; Liddle, 1987, 1992; Liddle et al., 1992; Williams, 
Gordon, Wright, & Bahramali, 2000; Williams et al., 2003). Chapter one reviewed 
the heterogeneity of schizophrenia symptoms and their organisation into factors. 
Three syndromes or factors (Liddle, Barnes, Morris, & Hague, 1989): reality 
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distortion, psychomotor retardation and disorganisation, (also called positive, 
negative and disorganisation factors in some studies, with minimal item differences), 
have been replicated extensively in factor analytic studies, even when additional 
factors have also been found (Andreasen, Arndt, Alliger, Miller, & Flaum, 1995; Bell 
et al., 1994; Hori et al., 1999; Johnstone & Frith, 1996; Lenzenweger & Dworkin, 
1996; Malla, Norman Williamson, Cortez, & Diaz, 1993; Maziade et al., 1995; 
Minas, Klimidis, Stuart, Copolov, & Singh, 1994; Murphy, Burke, Bray, Walsh, & 
Kendler,1994; Peralta, Cuesta, & Fan-e, 1997; Ratakonda, Gorman, Yale, & 
Amador,1998; Thomson & Meltzer, 1993) including recent onset psychosis studies 
(Gureje, Deribigbe, & Obikoya, 1995; Van de Does, Dingemans, Linszen, Nugter, & 
Scholte,1996; Vazquez- Barquero et al., 1996 - with 2 positive; but see McGorry , 
Bell , Dudgeon, & Jackson, 1998 & Van Os et al., 1996 who found different factor 
structures in FESz). 
Most studies which relate psychophysiological, neurocognitive and 
neuroanatomical structural and functional findings to symptom factors (Baxter & 
Liddle, 1998; Brown & White, 1992; Chua et al., 1997; Harris et al., 2001; 
Higashima et al., 1998; Liddle, 1987, Liddle & Morris, 1991; Liddle et al., 1992 
Norman et al.,1997a, 1997b; Schroder et al., 1992, 1995) limit these factors to these 
three core symptom factors. Although five or more factors can be obtained with the 
addition of the general psychopathology scale of the PANNS, the three factors have 
been shown to adequately account for the heterogeneity of the core schizophrenic 
symptoms. Other studies have only used two subgroups, for example, active and 
withdrawn (Gruzellier et al., 1999), positive and negative (Laurent et al., 1999). 
There are 14 items each in the Positive and Negative subscales of the PANSS, the 
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inclusion of the general psychopathology scale, which adds an additional 14 items 
would require a sample size of more than 120 patients with schizophrenia to meet the 
minimum subject to variable ratio requirements, while the sample size of most EEG, 
sMRI, fMRI and SPECT studies would preclude the use of principal component 
factor analysis with this number of items. 
Because of the relative reliability of the three factor solution derived by Liddle 
(1987) and to allow direct comparison with other psychophysiological studies (e.g. 
Norman et al., 1997; Harris et al., 2001; Higashima et al., 1998; Kawasaki et al., 
1997) correlations in Study 2 are based on Liddle's three factor solution: 
disorganisation, psychomotor poverty and reality distortion. This allows a 
comparison between the first episode and chronic groups in Study 2. The scores for 
the three factors were obtained by summing up PANS S scores according to the item 
structure of Liddle's factor analysis (Cuesta & Peralta, 1995; Liddle, 1992, Shean, 
1999; See Chapter 5, Table 5.3 for item structure). 
Disorganisation 
The disorganisation factor, reflecting thought disorder or cognitive 
impairment, has been assumed to represent the core feature of schizophrenia 
(Higashima et al., 1998). It has been found to be correlated with patients with a 
familial history of schizophrenia (Cardno, Rijsdijk, Sham, Murray, & McGuffin 
1997; Loffler and Hafner, 1999; Loftus, Delisi, & Crow, 1998), the highest 
neurological soft-signs scores (Arango, Kirkpatrick and Buchanan, 2000; Schroder et 
al., 1992) and putative psychophysiological markers such as smooth pursuit eye 
movement (SPEM) dysfunction (Lee and Williams, 2000; Lee, Williams, Loughland, 
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Davidson, & Gordon, 2001). High scores on this factor have been associated with 
poor performance in tasks which involve using context in information processing or 
the ability to inhibit irrelevant mental activity, as when the subject is required to: 
inhibit an established but inappropriate response (Liddle and Morris, 1991), suppress 
irrelevant verbal responses (Baxter and Liddle, 1998), use inhibition in a verbal 
fluency task (Cohen, Barch, Carter and Servan-Schreiber, 1999), inhibit proactive 
interference (Guillem, Bicu, Bloom, Wolf, Desautels et al., 2001), combine context 
related stimuli (Silverstein, Kovacs, Corry, and Valone, 2000), and by showing 
reversed negative priming (Williams, 1996) and perseveration on a test of set shifting 
ability (Cohen et al., 1999). 
Structural studies (MRI and CT) have either not found a relation between 
disorganisation and structural deficits (Flaum et al., 1995; Malla, Takhar, Norman, & 
Assis, 1999; Mozley et al., 1994) or have found a relationship with increased third 
and lateral ventricles and ventricle:brain ratio (Schroder, Buchsbaum, Siegel, Geider, 
& Niethammer, 1995) or increased bilateral parahippocampal grey cortex volume 
(Chua et al., 1997). Disorganisation has been more robustly associated with 
functional compared with structural changes, a pattern of results that suggests a 
widespread abnormality of function consistent with disconnectivity models (see 
Chapter 1). In functional imaging studies (PET and SPECT) disorganisation has been 
associated with increased anterior cingulate activity (Liddle et al., 1992; Schroeder et 
al., 1996; Yuasa et al., 1995) and decreased activity in the right ventrolateral 
prefrontal cortex and right and left angular gyms (Liddle, Friston, Frith, Hirsch, 
Jones and Frackowiak, 1992). 
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4.5.1 Psychomotor Poverty  
Psychomotor poverty has been associated with: slowing of mental activity 
(Baxter & Liddle, 1998; Bilder, Mukherjee, Rieder, & Pandurangi 1985; Johnson & 
Frith, 1996; Liddle & Morris, 1991; Sauer et al.,1999; Van der Does, Dingemans, 
Linszen, & Nugter, 1996), tasks that require planning abilities (Brown & White, 
1992; Himelhoch, Taylor, Goldman, & Tandon, 1996), memory - both long term 
and procedural (Norman et al., 1997; Schroeder, Tittel, Stockert, & Karr, 1996), and 
poor conceptual thinking (Bilder et al., 1985; Liddle, 1987). Differing patterns of 
structural and functional abnormalities have been associated with psychomotor 
poverty, the most consistent a relationship with frontal lobe structural abnormalities 
(Chua et al., 1997; Schroder et al., 1992, 1996; Liddle et al., 1992; Schroder et al., 
1996; Woodruff et al., 1997). The psychomotor poverty or negative dimension is 
thus associated with a loss of function and is correlated both with the existence of 
pre-morbid abilities (Sauer et al., 1999) and with eventual outcome (Carpiniello & 
Carta., 2002; Weiselgren, Lindstrom, & Lindstrom, 1996). 
4.5.2 Reality Distortion  
Reality distortion (or the positive/psychotic factor) has not been reliably 
correlated with neurocognitive measures, with a large number of studies failing to 
demonstrate a significant association (Brown & White, 1992; Frith, Leary, Cahill, & 
Johnstone, 1991; Gureje et al., 1995; Liddle & Morris, 1991; Sauer et al., 1999; Van 
der Does et al., 1993). However, a few studies have indicated an association between 
reality distortion and performance on tests of recognition and logical memory 
(Johnstone & Frith, 1996; Norman et al., 1997; Schroeder et al., 1996). Reality 
93 
distortion has also been associated structurally (NIRI & CT) with increased 
interhemipheric fissure (Schroder et al., 1995). 
4.5.3 Pychophysiology and symptom factor 
In resting EEG, reality distortion has been associated with reduced frontal-
temporal EEG coherence (Norman et al., 1997) and psychomotor poverty has been 
associated with increased levels of frontal slow wave activity (Gerez & Tello, 1995; 
Gattaz et al., 1992; Harris, Williams, Gordon, Bahramali, & Slewa-Younan, 1999). 
Correlations with P300 have not been consistent. Some studies have found no 
significant correlations between P300 and clinical symptoms (Pritchard, 1986) while 
others have found relations between P300 amplitude and both negative (Blackwood 
et al., 1987; Eikmeier, Lodemann, Zerbin, & Gastpar,1992; Pfefferbaum, Ford, 
White & Roth, 1989; Strik, Dierks, & Maurer, 1993) and positive symptoms (Egan 
et al., 1994; McCarley et al., 1989; Shenton et al., 1989). Disorganisation has been 
associated with reduced P200 amplitude and delayed N100 latency to non-target 
stimuli (Williams, Gordon, Wright, & Bahramali, 2000). 
4.6 OBJECTIVES FOR STUDY 2 
1. To clarify whether target and non-target ERP deficits are present among 
participants with FESz and chronic schizophrenia. 
2. To determine if a combination of target and non-target (T- I & T+1) ERP 
deficits can enhance prediction of diagnostic status derived solely from the 
P300 deficit to targets. 
94 
3. To determine if non-target sequence effects (T-1 & T+1) found in normal 
groups are present in first episode and chronic schizophrenia. 
4. To explore the relationship between ERP findings and clinical variables, 
especially clinical symptoms. 
5. To examine maturational effects on ERPs to target and non-target ERPs in 
schizophrenia and normal controls. 
6. To examine gender effects on ERPs to target and non-target ERPs in 
schizophrenia and normal controls. 
7. To examine topographical differences between the groups with schizophrenia 
and their control groups. 
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5 STUDY 2 - ERPs TO TARGET AND NON-TARGET (BEFORE & AFTER 
TARGET) STIMULI: FIRST EPISODE VS. CHRONIC SCHIZOPHRENIA 
The purpose of this Study was to examine target and non-target (T-1 & T+1) 
ERP disturbances in first episode and chronic schizophrenia. The main results have 
been published (Brown, Gonsalvez, Harris, Williams, & Gordon, 2002, see 
Appendix 2 for a copy of this article). A more complete account of the Study and its 
results is presented below. 
5.1 HYPOTHESES 
Compared to age and sex matched controls, chronic and FESz groups will 
show similar patterns of target and non-target ERP disturbances. Specifically: 
a) Non-targets (T- I & T+ I) 
1. N100 will be reduced to T- I and T+1 stimuli in the schizophrenia groups. 
2. P200 will be reduced and early to both T-1 and to T+1 stimuli in the 
schizophrenia groups. 
b) Targets 
1. N100 will be reduced and earlier to target stimuli in the schizophrenia 
groups. 
2. P200 will be increased and delayed to target stimuli in the schizophrenia 
groups. 
3. N200 and P300 will be reduced and delayed to target stimuli in the 
schizophrenia groups. 
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c) Between-stimuli 
1. N100 will be increased to target compared with non-target stimulus in the 
control but not the schizophrenia groups. 
2. N100 will be increased to T-I compared with T+1 stimuli in the control 
but not the schizophrenia groups. 
3. P200 amplitude will be increased and prolonged to non-target compared 
with target stimuli in the control but not the schizophrenia groups. 
4. P200 amplitude will be increased and prolonged to T-1 compared with 
T+1 stimuli in the control but not the schizophrenia groups. 
d) Gender effects on ERPs 
There will be an interaction between gender and groups. Specifically it is 
hypothesised that males will show greater deficts than females in the schizophrenia 
group. 
e) Age effects on ERPs 
In comparison to the control group, age effects on ERP components will be 
diminished (support for neurodevelopmental hypothesis) rather than enhanced 
(support for neurodegenerative) hypothesis in the schizophrenia group. Specifically: 
1. N100 amplitude to non-target stimuli will increase with age in the control, 
but not the schizophrenia groups. 
2. P300 will be reduced and delayed with age in the control, but not the 
schizophrenia groups. 
f) Symptom effects on ERPs 
ERP deficits in schizophrenia will be related to clinical symptoms, particularly 
severity of thought disorganisation. 
g) Sensitivity for schizophrenia 
Inclusion of variables derived from non-target ERPs such as N100 and P200 
components will improve classification rates for both first episode and chronic 
schizophrenia than classification using only target parameters (N200/P300). 
5.2 METHOD 
5.2.1 Participants  
5.2.1.1 Participants with chronic schizophrenia 
Forty l  participants with chronic schizophrenia, aged between 23 and 51 years of age, 
with a mean age of 36.0 years (SD = 7.1 years) were recruited from inpatient (both 
acute and long stay) and community settings in the western suburbs of Sydney (see 
Table 5.1 for demographic and clinical information). Diagnosis was confirmed using 
Section G (schizophrenia and psychotic disorders) of the Composite International 
Diagnostic Interview (World Health Organisation, 1992a) or by two psychiatrists 
according to the Diagnostic and Statistical Manual of Mental Disorders 4th edition 
(DSM — IV: American Psychiatric Association, 1994). Although chronic 
schizophrenia is defined as a period of symptomatic illness lasting for greater than 
two years, all participants had been diagnosed with schizophrenia for a minimum 
Twenty five of these were subjects included in Study 1. An additional 15 subjects were acquired to 
meet chronicity requirements. 
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period of at least four years (range 4 -34 years) with a mean duration of illness of 
14.3 yrs (SD = 7.0 yrs). All patients were medicated and details about medication are 
Table 5.1 Demographic and clinical variables of chronic schizophrenia and FESz 
participants. 
Chronic 
schizophrenia 
Male (n=26) 
Mean sd 
Female (n=14) 
Mean sd 
Total (n=40) 
Mean sd 
Age (yrs) 36.4 6.3 35.4 8.7 36.0 7.1 
Illness duration (yrs) 15.1 7.2 12.7 6.8 14.3 7.0 
Chlorpromazine equi 568 471 431 312 520 423 
Years of education 11.72 2.2 11.27 2.5 11.57 2.3 
PANSS scores 
Positive symptoms 20.5 7.0 19.9 5.5 20.3 6.5 
Negative symptoms 21.0 6.5 19.9 6.6 20.6 6.5 
General symptoms 37.2 8.4 38.3 8.4 37.6 8.3 
Total 78.7 19.5 78.1 17.9 78.5 18.7 
First episode 
schizophrenia 
Male (n=28) Female (n=12) Total (n=40) 
Mean sd Mean sd Mean sd 
Age (yrs) 19.7 2.7 19.5 4.4 19.6 3.2 
Chlorpromazine equi 262 215 222 173 250 202 
Years of education 11.5 1.8 11.2 2.1 11.3 1.9 
PANSS scores 
Positive symptoms 17.8 5.9 15.3 4.6 17.2 5.7 
Negative symptoms 21.0 6.2 15.9 4.6 19.5 6.2 
General symptoms 39.3 6.9 37.3 6.8 38.7 6.9 
Total 78.1 14.6 68.5 14.8 75.2 15.1 
Table 5.2 Medication 
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Chronic schizophrenia 
Males Females 
(n=26) (n=14) 
n % n % 
Total 
(n=40) 
n % 
FESz 
Males 
(n=28) 
n % 
Females 
(n=12) 
n % 
Total 
(n=40) 
n % 
Nil Medication 0 0 0 0 0 0 4 14 0 0 4 14 
Antipsychotics 
-typical 15 58 5 36 20 50 0 0 0 0 0 0 
-atypical 5 19 3 21 8 20 23 82 12 100 36 86 
-clozapine 7 27 6 43 13 33 1 27 0 0 1 3 
Antipsychotics 
alone 
15 58 8 57 23 58 19 68 9 75 28 70 
Antidepress ants 1 4 4 29 5 13 3 11 1 8 4 10 
Anticholinergics 8 31 2 14 10 25 3 11 1 8 4 10 
Anticonvulsants 3 12 0 0 3 8 0 0 0 0 0 0 
included in Table 5.2 Exclusion criteria were a recent history of substance abuse, 
past history of substance dependence, mental retardation, and other neurological 
disorders including epilepsy and head injury (defined as an injury requiring hospital 
observation for at least 4 hours or unconsciousness for greater than one hour). 
5.2.1.2 Participants with FESz 
Forty people with FESz aged between 14 yrs and 26 yrs (mean = 19.6 yrs; SD 
= 3.2 yrs), were recruited from community and hospital settings through the Western 
Sydney First Episode Psychosis Project (see Table 5.1 for clinical and demographic 
variables). Young people, presenting for the first time to health services, with 
psychotic symptoms that warranted a diagnosis of either schizophrenia or 
schizophreniform disorder were included. Diagnosis was made by means of a 
consensus conference (of at least three fully qualified psychiatrists) that drew upon 
information from a clinical interview by the participating psychiatrist, information 
from family and case manager and the case notes. Diagnoses were made according 
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to the Diagnostic and Statistical Manual of Mental Disorders (4th edition) (DSM - 
IV) (American Psychiatric Association, 1994). Exclusion criteria were the same as 
that for the chronic group. The majority of participants were medicated with atypical 
antipsychotics alone (M=250 chlorpromazine equivalents: SD = 202), though a small 
number were also receiving antidepressant or anticholinergic medications (see Table 
5.2 for details of medication). Four participants were not on medication. 
5.2.1.3 Positive and Negative Symptom Scale (PANS S) 
Schizophrenic symptoms for both chronic and FESz groups were rated, using 
the Positive and Negative Syndrome Scale (PANSS., Kay and Opler, 1987) by the 
interviewing psychiatrist on the same day as the data acquisition (see Table 5.1). 
5.2.1.4 Normal control participants 
Normal control participants for the two groups were recruited from the 
community and were age and gender-matched to within 2 years of the ages of their 
clinical counterparts under the age of 25 years, and to within 5 years for those over 
the age of 25 years. The rationale for closer age-matching of the younger 
participants derived from research indicating maturational changes in the EEG/ERP, 
occurring up to early adulthood (Niedermeyer, 1999; also see Chapter 4.1.1). The 
older control group, with a mean age of 36.7 yrs (SD = 7.6), was compared with the 
chronic schizophrenia group, and the younger control group, with a mean age of 
19.65 yrs (SD = 3.86), was compared with the FESz group. Persons with a recent or 
past history of mental illness, epilepsy, other neurological disorders, mental 
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retardation or head injury were excluded from the sample as were persons with a 
recent history of substance abuse, or past history of substance dependence. 
5.3 PROCEDURE AND DATA ACQUISITION 
After first obtaining voluntary consent, participants were interviewed using a 
semi-structured interview schedule and were questioned about their previous 
psychiatric history, family psychiatric history, medical history and level of 
educational attainment. The PANSS was also administered at this time. All 
participants were asked to refrain from smoking or drinking caffeine for three hours 
prior to testing. The Study was approved by Western Area Health Service and 
University of Wollongong ethics' committees. The task used and procedures for data 
acquisition were the same as Study 1 (see Chapter 3.2.2 p 53). Additionally, (T-I) 
non-targets which occurred immediately before the target were averaged separately 
from (T+1) non-targets which immediately followed the target tone. For targets 
N100, P200, N200 and P300 peaks were measured relative to a prestimulus (200ms) 
baseline by an automated system based on the detection of a consistent change in the 
direction of the gradient of the waveform (Haig et al., 1995). Thus a change from a 
consistently positive to a consistently negative gradient was identified as a positive 
peak, and vice versa for a negative peak. Although a 100 ms epoch is used for 
analysis graphs shown in this thesis are contracted to show 100ms before and 700 ms 
post stimulus, as all ERP components occur within this window and it allows the 
most efficient use of space in the figures. The time window for N100 was set at 80 - 
140ms, for P200 between 150-240ms, for N200 between 200-280ms and for P300 
between 250-500 ms. Components were scored at all 19 sites (Fpl, Fp2, Fz, F3, F4, 
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F7, F8,C3, C4, Cz, T3, T4, T5, T6, P3, P4, Pz, 01, 02) according to the 10-20 
International system (Bloom, 1982) in reference to linked-ear electrodes. 
5.4 ANALYSIS 
Analysis is considered under three main sections, midline ERPs, topography and 
response time. The Statistical Package for Social Sciences 10.0 program (SPSS Inc., 
1999) was used in all analyses. 
5.4.1 Midline ERPs  
5.4.2 Clinical vs. control groups  
N100 and P200 amplitudes and latencies were submitted separately to a 4-
way ANOVA repeated measures design, incorporating group (schizophrenia vs. 
controls) by gender (male vs. female) by stimuli (T-1, target and T+1) by electrode 
site (Fz, Cz, Pz) with repeated measures for electrode site and stimulus factors. For 
the stimulus factor, two specific planned contrasts were carried out: (i) target vs. non-
targets (T vs. T-1/T+1), to examine whether the target status influenced ERP 
components, and (ii) between non-targets (T-1 vs. T+1), to examine whether the 
sequential position of the non-target affected ERP components. For the site factor, 
linear and quadratic contrasts were examined, the linear contrast purporting to 
examine reduced amplitudes at parietal sites (Fz vs. Pz) and the quadratic contrast 
purporting to test the frequently observed maximal amplitudes at central sites (Cz vs. 
Fz + Pz). 
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N200 and P300 components were reliably observed only to the target 
stimulus and were therefore subjected to a 3-way ANOVA incorporating group 
(schizophrenia vs. controls) by gender (male vs. female) by site (Fz, Cz, Pz), with 
repeated measures for the site factor. Similar linear and quadratic contrasts as 
described above were conducted for the site factor. These analyses were done 
separately for the chronic schizophrenia group vs. older controls and the FESz group 
vs. younger controls. 
5.4.2.1 Effects of age on ERPs 
Pearson's two-tailed correlations between age and all component amplitudes 
and latencies at the site at which the component was maximal (N100 and P200 at Cz, 
N200 at Fz and P300 at Pz) were performed separately for the combined control 
group and the combined schizophrenia group. 
5.4.2.2 Effects of clinical symptom on ERPs 
This analysis was based on the three factor structure (see Table 5.3) identified 
by Liddle (Cuestra & Peralta, 1995; Liddle, 1982, Shean, 1999). 
Table 5.3 PANS S items included in each factor 
Reality Distortion Psychomotor poverty Disorganisation 
P1 Delusions N2 Emotional 
withdrawal 
P2 Conceptual 
disorganisation 
P6 Suspiciousness N4 Passive/apathetic 
social withdrawal 
N7 Stereotyped 
thinking 
P3 Hallucinatory 
behaviour 
N6 lack of spontaneity N5 Disorientation 
and difficulty in 
abstract thinking 
G7 Motor retardation 
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Pearson's two-tailed correlations between symptom factors and component 
amplitudes and latencies at the site at which the component was maximal (N100 and 
P200 at Cz, N200 at Fz and P300 at Pz) were performed separately for chronic and 
FESz groups. 
5.4.2.3 Classification of subjects into diagnostic groups 
The accuracy with which ERP components could be used to classify subjects 
into their respective diagnostic groups was examined by discriminant function 
analysis (DfA). Two separate stepwise DfA were performed: the first to determine 
the classification rate derived from the early components (N100 and P200) elicited 
by target and non-target stimuli; and the second, to determine whether classification 
rates improved with the inclusion of N200 and P300 amplitudes and latencies to 
target stimuli. In order to satisfy the subject-to-variable ratio of DfA, only variables 
that produced significant results in the ANOVAs previously conducted were entered 
in the analysis. Independent DfAs were conducted for the chronic schizophrenia 
group versus their controls, and for the FESz group versus their controls. The 
variables included in the first DfA are listed in Table 5.4 
Table 5.4 Variables entered for N100, P200 DfA. 
Chronic Sz 
T-1 N100 amplitude (Fz) 
T-1 P200 amplitude(Cz) 
T-1 P200 latency (Cz) 
target N100 amplitude (Fz) 
target P200 latency (Cz) 
T+1 N100 amplitude (Fz) 
T+1 P200 amplitude (Cz) 
T+1 P200 latency (Cz) 
FESz  
T-1 N100 amplitude (Fz) 
T-1 P200 amplitude(Cz) 
T-1 P200 latency (Cz) 
target N100 amplitude (Fz) 
target P200 latency (Cz) 
T+1 N100 amplitude (Fz) 
T+1 P200 amplitude (Cz) 
T+1 P200 latency (Cz) 
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Variables entered in the second DfA included target P300 amplitude and latency at 
Pz and N200 amplitude and latency at Fz (four variables). 
5.4.3 Topography effects  
For topographical analysis, all left handers (chronic schizophrenia = 3 and 
FESz = 6) were removed from the data set. T- land T+1 ERP components, (N100 and 
P200) and target ERP measures (N100, P200, N200, P300 amplitude & latency) were 
submitted separately to a 4-way ANOVA (3-way for N200 and P300 as there was 
only the target condition) with the between-group factor of diagnosis (schizophrenic 
vs. controls) and the within-group factors of stimulus (T-I, target, T+1 ), hemisphere 
(left/right) and site (left = F3, F7, C3, T3, T5, P3; right = F4, F8, C4, T4, T6, P4). To 
examine anterior/posterior differences in topography a similar 2 Group X 3 Stimulus 
X 2 region (anterior/posterior) X 7 sites (anterior = Fp 1, Fp2, Fz, F3, F4, F7, F8; 
posterior = 15, T6, Pz, P3, P4, 01, 02 ), was conducted. Because the primary focus 
was on lateralisation and regional effects and their interaction with stimulus and 
group, only these results are reported. Differences among the site factor are partially 
described earlier and are not further elaborated here. The use of vector scaling of 
ERP data when performing topographical analysis recommended by Picton et al. 
(2000) was not employed because in this case it was not necessarily appropriate, as 
suggested by other researchers (Haig, Gordon, & Hook, 1997; Urbach & Kutas, 
2002). 
106 
5.4.4 Response time  
Response times were determined for each participant to target tones. Only 
correct responses, defined as correctly identified targets for which a button press 
response was obtained within one second of the target tone, were analysed. The 
between-group (chronic schizophrenia vs. control, FESz vs control) differences were 
analysed by t-tests. 
5.5 RESULTS 
5.5.1 Midline sites  
The ERP waveforms are presented in Figures 5.1 and 5.2, the former to 
accentuate between-group differences at midline sites, and the latter to accentuate 
within group differences at the central site. Mean and standard deviation amplitude 
and latency scores appear in Table 5.5 and 5.6. A small percentage (between 1% and 
2.5% in each group) of ERP measures were identified as outliers (greater or less than 
one and a half the interquartile range from the upper and lower quartile). All results 
below are based on data with outliers; however, results remained significant 
following removal of outliers and covarying for medication (CPZ equivalents). Non-
significant results and values appear in Appendix 3 (the inclusion of these would 
make the results section unwieldy). 
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Figure 5.1 Average ERPs to target and non-target (T-1& T+1) stimuli, at midline 
sites, superimposed to show between-group differences. 
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Stimuli NT T NT NT NT NT T NT NT NT NT NT T NT 
Chronic schizophrenia Older controls 
100 500 300 100 300 500 -100 
Milliseconds 
—T-1 —Target —T+1 
Cz 
Young controls First episode schizophrenia 
Figure 5.2 Average ERPs to target and non-target (T-1 &T+1) stimuli, superimposed 
to show within subject differences at Cz. 
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Table 5.5 N100 and P200 mean and SD values to target stimuli for clinical and 
control groups. 
109 
Older NC Chronic Sz 
Mean SD Mean SD 
11=1111-"r7  
-5.6 4.2 
-5.9 3.5 
-3.5 2.1 
N100 amp Fz -9.1 2.6 
Cz -10.2 3.4 
Pz -6.2 2.7 
N100 lat Fz 105.2 16.1 
Cz 103 11.4 
Pz 101.8 12.1 
P200 amp Fz 3.2 3.1 
Cz 5.8 2.9 
Pz 3.9 2.2 
P200 lat Fz 201.9 27.7 
Cz 203.7 26.4 
Pz 192.1 28.9 
N100 amp Fz -10.2 3 
Cz -11.4 3.8 
Pz -6.6 3.1 
N100 lat Fz 108.3 16.6 
Cz 103.1 13.2 
Pz 101 12.6 
P200 amp Fz 0.8 3.7 
Cz -0.4 4.7 
Pz 1.5 3.3 
P200 lat Fz 172.4 16.1 
Cz 161.7 18.6 
Pz 163.2 17.4 
N100 amp Fz -8.1 4.1 
Cz -7.5 3.6 
Pz -5.4 2.4 
N100 lat Fz 100.5 12.7 
Cz 95.5 9.7 
Pz 98.6 13 
P200 amp Fz 3.4 4.3 
Cz 5.2 3.5 
Pz 3.7 3.2 
P200 lat Fz 199.7 26.4 
Cz 200.5 23.4 
Pz 199.5 26 
Yc 
Mean 
r NC 
SD 
FESz 
Mean SD 
-7.5 4 -6.3 2.8 
-7.7 3.9 -5.5 2.8 
-5.2 2.7 -4 2.5 
110.7 20.3 105.6 19.1 
106.1 16.6 101.5 18.1 
101.2 19 98.8 18.8 
105 3.9 1.6 3.2 
4.6 4.6 3.8 3.4 
3.5 3.6 3.2 3 
186.2 37.2 188.7 29.9 
184.2 31.2 192.8 28 
185.8 34.6 194.7 33 
-10.6 4.1 -5.9 3.6 
-9.3 4.5 -5.4 3.4 
-4.8 2.7 -3.9 3.1 
110.4 16.7 106.5 15.8 
104.5 12.2 97.1 15 
96.2 11.5 94.3 19.4 
-1.7 5.2 2.3 4.7 
1.7 6.2 4 4.5 
3.5 5.8 4.5 3.8 
171.9 17.3 168.4 13.9 
171.2 20.4 165.8 16.6 
160.8 31.7 158.1 25.2 
-5.5 3.5 -5.6 3.5 
-5.4 3.8 -4.4 2.9 
-4.4 3.6 -3.5 3.1 
106.9 17.5 113.5 31.7 
101.9 19.3 102.6 17.4 
100.7-1 16.4 95.2 18 
3.3 3.9 1.8 4.1 
5.8 4.4 3 3.9 
4.1 3.4 2.2 3 
185.4 20.3 181.6 25.5 
184.6 22.2 179.1 26.7 
184.6 23.2 172.2 31.7 
104.9 12.6 
104.5 11.2 
100.7 16.5 
4.7 4.1 
6.1 3.2 
5.4 2.9 
185.9 21.4 
182.6 19 
187.1 27.5 
Target 
-7.5 3.7 
-7.1 3.6 
4.2 2.4 
106.6 14.9 
101.1 11 
98.7 12.9 
3.5 4.6 
5.6 4.2 
5.4 3.1 
178.5 15.3 
174.9 16.7 
178.5 21.3 
MIWIT+1 
-6.2 4.5 
-5.9 3.2 
-4.3 2.5 
105.7 16.8 
104 15.6 
101 19.2 
3.9 3.6 
5.2 3.4 
3.5 2.7 
182.3 20.6 
184.6 20 
181.1 21.9 
Table 5.6 N200 and P300 Mean and SD to target stimuli for clinical and control 
groups. 
Older NC 
Mean SD 
Chronic Sz 
Mean SD 
Younger 
NC 
Mean SD 
FESz 
Mean SD 
N200 Fz -5.3 3.6 -3.9 4.4 -9.9 5.6 -5.8 4.6 
amp Cz -7.5 5.9 -1.7 4.8 -3.2 7.2 -0.9 5.5 
Pz -2.1 4.3 0.7 3.4 1.1 5.3 0.8 4.4 
N200 lat Fz 209.8 16.6 229.5 21.6 214.1 18.9 222.5 19.8 
Cz 207.2 13.1 220.6 18.2 209.3 18.1 216.1 21.6 
Pz 203.8 22.3 226.5 17.1 195.1 29.9 204.9 31 
P300 Fz 10.3 6.3 5.7 5.9 10.4 8.5 7.9 7.7 
amp Cz 11.9 8 11.2 7 18.9 10.6 13.3 8.2 
Pz 18.9 6.6 15.1 6.6 25.2 10.5 17.7 9.7 
P300 lat Fz 316.3 23.4 315.5 27.8 315.9 28.8 320.4 45.1 
Cz 316.8 23.7 309.2 32.6 316 35.8 317.7 38.5 
Pz 328 21.6 327.4 35.5 318.1 27.6 325.4 39.3 
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5.5.1.1 N100 Component 
5.5.1.1.1 Amplitude 
N100 amplitude statistical results for chronic schizophrenia vs. older controls, and 
FESz v. younger controls are summarised in Table 5.7. 
Chronic schizophrenia versus older controls 
For N100 amplitude there was a significant main effect for group with the 
chronic schizophrenia group manifesting reduced N100 amplitude compared with 
older controls. This main effect for group was further qualified by Group X Stimulus, 
Group X Site and Group X Stimulus X Site interactions (see Table 5.7, values in blue 
& Figure 5.3) as follows. With regard to the target, non-target comparisons, 
significant group differences were observed at the central compared with the fronto-
parietal sites indicating that the older control group had reduced N100 amplitude to 
non-target compared with target stimuli while the chronic schizophrenia group did 
not. Additionally, whereas the schizophrenia group did not differ in the way they 
responded to the two non-targets, controls did, with T+1 decreased compared with T-
1, with this pattern being specific to the central site (see Table 5.7, values in blue & 
Figure 5.3). 
Over group and site, targets produced larger amplitudes than non-targets, 
with this effect being pronounced at the central site rather than the fronto-parietal 
sites. The expected fronto-central maximum for N100 amplitude was also observed, 
with both linear and quadratic contrasts yielding significant results (see Table 5.7, 
values in green). 
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Contrasts Chronic Sz FESz 
4f (1,76) Stimulus Site 
Group 30.08 .0001 6.45 .01 
Group X Stimulus T vs NTs 9.61 .003 
T+1 vs T-1 6.14 .02 
Group X Site Cz vs Fz & Pz 15.22 .0002 10.98 .001 
Fz vs Pz 3.93 .05 
Group X Stim X Site T vs NTs Cz vs Fz & Pz 12.76 .0006 3.27 .07 
Fz vs Pz 31.32 .0001 
T+1 vs T-1 Cz vs Fz & Pz 11.44 .001 
Fz vs Pz 
Stimulus T vs NTs 15.78 .0002 15.37 .001 
Fz vs Pz 8.96 .004 
Stimulus X Site T vs NTs Cz vs Fz & Pz 24.37 .0000 13.04 .001 
Fz vs Pz 9.84 .002 19.72 .001 
T+1 vs T-1 Cz vs Fz & Pz 37.2 0.0001 13.37 .001 
Fz vs Pz 
Site Cz vs Fz & Pz 140.28 0.0001 25.86 .0001 
Fz vs Pz 123.65 0.0001 74.71 .0001 
Gender 5.57 0.02 3.9 .05 
Gender X Group 
Gen X Stim X Site T vs NT Cz vs Fz & Pz 
Fz vs Pz 
T+1 vs T-1 Cz vs Fz & Pz 8.57 0.005 
Fz vs Pz 
Table 5.7 Summary of N100 amplitude results 
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Figure 5.3 N100 amplitude to target and non-target stimulus at midline sites, for all 
groups. 
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The main effect for gender was significant (see Table 5.7, values in pink) 
with women producing larger amplitudes than men, with this effect further qualified 
by a Gender X Stimulus x Site interaction. In sum, the gender difference was 
maximal at frontal and parietal compared with the central site and greater for T+1 
stimuli than for T-1 stimuli. 
Summary: The chronic schizophrenia group did not differ in the way they responded 
to targets and non-targets however, the older controls did displaying larger N100s to 
targets compared to T-1, with this effect being prominent at the vertex. 
FESz versus younger controls 
There was a significant main effect for group, with the FESz group 
manifesting reduced N100 amplitude compared with younger controls. This main 
effect for group was further qualified by Group X Stimulus, Group X Site and Group 
X Stimulus X Site interactions, similar to those found in the chronic group (see Table 
5.7, values in blue & Figure 5.3). With regard to the target versus non-target 
comparisons, significant group differences were observed at the fronto-central 
compared with the parietal site indicating the younger control group had reduced 
N100 amplitude to non-target compared with target stimuli, while the FESz group 
did not differ in their response to target and non-target stimuli. 
Over group and site, targets produced larger amplitudes than non-targets, an 
effect more pronounced at the fronto-central, than parietal site (see Table 5.7, values 
in green). The expected fronto-central maximum for N100 amplitude was also 
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observed, with both linear and quadratic contrasts yielding significant results (see 
Table 5.7, values in red). 
The main effect for gender was significant with women producing larger 
amplitudes than men. There no further interaction between gender and group, stimuli 
or site (see Table 5.7, values in pink). 
Summary: The FESz group did not differ in the way they responded between targets 
and non-targets, however, the younger controls did displaying increased N100 to 
targets compared with non-targets, with this effect pronounced at the fronto-central 
rather than parietal sites. 
5.5.1.1.2 Latency 
Chronic schizophrenia versus older controls 
Effects were not significant for group, or group interactions with stimuli or 
site. There was a significant quadratic comparison for Group X Site, F(1,76) = 5.27, 
p < .05 with earlier N100 latency for older controls compared with chronic 
schizophrenia, specific to the vertex. 
There was a main effect for gender with earlier latencies for females 
compared to males, F(1,76) = 5.39, p < .02. This effect was maximal in latencies to 
target compared with non-target stimuli, F(1,76) = 7.46, p < .01, at central cf, frontal 
and parietal sites, F(1,76) = 4.05, p < .05. For the non-target contrast, females 
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showed earlier latencies to T-1 compared with T+1 stimulus, with this effect 
maximal at frontal compared with parietal sites. F(1,76) = 4.96, p < .05. 
FESz vs. younger controls 
Effects were not significant for group or group interactions with stimuli or 
site for N100 latency. Nor were effects for gender significant as a main effect, or as 
an interaction with group stimulus or site. 
5.5.1.1.3 Relationship between N100 and age 
Non-tar,Qets: N100 amplitude increased with age for non-target, T-I, and T+I, 
stimuli at the central site for the younger control group, but not for the schizophrenia 
group (see Table 5.8). Correlations between non-target N100 latency and age were 
not significant. 
Table 5.8 Pearsons two-tailed correlations between age and N100 amplitude2  
Non-target Target 
T-1 T+1 
Control r = -.34, p‹.002 r = -.24, p‹.05 r = -.29, p = .01 
Schizophrenia r = -.34, p‹.01 
Targets: N100 amplitude increased with age for target stimuli, at the central site for 
both the control and schizophrenia groups. However, further analysis revealed that 
Note that as N100 is a negative component. Hence correlations with N100 amplitude are the inverse 
of the r value sign. 
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these results were influenced by illness duration rather than age, because the 
correlation for the schizophrenia group did not remain significant after controlling 
for the effects of duration, r = -.2, p = .09, or the combination of duration and 
medication, r = -.1, p = .59. Correlations between target N100 latency and age were 
not significant. 
5.5.1.1.4  Relationship between N100 and symptomatology 
N100 amplitude correlated with the disorganisation factor at the central site 
across stimuli in the chronic schizophrenia group, and in the FESz group for non-
target but not target stimuli, indicating that the higher the score on the 
disorganisation factor the more reduced the N100 amplitude3  ( see Table 5.8). N100 
latency did not correlate with symptom factors. 
Table 5.9 N100 amplitude 2-tailed Pearson correlations with Disorganisation factor. 
Chronic schizophrenia FESz 
T-1 
Tar get 
T+1 
r = .42,p = 
r = .35, p = 
r = .36, p = 
.01 
.03 
.03 
r = .41, p = .02 
.06 r = .33, p = 
5.5.1.1.5 Summary 
3 Note that as N100 is a negative component. Hence correlations with N100 amplitude are the inverse 
of the r value sign. 
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Both chronic and FESz groups showed reduced N100 amplitude overall 
compared with controls, with the reduction to target stimuli mainly contributing to 
this result. Neither clinical group, showed the differential response between target 
and non-target stimuli, reduced N100 amplitude to non-target compared with target 
stimuli that was found in the control group. The chronic schizophrenia group did not 
show the differentiation between non-target stimuli, reduced N100 amplitude to T+1 
compared with T-1, displayed by the older control group. Reduced N100 amplitude 
was found for males compared with females, across control and clinical groups. 
However the enhanced N100 amplitudes associated with age, for non-target stimuli 
was found in the control groups, but not in the clinical groups. Higher 
disorganisation scores were related with reduced N100 amplitude across stimuli, but 
maximally with non-target stimuli. 
5.5.1.2 P200 Component 
5.5.1.2.1 Amplitude 
The results of the statistical analyses are summarised in Table 5.10. 
Chronic schizophrenia versus older controls 
There was a significant main effect for group, with the chronic schizophrenia group 
demonstrating increased P200 amplitude compared with older controls. This main 
effect was qualified by significant Group X Stimulus, Group X Site and Group X 
Stimulus X Site interactions as described below (see Table 5.10, values in blue & 
Figure 5.4). With regard to the target vs. non-target comparisons, whereas the 
chronic schizophrenia group responded similarly to targend non-target stimuli, older 
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controls responded differentially, with decreased P200 to target compared with non-
target stimuli, with this difference being most marked at the vertex (see Figure 5.4). 
Table 5.10 Summary of results for P200 amplitude 
Contrasts Chronic Sz FESz 
4f (1,76) Stimulus Site F p F p 
Group 12.21 .001 -- 
Group X Stimulus T vs NTs 24.98 .000 5.45 .022 
T-1 vs T+1 -- 3.90 .052 
Group X Site Cz vs Fz & Pz 3.62 .061 
Fz vs Pz -- 4.36 .040 
Group X Stim X Site T vs NTs Cz vs Fz & Pz 18.87 .000 
Fz vs Pz 3.60 .062 3.98 .050 
T-1 vs T+1 Cz vs Fz & Pz 
Fz vs Pz 
Stimulus T vs NTs 12.35 .001 
T-1 vs T+1 
Stimulus X Site T vs NTs Cz vs Fz & Pz 25.17 .000 3.81 .05 
Fz vs Pz 7.54 .008 12.78 .001 
T-1 vs T+1 Cz vs Fz & Pz 3.62 .061 
Fz vs Pz -- 5.51 .02 
Site Cz vs Fz & Pz 57.16 .000 47.79 .000 
Fz vs Pz 4.11 .046 33.63 .000 
Gender 
Gender X Group 
Gender X Stimulus T vs NTs 8.83 .004 
T-1 vs T+1 
Gender X Site Cz vs Fz & Pz 
Fz vs Pz 3.54 0.064 
Gen X Stim X Site T vs NTs Cz vs Fz & Pz 4.73 .033 
Fz vs Pz 
T-1 vs T+1 Cz vs Fz & Pz 8.32 .005 
Fz vs Pz 
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Figure 5.4 P200 amplitude to target and non-target stimulus at midline sites, for all 
groups. 
121 
Over group and site, targets produced reduced amplitudes compared with 
non-targets, with this effect being most pronounced at the central site. As mentioned 
above, this effect was qualified by a group interaction with the results of the older 
control group contributing to these effects (see Table 5.10 values in green). 
Additionally across group P200amplitude appeared to be reduced to T+1 compared 
with T-1, at the central compared with frontal and parietal sites, with the results 
approaching significance (p = .06). The expected centro-parital maximum for P200 
amplitude was also observed, with both linear and quadratic contrasts yielding 
significant results (see Table 5.10, values in red). 
Although effects were not significant for gender or Gender X Group, there 
were significant Gender X Stimulus and Gender X Stimulus X Site interactions as 
follow (see Table 5.10, values in pink). Across groups, males demonstrated reduced 
P200 amplitude to targets compared with non-target stimulus and to T-1 compared 
withT+1 stimulus, with this effect maximal at the central compared with frontal and 
parietal sites. 
FESz versus younger controls 
The main effect for group was not significant. However, there were 
significant Group X Stimulus, Group X Site, and Group X Stimulus X Site 
interactions for P200 amplitude as follows (see Table 5.10, values in blue and Figure 
5.4). The FESz group responded similarly to target and non-target stimuli, whereas 
younger controls responded differentially with decreased P200 to target compared 
with non-target stimuli, with the difference being most marked at Fz (see Figure 5.4). 
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Additionally, whereas the FESz group did not differ in the way they responded to the 
two non-targets, younger controls did, showing T-1 decreased compared with T+1. 
As a result the FESz group demonstrated increased P200 to target stimulus compared 
with younger controls and decreased P200 to T+1 stimulus compared with younger 
controls (see Figure 5.4). 
Over group P200 amplitude to target stimuli was reduced compared with non-
target stimuli, with this effect maximal at fronto-central compared with parietal sites, 
and P200 amplitude was reduced to T-1 compared with T+1 stimuli at frontal 
compared with parietal sites. As mentioned above, these effects were qualified by 
group interaction with the results of the younger control group contributing to these 
effects. 
Significant linear and quadratic effects indicated that amplitude was maximal 
centro-parietally over group and stimuli. Effects were not significant for gender or 
interactions between gender and other factors such as group, stimulus or site. 
5.5.1.2.2 Latency 
The results of the statistical analyses are summarised in Table 5.11. 
Chronic schizophrenia versus older controls 
For P200 latency, there was a significant main effect for group, with the 
chronic schizophrenia group manifesting earlier P200 latency compared with older 
controls. This main effect for group was further qualified by Group X Stimulus and 
Group X Stimulus X Site interactions as described below. With regard to the target 
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vs. non-target comparisons, whereas the chronic schizophrenia group responded 
similarly to target and non-target stimuli, older controls responded differentially, 
with dramatically earlier P200 to target compared with non-target stimuli, the 
difference being most marked at Cz (see Table 5.11, values in blue & Figure 5.5). 
Thus, the finding of earlier latency in the chronic schizophrenia group compared with 
older controls was specific to non-target stimuli, with P200 latency to target stimuli 
prolonged in the chronic schizophrenia group compared with older controls (see 
Figure 5.5). 
Over group and site, targets produced earlier latencies than non-targets, with 
this effect being maximal at the central site (see Table 5.10, values in green). As 
mentioned earlier, this stimulus effect was more dramatic for the older control group. 
There was also a main effect for site with P200 most prolonged at parietal compared 
with frontal sites (see Table 5.10, values in red). 
Although effects were not significant for gender or Gender X Group, there 
were significant Gender X Group X Stimuli, Gender X Group X Site and Gender X 
Group X Stimuli X Site interactions as follow (see Table 5.10, values in pink & 
Figure 5.6). Essentially the pattern identified above, whereby the chronic 
schizophrenia group responded more uniformly to both targets and non-targets, was 
replicated for both males and females, with the between-group differences 
(schizophrenia vs. older control) being more marked for females than they were for 
males. The four-way interaction involving the site factor suggested that parietal site 
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was more sensitive to between-group differences for females, while the central site 
was more sensitive for males. 
Table 5.11 Summary of P200 latency results 
4f(1,76) Contrasts Chronic Sz FESz 
Factor Stimulus Site F p F p 
Group 5.62 .02 -- 
Group X Stimulus T vs NTs 40.50 .0000 3.72 .06 
T-1 vs T+1 
Group X Site Cz vs Fz & Pz 
Fz vs Pz 
Group X Stim X Site T vs NTs Cz vs Fz & Pz 3.88 0.05 -- 
Fz vs Pz 
T-1 vs T+1 Cz vs Fz & Pz 
Fz vs Pz 
Stimulus T vs NTs 65.18 .0001 32.95 .0001 
T-1 vs T+1 
Stimulus X Site T vs NTs Cz vs Fz & Pz 15.51 0.0002 -- 
Fz vs Pz 4.30 .04 
T-1 vs T+1 Cz vs Fz & Pz 
Fz vs Pz 3.43 .07 -- 
Site Cz vs Fz & Pz -- 
Fz vs Pz 4.37 .04 -- 
Gender 
Gender X Group 
Gen X Group X Stim T vs NTs 4.67 .03 -- 
T-1 vs T+1 
Gen X Group X Site Cz vs Fz & Pz 3.64 .06 -- 
Fz vs Pz 4.32 .04 -- 
Gen X Group X T vs NTs Cz vs Fz & Pz 5.54 .02 5.22 .02 
Stimuli X Site Fz vs Pz 
T-1 vs T+1 Cz vs Fz & Pz 
Fz vs Pz 
Older controls 
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Figure 5.5 P200 latency to target and non-target stimuli at midline sites for chronic 
schizophrenia and older controls 
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Figure 5.6 P200 latency to target and non-target stimulus in males and females, for 
chronic schizophrenia and older control groups 
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FESz versus younger controls 
Effects were not significant for Group, Group X Stimulus, Group X Site or 
Group X Stimulus X Site for P200 latency. Over group and site, targets were 
responded to earlier than non-targets, with this effect maximal parietally (see Table 
5.10, values in green). There was a significant Gender X Group X Stimulus X Site 
interaction (see Table 5.10, values in pink, Figure 5.7) indicating that males 
responded earlier to targets compared with non-targets, (see Table 5.10, values in 
pink, Figure 5.7), whereas females responded similarly to target and non-target 
stimulus across both group. Quadratic contrasts indicated that this effect was 
maximal at central compared with frontal or parietal sites. 
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Figure 5.7 P200 latency to target and non-target stimulus in males and females, for 
FESz and younger control groups. 
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5.5.1.2.3 Relationship between P200 and age 
Non-targets: Correlations between age and P200 amplitude to non-target stimuli at 
the central site were not significant in the control group however there was a 
positive correlation between age and P200 amplitude to T+1 stimuli, r = .24, p<.05, 
for the schizophrenia group. In the control group P200 latency to T-1 and T+1 was 
delayed with age progression, r = .27, p<.02 and T+1, r = .32, p‹.01, respectively, 
while age and latency to non-target stimuli were not significantly correlated in the 
schizophrenia group. 
Targets: Correlations between target P200 amplitude and age were not significant for 
the control or schizophrenia group. For P200 latency, the schizophrenia group 
showed a significant correlation between age and P200 latency to target stimuli, r = 
.23, p<.05 with latency increasing with age. 
5.5.1.2.4 Relationship between P200 and symptomatology 
Correlations between symptom factors and P200 amplitude and latency were 
not significant. 
5.5.1.2.5 Summary 
Both control groups had earlier and reduced P200 components to targets and 
delayed and increased to non-target stimuli. This differentiation was not found in the 
chronic schizophrenia group. The FESz group differentiated between target and non-
target stimuli in latency, but not in amplitude. The combined schizophrenia group did 
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not show prolonged P200 latency to non-target stimuli with age as the combined 
control group did. Differential gender effects were found for both amplitude (present 
in clinical not in control groups) and latency (present in control but not in clinical 
groups). 
5.5.1.3 N200 
5.5.1.3.1 Amplitude 
Chronic schizophrenia versus older controls 
There was a significant main effect for group, F(1,78) =17.98, p < .001, with 
N200 reduced in the chronic schizophrenia group compared with the older control 
group. This was qualified by a significant Group X Site interaction with the quadratic 
contrast, F(1,76) = 19.8, p < .0001, indicating that the group difference was maximal 
at Cz (see Figure 5.8). Significant quadratic, F(1,76) = 10.73, p < .001, and linear, 
F(1,76) = 132.9, p <. 0001, contrasts for site indicated N200 was maximal at fronto-
central sites. 
There was also a significant main effect for gender, F(1,76) = 7.6, p‹.01, 
with N200 reduced in females compared to males, and a significant Gender X Group 
X Site linear contrast, F(1,76) = 4.39, p‹.05, as the reduced N200 for the chronic 
group was due to difference between female rather than male subjects, with this 
effect specific to the frontal site. 
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Older controls 
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Figure 5.8 N200 amplitude (above) and latency (below) at midline sites for clinical 
and control groups. 
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FESz versus younger controls 
The main effect for group was not significant, however, there was a significant 
Group X Site linear contrast, F(1, 75) =6.76, p < .01, as the first episode group 
demonstrated reduced P200 amplitude at the frontal compared with the parietal site. 
There were significant linear, F(1,75) = 132.95, p < .001, and quadratic, F(1,75) = 
10.73, p < .01, contrasts for site indicating a fronto-central maximum for N200 
amplitude. Effects for gender were not significant, nor were any interaction effects 
for gender with group or site significant. 
5.5.1.3.2 Latency 
Chronic schizophrenia versus older control 
There was a significant main effect for group, F(1,76) = 5.25, p < .05, with 
N200 latency prolonged in the chronic schizophrenia group compared with older 
controls. This main effect was qualified by a Group X Site interaction with the 
significant quadratic contrast, F(1,76) = 11.89, p <.0.001, indicating this delay was 
maximal at frontal and parietal sites compared with the central site (see Figure 5.8). 
Significant linear, F(1,76) = 152.75, p <.0001 and quadratic, F(1,76) = 4.52, p < .05, 
contrasts for site indicated that latency was maximal frontally, plateauing at central 
and parietal sites. 
Effects for gender were not significant, nor were any interaction effects for 
gender with group or site significant. 
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FESz versus younger controls 
Main effects for group were not significant. Across groups there was a 
significant linear contrast, F(1,75) = 24.20, p < .0001, for site with N200 latency 
prolonged at frontal compared with central and parietal sites. Site and Group did not 
interact significantly. 
Effects for gender were not significant, nor were any interaction effects for 
gender with group or site significant. 
5.5.1.3.3 Relationship between A1200 and age 
N200 amplitude to target stimulus decreased with age for the combined 
control group, r = .439, p < .05, but not for the combined schizophrenia group, r = 
.21, p = .07. Correlations between target N200 latency and age were not significant 
for the combined control or combined schizophrenia group. 
5.5.1.3.4 Relationship between the A1200 and symptomatology 
Correlations between N200 amplitude and latency at Fz and symptom factors 
were not significant. 
5.5.1.3.5 Summary 
A significant reduced and prolonged N200 occurred in chronic schizophrenia 
and a similar trend occurred in the FESz group (latency was significant when 
extended over full topography [see topographical analysis 5.2.2], while not 
133 
significant over midline sites). The reduction was maximal centrally in the chronic 
group and frontally in the first episode group. The decrease in N200 amplitude with 
age progression found in the combined control group did not reach significance in 
the schizophrenia group. No gender effects or correlations with symptom factors 
were found. 
5.5.1.4 P300 Component 
5.5.1.5 Amplitude 
Chronic schizophrenia versus older controls 
The chronic schizophrenia group showed an overall reduced P300 amplitude, 
F(1,76) = 5.25, p<.05. This main effect was qualified by a Group X Site interaction 
with the significant quadratic contrast, F(1,76) = 11.89, p <.0.001 indicating this 
reduction was maximal at frontal and parietal sites compared with the central site 
(see Figure 5.9) There was also a main effect for site, with linear, F(1,78) = 161.39, p 
< .001 and quadratic, F(1,78) = 4.30, p <.05, contrasts indicating maximal amplitude 
at the parietal site, plateauing between fronto-central sites (see Figure 5.9). Neither 
the main effect for gender, nor any of its interaction effects were significant. 
FESz versus younger controls 
There was a significant main effect for group, F(1,78) = 5.31, p < .05 with 
the FESz group manifesting reduced P300 amplitude compared with younger 
controls. This main effect for group was further qualified by a Group X Site 
interaction, with a significant linear contrast, F(1,78) = 4.34, p < .05, indicating that 
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this reduction was maximal at the parietal compared with the frontal site (see Figure 
5.9). There was also a significant linear contrast for site, with P300 amplitude 
maximal at the parietal site. Effects for gender were not significant, nor were any 
interaction effects for gender with group or site significant. 
Chronic schizophrenia vs. 
Older controls 
,5, 15 
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-  First episode schizophrenia 
Figure 5.9 P300 amplitude at midline sites. 
135 
5.5.1.5.1 Latency 
Chronic schizophrenia versus older controls 
Main effects for group were not significant. Across groups, there were 
significant linear, F(1,76) = 10.15, p < .01, and quadratic, F(1,76) = 14.71, p < .001, 
contrasts for site, with P300 latency prolonged maximally at the parietal site (See 
mean values in Table 5.6). Site and Group did not interact significantly. Effects for 
gender were not significant, nor were any interaction effects for gender with group or 
site significant. 
FESz versus younger controls 
For P300 latency there was no significant effects for group, site, group by site 
interaction, or gender. 
5.5.1.5.2 Relationship between P300 and age 
P300 amplitude to target stimulus decreased with increases in age for both the 
control group, r = -.39, p < .001, and the schizophrenia group, r = -.22, p = .05. 
Although this relationship was stronger for the controls group, a Z test comparison 
did not reveal a significant difference between these two correlations, z dill = -1.19, p 
= 0.23. When the effects of duration of illness were taken in to account, the 
correlation between age and P300 amplitude in schizophrenia did not remain 
significant, r = -.12, p = .32. This analysis was also applied to the chronic 
schizophrenia group alone, as the first episode group where assessed at onset. In this 
analysis, again the relationship between P300 amplitude and age was no longer 
significant when the correlation controlled for duration, r = -.04, p = .80. 
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Increasing age has consistently been found to be associated with prolonged 
P300 latency, and this prediction was supported in the current Study with P300 
latency being positively correlated with age, r = .205, p = .03 (one-tailed test) in the 
combined control group, but not in the combined schizophrenia group, r = -.12, p 
=.432 (one-tailed test). 
5.5.1.5.3 Relationship between P300 and symptomatology 
There were no significant correlations between P300 amplitude or latency and the 
symptom factors. 
5.5.1.5.4 Summary 
P300 amplitude was reduced for both the chronic and FESz groups compared with 
normal controls. P300 amplitude was observed to reduce with age for both the 
normal and schizophrenia groups. However the P300 reduction in the schizophrenia 
group was related more to illness duration than age. P300 latency was prolonged 
with age in the combined control group but not in the combined schizophrenia group. 
There were no gender effects or symptom correlations for P300 amplitude or latency. 
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5.5.1.6 Discriminant Function Analysis 
To compare the relative accuracy of classification, schizophrenia or normal, based 
on target and non-target N100, P200 components compared with target N200, P300 
components this Study compared two separate stepwise discriminant function 
analyses. The results of these analyses are summarised in Table 5.12, showing 
improved classification from the DfA based on the earlier N100 and 200 components 
to target and non-target stimuli compared with the DfA based on N200 and P300 to 
targets. 
Table 5.12 Discriminant function analysis classification results 
Chronic Older FESz Younger 
schizophrenia control control 
1. N100 P200 82.5% 82.5% 
Wilk's 2(2,76) = 0.69, 
x
2 
= 28.5, p = .000 
82.5% 80% 
Wilk's 2(3,78) = 0.56, 
Z
2 
= 44.81, p = .000 
Variables selected by 
stepwise DA 
(standardized canonical 
discriminant function) 
2. N200 P300 
Variables selected by 
stepwise DA 
(standardized canonical 
discriminant function) 
T P200 latency (0.62) 
T-1 P200 latency (-0.49) 
T-1 N100 amplitude (0.49) 
75% 65% 
Wilk's 42,77) = 0.82, 
x
2 
= 15.78, p = .000 
N200 latency (1.0) 
T N100 amplitude (1.06) 
T+1 N100 amplitude (-0.46) 
62.5% 77.5% 
Wilk's 41,78) = 0.79, 
x
2 
= 18.49, p = .000 
P300 amplitude (0.72) 
N200 amplitude (-0.62) 
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5.5.2 Topography  
The effects of factors, including group and stimulus, along with their 
interactions, have been examined earlier for midline sites. Hence the following 
analyses focuses on main and interaction effects associated with hemisphere (left vs. 
right) and region (anterior vs. posterior). Results for other factors including group 
and stimulus emerging from this analysis replicate results from the earlier analysis 
and will not be reported here, but details are made available in a CD Rom in 
Appendix 3. Also only statistical values at .05 or above are reported below, with 
more comprehensive outputs available in Appendix 3. 
5.5.2.1 N100 component 
5.5.2.1.1 Amplitude 
Topographical head maps for N100 amplitude to target and non-target stimuli, for 
control and clinical groups appear in Figure 5.10. The results of the statistical 
analysis are summarised in Table 5.13. 
Figure 5.10 N100 amplitude topographical head maps for target and non-target 
stimulus for clinical and control groups. 
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Table 5.13 Summary of N100 amplitude results 
Chronic Sz FESz  
Stimulus Location F 
Hemisphere L vs R 
Hemisphere Group L vs R 
Hemisphere X Stim T vs NTs L vs R 
T-1 vs T+1 L vs R 10.51 .002 -- 
Hem X Grp X Stim T vs NTs L vs R 
T-1 vs T+1 L vs R 
Region A vs P 97.06 .000 100.75 .000 
Region X Group A vs P 5.11 .027 
Region X Stim T vs NTs A vs P 7.18 .009 28.45 .000 
T-1 vs T+1 AvsP  
Region X Grp X Stim T vs NTs A vs P 19.61 .000 
T-1 vs T+1 AvsP 
Chronic schizophrenia versus Older controls 
Left versus right hemisphere 
Neither the main effect for hemisphere nor its interaction with group was 
significant. However, the Hemisphere X Stimulus interaction for the T+1 vs. T-1 
contrast was significant indicating increased N100 amplitude to T-1 compared with 
T+1 in the left compared with the right hemisphere, (see Table 5.13 values in blue & 
Figure 5.11). 
Anterior versus posterior 
There was a significant effect for region signifying increased N100 amplitude 
in the anterior compared with the posterior region and a significant Region X 
Stimulus interaction, with the increase in N100 amplitude to target compared with 
non-target stimulus maximal in the anterior region (see Table 5.13 values in green & 
Figure 5.11). 
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Figure 5.11 N100 amplitude to non-target stimuli by hemisphere (left panel) and to 
target and non-target stimuli by region (right panel), across chronic schizophrenia 
and older control groups. 
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Figure 5.12 N100 amplitude by region in FESz and younger controls. 
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FESz versus Younger controls. 
Left versus right hemisphere 
Neither the main effect for hemisphere nor any of its interaction effects were 
significant (see Table 5.13 values in blue). 
Anterior versus posterior 
The main effect for region was significant indicating that, N100 amplitude 
increased in the anterior compared with the posterior region. This effect was 
qualified, however, by Region X Group, Region X Stimulus and Group X Region X 
Stimulus interactions. The critical finding was that the younger control group 
responded with increased N100 amplitude to target (compared with non-target) 
stimuli, where as the FESz group did not, with this group difference being observable 
only in the anterior region (see Table 5.13, values in green & Figure 5.12). 
Summary 
Over the older control and chronic schizophrenia groups, differences between 
T-1 and T+1 were more obvious in recordings over left (vs. right) hemisphere, as 
N100amplitude to T-1, but not T+1, was increased in the left (vs right) hemisphere. 
An increase in N100 amplitude to target compared with non-target stimuli found 
across the older control and chronic schizophrenia groups, in the younger group 
comparison this effect was found in the control, but not the FESz group who 
responded to target and non-target stimulus similarly in the anterior and posterior 
region. 
5.5.2.1.2 Latency 
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Topographical head maps for N100 latency to target and non-target stimuli, for 
control and clinical groups appear in Figure 5.13. 
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Chronic schizophrenia versus older controls 
Left versus right 
Effects were not significant for hemisphere or its interactions. 
Anterior versus posterior 
There was a significant effect for region, F(1,60) = 9.77, p <.01, with N100 
latency prolonged in the anterior compared with the posterior region. This effect was 
qualified by a Region X Stimulus significant contrast, F(1,60) = 11.51, p <.001 
demonstrating that the regional effect on latency was maximal for the target 
compared with non-target stimulus. There were no significant interactions between-
group and region. 
Chronic Sz and control FESz and controls 
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Figure 5.14 N100 latency to target and non-target stimulus at anterior and posterior 
regions. 
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FESz versus younger controls 
Left versus right 
Effects were not significant for hemisphere or interactions between hemisphere and 
group or stimulus. 
Anterior versus posterior 
There was a significant effect for region, F(1,60) = 34.98, p <.001, with N100 
latency prolonged in the anterior compared with the posterior region. This effect was 
qualified by a Region X Stimulus significant contrast, F(1,60) = 5.78, p <.05, for the 
non-target comparison, as the region effect was maximal for the T+1 compared with 
T-1 stimulus. The target vs non-target contrast was not significant. As seen in Figure 
5.13, this appears to be because N100 amplitude to T+1 stimulus is also increased. 
Group and region did not interact significantly. 
Summary 
Analysis by hemisphere and region revealed no between-group differences for N100 
latency. All four groups showed a similar pattern of prolonged N100 latency to 
targets (compared with non-targets) especially at anterior sites. 
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5.5.2.2 P200 
5.5.2.2.1 Amplitude 
Topographical head maps for P200 amplitude to target and non-target stimuli, for 
control and clinical groups appear in Figure 5.15. The results of the statistical 
analysis are summarised in Table 5.14 
Table 5.14 Summary of P200 amplitude results 
Chronic Sz FESz 
df (1,59) Stimulus Location F p F p 
Hemisphere L vs R 
Hemisphere X Group L vs R 
Hem X Stimulus T vs NTs L vs R 
T-1 vs T+1 L vs R 10.70 0.002 5.47 0.023 
Hem X Stim X Grp T vs NTs L vs R 
T-1 vs T+1 L vs R 
Region A vs P 5.68 0.020 35.49 0.000 
Region X Group A vs P 
Region X Stim T vs NTs A vs P 12.01 0.001  4.62 0.036 
T-1 vs T+1 A vs P 
Grp X Reg X Stim T vs NTs A vs P 
T-1 vs T+1 A vs P 
Chronic schizophrenia versus older controls 
Left versus Right 
Effects were not significant for hemisphere or interactions between hemisphere and 
group. However, the Hemisphere X Stimulus interaction for the T+1 vs. T-1 contrast 
was significant indicating that P200 amplitude was larger in the left compared with 
the right hemisphere, to the T+1 stimulus (see Table 5.14, values in blue & Figure 
5.16). 
Anterior versus posterior 
There was a significant effect for region, reflecting increased P200 
amplitude in the posterior compared with the anterior region. This effect was 
qualified by a significant Region X Stimulus contrast for the target vs. non-target 
comparison, as the stimulus effect was maximal for the posterior region (see Table 
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5.14 values in green & Figure 5.16). There were no significant interactions between- 
group and region. 
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Figure 5.16 P200 amplitude to T-1 and T+1 stimulus, by hemisphere(left panels) 
and to target and non-target stimuli by region (right panels). 
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FESz versus younger controls 
Left versus Right 
Effects were not significant for hemisphere or interactions between 
hemisphere and group. However, the Hemisphere X Stimulus interaction for the T+1 
vs. T-1 contrast was significant, indicating that P200 amplitude was larger in the left 
compared with the right hemisphere for the T+1 stimulus (see Table 5.14 values in 
blue & Figure 5.16). 
Anterior versus posterior 
There was a significant effect for region, indicating increased P200 amplitude 
in the posterior compared with the anterior region. This effect was qualified by a 
significant Region X Stimulus contrast for the target vs. non-target comparison, as 
the region effect was maximal for the target compared with the non-target stimulus 
(see Table 5.14 values in green & Figure 5.16). There were no significant 
interactions between group and region. 
Summary 
Across groups, P200 amplitude was maximal in the posterior region and 
increased to the T+1 stimulus on the left compared with right hemisphere. 
5.5.2.2.2 Latency 
Topographical head maps for P200 latency to target and non-target stimuli, 
for control and clinical groups appear in Figure 5.17. The results of the statistical 
analysis are summarised in Table 5.15. 
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Table 5.15 Summary of P200 latency results 
Chronic Sz FES z 
4f (1,59) Stimulus Location F 
Hemisphere L vs R -- 4.30 .04 
Hemisphere X Group L vs R 4.67 .035 
Hemisphere X Stim T vs NTs L vs R -- 3.86 .05 
T-1 vs T+1 LvsR  
Hem X Stim X Grp T vs NTs L vs R 
T-1 vs T+1 LvsR   
Region A vs P 10.36 .002 10.86 .002 
Region X Group A vs P 
Region X Stim T vs NTs A vs P -- 4.45 .04 
T-1 vs T+1 A vs P 
Reg X Grp X Stim T vs NTs A vs P 6.49 .01 
T-1 vs T+1 A vs P 
Chronic versus Older controls 
Left versus Right 
Effects were not significant for hemisphere or interactions between 
hemisphere and stimulus. However, the Hemisphere X Group interaction was 
significant, indicating that P200 latency delay in the older control compared with 
chronic schizophrenia group was maximal in the left hemisphere (see Table 5.15, 
values in blue & Figure 5.18). 
Anterior versus posterior 
There was a significant effect for region, with P200 latency prolonged in the 
anterior compared with posterior region. This effect was qualified by a Region X 
Stimulus X Group interaction with the target vs. non-target contrast significant, as 
the stimulus effect was maximal in the posterior compared with anterior region (see 
Table 5.15 values in blue & Figure 5.19). 
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Figure 5.18 P200 latency across stimuli for chronic schizophrenia and older control 
groups, by hemisphere (left panel), and to target and non-target stimulus, across 
FESz and younger control groups, by hemisphere (right panel). 
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Figure 5.19 P200 latency to target and non-target stimulus in anterior and posterior 
regions, for chronic schizophrenia and older control groups (top panel) and across 
group for FESz and younger control groups. 
154 
FESz 
Left versus right 
There was a significant effect for hemisphere, signifying prolonged P200 
latency in the left compared with right hemisphere. This effect was qualified by a 
Hemisphere X Stimulus interaction, with the target vs. non-target contrast 
significant, as the stimulus effect was maximal in the left compared with right 
hemisphere (see Table 5.15 values in green & Figure 5.18). There were no 
significant interactions between group and hemisphere. 
Anterior versus posterior 
There was a significant effect for region, indicating prolonged P200 latency 
in the anterior compared with posterior region. This effect was qualified by a Region 
X Stimulus interaction, with the target vs. non-target contrast significant, as the 
stimulus effect was maximal in the anterior compared with posterior region (see 
Table 5.15 values in blue & Figure 5.19). There were no significant interactions 
between group and region. 
Summary 
Delayed P200 latency in the anterior (compared with posterior) region was 
found over stimuli and groups. For the older controls (compared with chronic 
schizophrenic) the delayed P200 latency was found in target (compared with non-
target) stimuli at anterior sites, and across stimuli on the left (compared with right) 
hemisphere. In the FESz and younger control groups, delayed P200 latency was 
evident to T-1 (compared with T+1) stimuli at anterior sites, and to non-target 
(compared with target) stimuli on the left (compared with right) hemisphere. 
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5.5.2.3 N200 component 
Topographical head maps for N200 amplitude and latency to target stimuli, for 
control and clinical groups appear in Figure 5.20 
Old control Chronic Sz 
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Anterior versus posterior 
There was a significant effect for region, F(1,70) = 23.4, p <.001, indicating 
increased N200 amplitude in the anterior (compared with posterior) region. This 
effect was qualified by a significant Region X Group interaction, F(1,70) = 11.51, p 
<.01, suggesting that this pattern was mainly attributable to the chronic 
schizophrenia group (see Figure 5.21). 
FESz versus younger controls 
Left versus Right 
There was a significant main effect for hemisphere, F(1,59) = 4.33, p< .05, 
indicating increased N200 amplitude in the right (compared with left) hemisphere in 
both groups. Effects were not significant for the interaction between group and 
hemisphere. 
Anterior versus posterior 
There was a significant effect for region, F(1,60) = 88.8, p <.001, with N200 
amplitude increased in the anterior compared with posterior region, however this 
effect was qualified by a significant Region X Group interaction, F(1,60) = 4.36, p 
<.05, suggesting that this pattern was maximal in the young control group (see 
Figure 5.21). 
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Figure 5.21 N200 amplitude at anterior and posterior regions. 
5.5.2.3.2 Latency 
Chronic schizophrenia versus older controls 
Left versus Right 
Effects were not significant for hemisphere or the interaction between group 
and hemisphere for N200 latency. 
Anterior versus posterior 
There was a significant effect for region, F(1,70) = 12.06, p <.001, with 
P200 latency prolonged in the anterior compared with posterior region. Effects were 
not significant for the Group X Region interaction. 
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FESz versus younger controls 
Left versus right 
Effects were not significant for hemisphere, however, there was a Group X 
Hemisphere interaction, F(1,59) = 5.38, as the younger control group were more 
delayed in the left compared with the right hemisphere whereas the FESz group were 
more delayed in the right compared with the left hemisphere. Hence the delay for the 
FESz group was more pronounced in the right hemisphere. 
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Figure 5.22 N200 latency for FESz and younger controls by hemisphere. 
Anterior versus posterior 
There was a significant main effect for region, F(1,59) = 67.46, p <.05, with 
N200 latency delayed in the anterior compared with posterior region. Effects were 
not significant for the Group X Region interaction. 
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Summary 
Increased anterior compared with posterior N200 amplitude was found across 
all groups, however, this effect was stronger in the chronic schizophrenia group 
compared with older controls and in younger controls compared with FESz group. 
The FESz group showed the opposite pattern of hemisphere effects compared to their 
control group, displaying delayed N200 latency in the left hemisphere. 
5.5.2.4 P300 component 
Topographical head maps for P300 amplitude and latency to target stimuli, 
for control and clinical groups appear in Figure 5.23 
Old control  Chronic Sz 
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5.5.2.4.1 Amplitude 
Chronic schizophrenia versus older controls 
Left versus Right 
Effects were not significant for hemisphere, or the interaction between group 
and hemisphere, for P300 amplitude, nor was there a significant Group X Site 
interaction evident when the P300 amplitude analysis was restricted to T3 and T4 
sites, F(1,72) = .02, p = .87. 
Anterior versus posterior 
The expected effect for region associated with P300 was observed, F(1,66) = 
142.87, p <.001, indicating P300 amplitude was maximal in the posterior compared 
with anterior region. Effects were not significant for the Group X Region 
interaction. 
FESz versus younger controls 
Left versus Right 
Effects were not significant for hemisphere or the interaction between group 
and hemisphere for P300 amplitude, nor was there a significant Group X Site 
interaction when the P300 amplitude analysis was restricted to T3 and T4 sites, 
F(1,66) = .01, p = .92. 
Anterior versus posterior 
There was a significant main effect for group, F(1,60) = 88.8, p ‹.001, 
indicating P300 amplitude was maximal in the posterior compared with anterior 
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region. However, this effect was qualified by a significant Region X Group 
interaction, F(1,60) = 4.36, p <.05, suggesting that this pattern was maximal in the 
young control group (see Figure 5.24). 
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Figure 5.24 P300 amplitude by region for FESz and younger control groups. 
5.5.2.4.2 Latency 
Chronic schizophrenia versus older controls 
Left versus right 
Effects were not significant for hemisphere or the interaction between group 
and hemisphere for P300 latency. 
Anterior versus posterior 
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There was a significant effect for region, F(1,70) = 11.664, p = .001, 
indicating that P300 latency was prolonged in the posterior compared with anterior 
region. Effects were not significant for Group X Region interaction. 
FESz versus younger controls 
Left versus right 
Effects were not significant for hemisphere or the interaction between group 
and hemisphere for P300 latency. 
Anterior versus posterior 
Effects were not significant for region or the interaction between group and 
region for P300 latency. 
Summary 
Analysis for hemisphere did not produce significant between-group results 
for P300 amplitude or latency, for either of the two comparisons. A focussed 
analysis, did not find smaller P300s over the left (T3) site than over the right (T4) 
site in either the chronic or FESz groups (compared with normal controls). Analysis 
by region, demonstrated a generally increased and delayed P300, in the posterior 
(compared with anterior) region across the older control and chronic schizophrenia 
groups. 
5.5.3 Response time  
Both the chronic schizophrenia group (mean = 405ms, SD = 10ms) and the 
FESz group (mean = 367mss, SD = 9ms), showed significantly slower response 
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times (df =1,78, p<.001 and df=78, p‹.01 respectively) than their normal controls 
(mean = 315ms, SD = 15ms; mean = 308ms, SD = 9ms). There were no significant 
differences between the chronic schizophrenia and FESz groups, or between the two 
control groups. Control groups averaged 99.8% (older) and 99.9% (younger) 
accuracy and the clinical groups averaged 93% (chronic schizophrenia) and 96.2% 
(FESz) accuracy 
5.6 DISCUSSION 
Results from this Study strongly suggest that abnormalities in ERPs in 
schizophrenia are not restricted to target stimuli, but occur to both target and non-
target stimuli, and are evident at both the onset of schizophrenia and the chronic state 
of the illness. The results are, therefore, consistent with the hypothesis that ERP 
deficits in schizophrenia are trait like and not due to secondary effects of chronic 
morbidity, neuroleptics or institutionalisation. The examination of ERP responses to 
target and non-target stimuli, and further to T-1 vs. T+1 non-target stimuli, produced 
striking results. The chronic and FESz groups did not demonstrate the differential 
N100 and P200 amplitude responses to target and non-target stimuli shown by both 
older and younger control groups. In addition the chronic schizophrenia group did 
not differentiate in their response to T-1 and T+1 non-target stimuli for N100 
amplitude, as did the older and younger control groups. Most importantly the 
stepwise discriminant function analysis demonstrated a superior classification for 
both chronic and FESz using the early components to both target and non-target 
stimuli in comparison to the previous focus on the P300 component elicited by target 
stimuli. The inclusion of ERP components to non-target stimuli, in addition to target 
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stimuli also provided evidence of differential aging effects on ERPs in schizophrenia 
versus normal controls and the most robust correlation with symptom factors. 
Schizophrenia versus Controls: For both the chronic schizophrenia and FESz groups, 
the traditional averaged ERP to target stimuli showed decreased N100, N200 and 
P300 amplitude and increased P200 amplitude when compared to their controls. The 
reduced N100, N200 and P300 amplitude are consistent with previous ERP studies 
with schizophrenia (Ogura et al., 1991; Boutros et al., 1997; Brown et al. 2000) and 
with previously reported reduced N200 and P300 amplitude findings in FESz studies 
(Demiralp et al., 2002; Hirayasu et al., 1998; Salisbury et al., 1998). Previous target 
P200 amplitude findings have been mixed, however, the increased P200 amplitude in 
this Study replicates findings by Ogura et al. (1991) in an unmedicated sample. P200 
amplitude has been reported to reflect aspects of decision-making or stimulus 
encoding (McCarley et al., 1991). 
There were some differences, however between the chronic schizophrenia 
and FESz groups and their respective controls. While amplitude disturbances were 
common to both groups, latency deficits were specific to the chronic group, who 
showed delayed P200 and N200 latencies to targets, and earlier P200 latency for 
non-targets. The FESz group, in contrast, showed no significant latency differences 
in comparison to their control group. One possible explanation for this pattern of 
results is that the observed amplitude deficits manifest an association with more 
primary aspects of the disease, whereas latency differences represent secondary or 
subsequent aspects, for example, direct consequences associated with the progression 
of the disease or indirect consequences of chronicity such as institutionalisation. In 
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addition, the reduced P200 amplitude to T+1 stimulus found in the FESz was not 
found in the chronic schizophrenia group. 
Target versus non-target: The disturbance in information processing is also 
elucidated by within group comparisons. The pattern of significant differences 
between targets and non-targets (smaller earlier P200 to targets versus increased 
delayed P200 to non-targets), shown by the controls, was not shown either by the 
chronic schizophrenia or FESz groups (see Figures 5.2 and 5.4). In the chronic 
schizophrenia group, P200 amplitude and latency did not vary significantly between 
target and non-target stimuli. In the FESz group, P200 amplitude either did not 
differentiate at fronto-central sites, or differentiated by increasing to target 
(compared with non-target) stimuli at the parietal site. This is in the opposite 
direction to the control group, where P200 amplitude is reduced to target (compared 
with non-target) stimuli. The FESz group, showed a shift in P200 latency between 
target and non-target stimuli. Scrutiny of the waveforms (Figure 5.1) suggests that 
the P200 amplitude and latency shift between targets and non-targets, shown by the 
controls, may result from the overlap with the N200 components in ERPs to target 
stimuli. Thus, the large and wide P200 amplitude component normally elicited by 
non-target stimuli is reduced and narrowed by the negative shift associated with the 
N200 component in ERPs elicited by target stimuli. It is possible that this does not 
occur to the same extent in the chronic and FESz groups because their N200, and 
P300 components are reduced compared to controls, and so the N200 overlap is not 
so prominent in the P200 component. This would contribute to the larger P200 
amplitude to targets found in the chronic schizophrenia group compared to controls. 
It should be noted, however, that the P200 amplitude produced by the target stimuli 
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is actually larger than the P200 amplitude produced by the non-target stimuli in the 
FESz group despite the presence of the N200 component in the target elicited ERP. 
Although not within the scope of this thesis, a new single trial method (Melkonian et 
al., 2001) will be applied to this data to tease out the overlapping components to 
investigate, amongst other questions, whether P200 differences remain when the 
effects of the N200 overlap are removed. 
The N100 component is correlated with specific aspects of stimulus features 
(Pritchard, 1986; Naatanen and Picton, 1987), but may also reflect attention, as it is 
generally larger with increasing attentional requirements (Maclean et al., 1975). It is 
also affected by non-specific arousal (Rockstroh, Muller, Wagner, Cohen, & Elbert, 
1994). The chronic and FESz groups, in addition to showing an overall reduction of 
N100 amplitude, also failed to show the distinct pattern of N100 amplitude to target 
>T-1 > T+1 stimuli found in the control groups. The stimulus features of the T+1 and 
T-1 stimuli are identical. It is therefore possible that the reduction in N100 amplitude 
to T+1 stimuli found in normal controls, but not in patient participants, could be due 
to temporal recovery, as the T+1 stimuli follows a target that requires a cognitive and 
motor response. Alternatively, it could reflect reduced attentional requirements for 
T+1 stimulus due to changes in states of vigilance or preparedness, as a target 
stimulus is always followed by a non-target stimulus in this paradigm. This 
possibility is further explored in Study 3, employing a paradigm in which target 
stimuli are equiprobably followed by target or non-target stimuli. Further support for 
this proposition comes from the results of an associative learning study utilising 
visual stimuli, in which the N100 amplitude evoked by a stimulus 2(S2) following a 
predictive stimulus 1(S1) was reduced (Rose, Verleger, & Wascher, 2001). The 
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authors interpreted this reduction as indicative of a reduced need to allocate spatial 
attention to S2 because S1 had provided reliable information about S2. If this 
interpretation is accurate, the results of the present Study would indicate that a 
similar process applies to the auditory attentional system 
The patient group's diminished discrimination between target and non-target 
stimuli (and also between T-1 and T+1) suggests that they are less flexible in 
differentiating and processing target and inhibiting non-target information than 
controls. This pattern is consistent with Gray's (1998) model in which 
"misattributions" in the match/mismatching of target: non-target information is 
proposed to underlie the core positive symptoms in schizophrenia. A failure to 
develop an expectancy that a non-target would follow a target could be further 
evidence of this dysfunction, and may stem from the failure to make use of stored 
regularities in information processing. Amongst other possibilities, it may be viewed 
as a disturbance in implicit memory. 
N100 amplitude was robustly correlated with the disorganisation factor for 
both the chronic and FESz groups. As disorganisation increased, N100 amplitude 
reduced. As predicted, this correlation was stronger for non-target stimuli in 
comparison to target stimuli. Perhaps increased disorganisation in schizophrenia is 
more strongly associated with the failure to inhibit, or dampen the processing of 
irrelevant stimuli (non-targets) than it is related to preferential processing of relevant 
stimuli (targets). These fmdings indicate that the reduced N100 amplitude in 
schizophrenia is present at the onset of illness, as well as later chronic stages. This 
reduction to non-target stimuli related to disorganisation, the putative core factor of 
schizophrenia. 
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Increased N100 amplitude to non-target stimulus and decreased and delayed 
P300 component to target stimulus with age are robust findings (see 4.1.1) and were 
found in the combined (younger + older) normal control group in this Study. In the 
combined schizophrenia group, however, correlations were not significant between 
age and both N100 amplitude and P300 latency. For P300 amplitude the correlation 
only just reached significance. Further differential age effects were found for P200 
latency. The control group showed prolonged P200 latency to non-target stimuli with 
age, whereas the schizophrenia groups showed prolonged P200 latency to target 
stimuli with age. The combined normal control group also demonstrated a decrease 
in N200 amplitude with age, an effect not found in the schizophrenia groups. These 
results do not suggest the accelerated ageing that would be expected with a 
neurodegenerative illness. The pattern of results, including the absence of age 
effects, along with the presence of similar deficits in both first episode and chronic 
schizophrenia, are more consistent with a neurodevelopmental hypothesis. 
Compared to the N200 and P300 components, which have been the focus of 
schizophrenia research, the N100 and P200 components acquired in response to both 
targets and non-targets provided a more accurate classification for both the chronic 
schizophrenia group (improved from 75% to 82.5%) and the FESz group (improved 
from 62.5% to 82.5%). Thus, the emphasis on extending ERP investigations to 
components other than P300 in the current Study is strongly supported. 
Perceptual abnormalities are an early sign of the onset of psychosis 
(Chapman, 1966) and the development of investigational methods to assess this is 
important. Given the current emphasis in first episode psychosis treatment on early 
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identification and active treatment of young people at risk (McGlashan 2001a, 
McGlashan 2001b), a method to help highlight risk prior to a psychotic episode, and 
track treatment progress is necessary. For these purposes, and to avoid unnecessary 
use of antipsychotic medication, it is imperative to correctly differentiate FESz 
patients from normal and other non-psychotic controls. The benefit of using the 
earlier components to target and non-target stimuli is illustrated by the reduction in 
false positive classifications i.e. 37.5% of the controls would have been falsely 
classified as FESz using the N200 and P300 components to target stimulus versus 
20% using the N100 and P200 components to both target and non-target stimuli. 
However, because this Study did not use a clinical control group, the specificity of 
these findings needs to be examined. 
Gender effects did not differ for the schizophrenia group compared with 
controls for N100 amplitude and latency or P200 amplitude. However, males with 
schizophrenia (both first episode and chronic) compared with females, showed 
shorter P200 latency to target compared to non-target stimuli. This effect was 
maximal at the central site. In addition, the reduced N200 amplitude in the chronic 
schizophrenia compared with the control group arose predominantly from a 
reduction in females in the schizophrenia group. These were unexpected findings, as 
one might expect gender differences in schizophrenia to favour females rather than 
males. Previous schizophrenia research has indicated improved outcomes for females 
compared to males (Tamminga, 1997; Castle et al., 2000), suggesting that females 
appear to have a less virulent form of the disorder (Flor-Henry, 1985; Andia et al., 
1995; Kulkarni, 1997). 
170 
Overall there were few group topographical differences. The left lateralised 
P300 amplitude deficit found in some studies (see Chapter 4.5) did not occur, even 
when restricting the comparison to T3 and T4 electrode sites. The left lateralised 
P300 deficit has been found more commonly in studies using a count response than 
button press. It is possible, therefore, that the button press response used in this Study 
has contributed to the absence of the lateralised P300 amplitude deficit, although 
Turetsky et al. (1998) has demonstrated this lateralised deficit, using the button press. 
Another possible contributing factor is that the EEG recording was not acquired from 
TCP1 and TCP2 sites which were found to show a greater effect than T3 and T4 in a 
meta- analysis of P300 topography studies (Jeon &Polich, 2001). 
In conclusion, this Study found that: 
(i) N100 and P200 target versus non-targets differences and non-target sequence 
effect differences (T-1 vs. T+1) are diminished in schizophrenia. 
(ii) In comparison to target generated P300amplitude, N100 and P200 deficts to 
target and non-target stimuli show improved sensitivity for schizophrenia. 
These findings led to further investigations in subsequent studies. The next Study 
(Chapter 6) explores whether sequence effects on ERPs to target stimuli, as well as 
non-target stimuli, are disturbed in first episode schizophrenia. It also examines 
whether N100 non-target (T-1, T+1) sequence effects are found when target stimuli 
are equiprobably followed by a target or non-target stimulus. Study 4 (Chapter 7) 
focuses on the important issue of whether these findings are specific to first episode 
schizophrenia, compared to a clinical control group (ADHD) in which P300 
amplitude has also been found to be reduced. 
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6 ERP SEQUENCE EFFECTS IN FIRST EPISODE SCHIZOPHRENIA 
6.1 INTRODUCTION 
Studies 1 and 2 (Chapters 3 & 5) suggested a problem in schizophrenia, with 
either the independent processing of target and non-target stimuli, and/or the 
interactional effects emerging from the ongoing processing of these two stimuli. 
These findings were robust, present at the first onset of illness and also in chronic 
schizophrenia, and consistent with preliminary findings in the literature. This 
problem could underlie the core information processing problems in schizophrenia 
and may link ERP findings to investigations using alternate methodologies, for 
example, deficits in latent inhibition and Kamin Blocking in people with 
schizophrenia and their first degree schizotypal and non-schizotypal relatives 
(Baruch, Hemsley, & Gray, 1988; Jones, Gray and Hemsley, 1992; Martins, Jones, 
Toone, & Gray, 2001). Latent inhibition is a weakening of associative learning if the 
to be conditioned' stimulus is first pre-exposed a number of times without any 
consequence. Similarly, in Kamin Blocking, pre-exposure to a first association 
between a conditioned (CS1) and unconditioned stimulus (UCS), results in a block to 
the learning of a compound stimulus (CS1 + CS2), followed by the same UCS. 
Deficits on these tasks are interpreted as possibly arising from a basic impairment in 
associative learning, also suggesting that the association between two stimuli are not 
processed accurately in schizophrenia. 
The Gray-Hemsley model (Gray, Feldon, Rawlins, Hemsley, & Smith, 1991; 
Gray, 1998; Hemsley, 1993, 1994) proposes that people with schizophrenia fail to 
establish appropriate response biases because they are unable to use stored memories 
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of regularities based on their previous experience. This results in a failure to make 
use of temporal and spatial redundancy to reduce information processing demands. 
Although the Gray-Hemsley model is derived from empirical research in a different 
field, it is worthwhile and intriguing to determine whether the same dysfunctional 
mechanisms postulated might underlie observed ERP deficits in the auditory oddball 
paradigm. To this end, the current Chapter will investigate P300 and reaction time to 
target stimuli, and N100 amplitude to non-target stimuli, on tasks involving 
repetition of two stimuli: target (T) and non-target (N). 
As ERP deficits are found in schizophrenia at first episode (Study 2, Chapter 
5) it was decided to investigate a group with first episode schizophrenia to reduce 
confounding effects which may be secondary to chronic morbidity, such as 
prolonged use of neuroleptic medication, or hospitalisation. 
6.1.1  Sequence effects on P300 and RT  
Attempts to examine the relationship between two repeating stimuli 
presented in random sequence have been made in studies examining sequence 
effects. In these studies, the sequential structure of stimuli preceding the target 
stimuli has been consistently shown to affect target response. For example, subjects 
tend to respond more quickly to the continuation of a stimulus repetition (TT), than 
to its discontinuation (NT). Studies which have examined sequence effects have in 
general, either used a simple RT task, where the subject is asked to respond to targets 
and ignore non-targets, or a choice reaction time task (CRT), in which different 
responses (e.g. left vs. right button presses) are required to targets and non-targets. 
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Sequence effects were first demonstrated in reaction time (Remington, 1969) 
and have been robustly replicated (Kirby, 1976, 1980; Soetens, Boer, & Heuting, 
1985; Soetens, Deboek, & Hueting, 1984). It was found that RTs were influenced, 
not only by the current stimulus, but also by the sequence of preceding stimuli. Two 
types of sequence effects are observed in choice RT tasks. First order effects are 
attributable to the immediately preceding event, whereas higher order effects are 
caused by events earlier in the sequence (Kirby, 1980; Soetens, Boer, & Heuting, 
1985). Both these effects are dependent on the response-stimulus interval (RSI), the 
interval from the preceding response to the next stimulus presentation. For first order 
effects, RTs are shorter for repetitions than alternations (TT<NT)4  at RSIs less than 
500ms, and shorter for alternations than for repetitions (NT<TT) when RSIs are 
longer than 500ms (Hale, 1967; Kirby, 1976; Soetens, Boer, & Heuting, 1985; 
Soetens, Deboek, & Hueting, 1984). Higher order sequential effects are observed 
after continued runs of stimulus repetitions or stimulus alternations (TTTT or 
NTNT), or conversely discontinuations of these runs (NNNT or NTNTT), with faster 
RTs to continuations than to discontinuations (Remington, 1969; Soetens Boeing, & 
Hueting, 1985). At shorter RSIs, these patterns, referred to as cost-benefit patterns, 
are not found; instead a benefit only pattern is found (Kirby, 1976: Soetens, Deboeck 
& Hueting, 1984; Vervaeck & Boer, 1980). The cost-benefit patterns found with long 
RSIs were explained by confirmations and disconfirmations of expectancies, arising 
4  Various terminologies have been used for the two alternate stimuli in sequence studies, for example, 
A/B, A/R, and NIT. To avoid confusion the two stimuli will be referred to as T and N in this thesis. 
When used with a CRT task, T and N refer to the two alternate target stimuli, when used with a simple 
RT task the T refers to the target stimuli and the N refers to the non-target stimuli. 
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from the preceding sequence of stimuli. If expectancy is confirmed, RT is short, and 
if it is disconfirmed, RT is long. 
Squires, Wickens, Squires and Donchin (1976) demonstrated that ERPs also 
reflected sequence effects. Thus, in addition to RT as an index of performance, ERPs 
might also provide an index of the underlying psychophysiology. These studies, and 
others (Duncan-Johnson & Donchin, 1982, Johnson & Donchin, 1980), demonstrated 
that target stimuli that continue a series of repetitions (TT, TTT, TTTT, or 
alternations (NT, NTN, NTNT) elicit smaller P300s and earlier RTs than target 
stimuli that discontinue a sequence of repetitions ( T), or alternations 
(NTNTT). Most low probability oddball studies average over sequence types, 
thereby losing valuable information when sequences have been a determinant of 
P300 amplitude. 
A methodological issue that deserves mention, is that most of the earlier 
sequence studies (Duncan-Johnson, Roth, & Kopell, 1984; Duncan-Johnson & 
Donchin, 1982, Johnson & Donchin, 1980; Squires, Wickens, Squires, & Donchin, 
1976) examined sequence effects in a hierarchical cumulative manner, where first 
order effects, attributable to the immediately preceding event (e.g. TN), include 
higher order effects, events that are earlier in the sequence (NNT, TNT, NTNT, 
TTNT etc.). For example, Duncan Johnson et al., 1984 used a Group X Stimuli X 
Sequence (repetition vs. alternation) X Outcome (continuing vs. discontinuing) X 
Site analysis. This hierarchical cumulative approach does not facilitate analysis of 
lower vs. higher order effects (NT vs. NNT vs. NNNT) which are the focus of this 
Study. 
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Mean ERP scores to different sequences, commonly visually presented as 
"sequence trees" in sequence studies (Duncan-Johnson et al., 1984, Johnson & 
Donchin, 1980; Squires,Wickens, Squires, & Donchin,1976) indicate that in addition 
to the 'continuation versus discontinuation' and 'alternation versus repetition' 
comparisons, there appear to be linear relationships within these series, for example, 
consistent linear increases in P300 amplitude to discontinuation of repetition or DR 
series (DR5>DR4>DR3>DR2>DR1) and perhaps more minimally to discontinuation 
of alternations (DA3>DA2>DA1). However, because of the statistical approach 
mentioned above, the significance of these possible linear relationships has not been 
tested. In normal controls, RT appears to decrease within the DR series (Duncan-
Johnson et al., Gonsalvez et al.) and increase with the DA series (Duncan-Johnson et 
al.). The P300 latency results across DR or DA series have been examined 
infrequently. 
As sequence manipulations resulted in effects on both RT and P300 
amplitude, initial efforts sought a single explanation for both effects. For example, 
the expectancy model that was used to explain the cost-benefit pattern in RT results, 
was generalised to ERPs (Duncan-Johnson & Donchin, 1982, Johnson & Donchin, 
1980; Squires, Wickens, Squires, & Donchin, 1976). However, the expectancy 
explanation of sequence effects has now been challenged from a number of 
directions. Sequential effects in RTs show properties that are not explainable by 
expectancy (Soetens et al., 1985). In the stimulus repetition effect, for example, 
faster RTs for repetitions than alternations with a faster stimulus presentation rate, 
have been associated with an automatic facilitation or priming, rather than the 
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subjective expectancy associated with slower presentation rate (Kirby, 1980; 
Soetens, 1998; Soetens et al., 1985). 
Studies showing evidence of dissociation between sequence dependent RT 
and P300 amplitude patterns (e.g. some experimental manipulations have produced 
RT and ERP results in opposite directions) have challenged the idea of a common 
expectancy mechanism for RT and P300 amplitude sequence effects (Leuthold & 
Sommer, 1993). The effects of "practice" (Sommer et al., 1990) and "manipulated 
expectations" (Matt, Leuthold, and Sommer, 1992) have been found in RTs, but were 
absent (practise), or minimal (manipulated expectancies) in P300 amplitude. 
Leuthhold & Sommer (1993) found that the first order repetition effect in P300 
amplitude was only observed at a 1.3 sec ISI, and not at slower presentation rates, 
wheras higher order effects were unmodulated by ISI. P300 amplitude is usually 
smaller, whereas RT may be longer for first order repetitions, as compared to 
alternations (Sommer, Leuthold and Soetens 1999; Sommer, Leuthhold, & Matt, 
1998). In higher order sequential effects, Sommer, Leuthold and Soetens (1999) 
found the sequential pattern in RTs changed from cost-benefit to cost, only when RSI 
was decreased from 500 to 40ms, wheras P300 consistently showed a cost-benefit 
pattern at both RSIs. 
Other findings have also challenged the expectancy hypothesis. Sommer, 
Matt, & Leuthold (1990b) showed that conscious expectancies for a given stimulus, 
as measured by subjective ratings, are barely affected by the trial sequence. The 
ability to develop trial to trial expectancies would presumably rely on being able to 
encode and hold in immediate memory the recent stimulus pattern, in order to 
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categorise the current stimulus as locally frequent or rare, yet P300 sequence effects 
have been found in groups with diminished immediate memory capacity and function 
(Polich and Broderant, 1997). 
The above reasons have led researchers to question the notion that expectancy 
disconfirmation underpins observed variations in P300 amplitude (e.g. Verleger, 
1988; Gonsalvez et al., 1999; Gonsalvez & Polich, 2002; Croft, Gonsalvez, Gabriel, 
& Barry, 2003). Gonsalvez and colleagues (Gonsalvez et al., 1999; Gonsalvez & 
Polich, 2002; Croft, Gonsalvez, Gabriel, & Barry, 2003) suggest an alternative 
explanation for at least some sequence effects, arguing that the first order, or 
stimulus mismatch versus stimulus match effect (NT vs TT), and the higher order 
discontinuation of repetition ( DR) series or non-target sequence length effect (NNNT 
vs. NNT vs. NT) upon P300 amplitude are the result of target-to-target interval (TTI) 
rather than sequence effects. This hypothesis is explained by resource limitation, i.e. 
P300 updating processes are primarily influenced by the interval between stimuli 
rather than the sequence structure context effects (Gonsalvez & Polich, 2002). 
6.1.1.1 DA effects on ERPs: Are they an index of cognitive processes implicated 
in associative learning? 
Several sequence studies have found an interesting relationship between 
P300 amplitude and discontinuation of alternation ( DA) series. DA effects occur 
where a preceding alternation or series of alternations is terminated by a repetition of 
the penultimate stimuli, thus discontinuing the alternation pattern as in the following: 
NTT (DA1); NTNTT (DA2); NTNTNTT (DA3). Although not as dramatic as DR 
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effects, DA effects have been reported in several studies (Duncan-Johnson et al., 
1984; Squires et al., 1976) in a consistent direction, with P300 amplitude increasing 
with increases in the number of alternations preceding the final stimulus mismatch 
(DA3>DA2>DA1). The DA effect on P300 amplitude cannot be explained by the TTI 
hypothesis, as TTI remains unchanged with increases in DA series. 
Previous studies have explained alternation and DA series by invoking 
expectancy theory. The subject expects alternations to continue, larger numbers of 
alternations increase this expectancy, leading to reduced P300 amplitude. The final 
repetition violates this expectancy, leading to larger P300 amplitude (Duncan-
Johnson et al., 1984; Squires et al., 1976). Regardless of whether expectancy 
underlies the DA effect, available evidence points to the fact that ERPs are sensitive 
to pair-wise occurrences of stimuli or to the relationship between contiguous 
occurrences of stimuli. The brain (consciously or unconsciously) recognises a pattern 
of two alternating stimuli and responds differently when this pattern is continued 
versus when it is discontinued. In addition, the number of preceding pairs appears to 
influence P300 amplitude in a consistent way, leading to the intriguing prospect that 
ERPs may be an objective measure of strength of associative coding. This 
possibility opens up a large number of exciting research avenues with significant 
clinical and theoretical implications. For example, if P300 to certain sequence types 
is indicative of associate encoding strength (at least in paradigms that elicit these 
sequence effects), reduced P300 may indicate poor encoding of stimulus pairs. This 
may underlie the widespread P300 amplitude deficit amongst people with 
schizophrenia, on oddball tasks. Poor encoding of contiguous occurrences of events 
could also explain latent inhibition and Kamin blocking results, and may be a core 
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cognitive deficit of schizophrenia. There are advantages in determining an objective 
measure of this, including an understanding of the psychophysiology of this deficit, 
as well as the provision of a biological marker for the disorder. 
There is some support for the use of P300 as a correlate of associate learning 
from a study which isolated associative cognitive learning from non-associative 
adaptive mechanisms (Rose, Verleger, & Wascher, 2001). In this Study, amplitude 
of P300 evoked by the predictive first stimulus (S1) increased linearly over blocks, 
and P300 amplitudes, evoked by the second stimulus (S2) following the predictive 
S 1, decreased in the course of learning with a quadratic trend, while there were no 
modifications to P300 on the control task. The authors interpreted these trends as a 
fast decrease in neglecting the information of S2 and a continuous increase of the 
meaning of S 1. 
An expectancy effect, based on paired associations, would predict that the 
increase in P300 amplitude to the terminating target in DA series compared to 
alternation series (which should be a decrease, according to TTI, as it immediately 
follows a target) is caused by a disconfirmation of this expected association. As it 
would take more than one pair to establish this association, this would be seen in 
linear increases of P300 amplitude within DA series. Previous studies have used 
shorter series (Duncan-Johnson et al., 1984 Squires et al., 1976) A systematic 
investigation of the effects of increasing DA series, may therefore, require longer 
series of stimuli than those normally used in sequence studies. 
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The primary focus of this Study was to examine the effect of increasing 
levels of DA series on the P300 component and RT of patients with FESz and normal 
controls. The current Study predicted that, in normal controls, there would be linear 
increases in P300 amplitude as a function of increases in the DA series, as suggested 
by a few earlier studies (Duncan-Johnson et al., 1984 Squires et al., 1976), reflecting 
appropriate associative encoding for stimulus pairs. It was hypothesised that this 
P300 amplitude pattern would not occur in the FESz group, indicating a problem 
with associative encoding. On the other hand, linear increases in DR series effects 
were predicted to occur in both the control and FESz group, according to the TTI 
hypothesis and previous findings (Duncan-Johnson et al., 1984; Gonsalvez et al., 
1995). To examine these hypotheses, a specialised version of the oddball paradigm 
that included DA sequences ranging from DA1 to DA3 was developed. 
6.1.2 Sequence effects on P300 and RT in schizophrenia 
Sequence effects on the P300 have been well established in normal healthy 
subjects. However, there has been a dearth of sequence effects studies in 
schizophrenia, with only two studies (Duncan-Johnson, Roth and Kopell, 1984; 
Gonsalvez et al. 1999) evident. One reason is that ERPs to each stimuli type need to 
be sub-averaged separately, and signal-to-noise requirements result in lengthy 
paradigms that are difficult for clinical populations, including schizophrenia, to 
complete. The Duncan-Johnson et al. study investigated sequence effects in a 
schizophrenia group, with a 0.5 probability CRT, where subjects responded to each 
of two tones by pressing one of two buttons. Although special attention was not paid 
to the DA series, the authors reported a similar overall pattern (sequence tree) of 
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P300 amplitude and RT changes in both the schizophrenia and normal control 
groups. The authors interpreted these ERP findings as an indication that people with 
schizophrenia formulate trial to trial expectancies, with RT findings indicating that 
these expectancies were applied to response preparation processes. 
At first glance the above results would not appear to support the Gray-
Hemsley model, or suggest that ERPs do not reliably index the deficit that these 
models hold as central to schizophrenia. It would suggest that people with 
schizophrenia accurately encode recent stimulus patterns and can categorise and 
respond to the next stimulus as locally frequent or rare, i.e. make connections 
between previous stimuli which then bias their response to the next incoming stimuli. 
On the other hand, it could be argued that the Gray-Hemsley model refers to 
"reliable" associations between stimuli, whereas the sequence effects refer to 
"random" stimuli. Of importance is the fact that the Gray Hemsley model applies 
more specifically to DA effects and DA effects were not examined by Duncan-
Johnson et al. (1984) in a comprehensive manner. Consequently the results may have 
been swayed by the DR or other sequence types (where the schizophrenia group 
showed a similar pattern as normal controls), which could be attributed to TTI, rather 
than by the DA series. 
Gonsalvez et al. (1995) examined sequence effects in schizophrenia utilising 
a simple reaction time auditory oddball paradigm. Subjects responded (button press) 
only to target stimuli, separated by equiprobable series of 1,3,5,7,9 or 11 non-targets 
(1.3 seconds fixed ISI) with a 0.16 probability for target stimuli. Target ERPs were 
subaveraged according to the number of preceding non-targets, similar to stimuli in 
182 
DR series, but differing in extending the length of the sequence, with DR ranging 
from DR1 through to DR9. Where the previously quoted studies had analysed the 
statistical difference between continuation and discontinuation of sequences, this 
Study examined whether P300 amplitude and RT varied in a linear way as DR series 
was manipulated, ranging from DR1 to DR9. P300 amplitude increased with 
increasing numbers of non-targets preceding the target in schizophrenia patients as 
well as controls, however the reduction in P300 amplitude for the schizophrenia 
group compared with the control group was only significant to the target stimuli 
following non-target series of intermediate length (i.e. preceded by 3, 5 or 7 non-
targets) and not when targets followed a short (1) or long (9) series of non-targets. 
Thus both studies (Duncan-Johnson et al.; Gonsalvez et al.) indicated a linear effect 
for DR series in schizophrenia, although Gonsalvez et al. was the only study to test 
this statistically. 
6.1.3 Sequence effects on N100 amplitude  
Most sequence studies have focused on the P300 component elicited by target 
stimuli. However, there are a number of studies which have found sequence effects 
on N100 amplitude to non-target stimuli (Hermanutz, Cohen, & Sommer, 1981; 
Hirata & Lehmann, 1990; Brown et al., 2002; Roth & Cannon, 1972; Starr, 
Aquinaldo, Roe and Michalewski, 1997; Staff, Sandroni & Michalewski, 1995). 
These studies all used simple RT rather than CRT tasks. Several studies (Hermanutz 
et al.; Hirata & Lehmann; Starr, Aquinaldo et al.; Starr, Sandroni et al.) have found a 
repetition effect demonstrating increasing N100 amplitude to non-target stimuli with 
longer trains of preceding non-targets. This is the opposite pattern to P300 amplitude 
to target stimuli which decreases with longer trains of preceding target stimuli (see 
183 
6.1.1). The results of Study 2 in this thesis demonstrated another sequence effect on 
N100 in normal controls; a reduction in N100 amplitude to T+1 compared to T-1, an 
effect found in normal populations in some other studies (Roth & Cannon; Starr, 
Aquinaldo et al., Starr, Sandroni et al.) These studies have used oddball paradigms 
where target frequency is low and occurrences of TT are absent. A study that 
examined changes associated with all four 2nd  order sequence effects (TT NT, NN & 
TN) did not find significant effects on N100 amplitude (Polich & Broderant, 1996). 
This suggests that the reduction to T+1 compared to T-1 stimuli may not be found 
when target stimuli may be followed by either target or non-target stimuli 
Study 3 also sought to determine whether the reduction in N100 amplitude to 
T+1 compared with T-1 stimuli found in the control, but not the schizophrenia group 
in Study 2 (Chapter 3), was related to recovery cycle effects. If N100 amplitude 
reduction to T+1 stimuli was attributable to recovery following a target, it should 
also be found in the paradigm used in this study using the same ISI as in S2, but with 
target probability raised to 0.5. Consequent to the probability manipulation, in Study 
3, the T+1 stimulus would no longer remain predictable as it could now be either a T 
or N, unlike in Study 2 where it was always an N. Therefore, if Study 3 replicated 
results of Study 2 (N100 amplitude to T+1 < T-1) the recovery hypothesis would be 
supported, whereas if it did not, alternative explanations would have to be 
considered, for example, the predictability of the stimulus. 
6.1.4 Sequence effects on N100 amplitude in schizophrenia  
Only two studies have investigated sequence effects on N100 amplitude in 
schizophrenia, one the published results from Study 2 of this thesis (Brown et al., 
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2002) and the other, an early study on the ERP in schizophrenia (Roth & Cannon, 
1972). Roth and Cannon used an auditory oddball task with an ISI of 1 second, in 21 
male subjects with schizophrenia having a similar duration of illness to the chronic 
group used in Study 2 (mean of 13.6 ± 9 years since initial hospitalisation). These 
researchers used rare and standard stimuli, akin to the target and non-target stimuli in 
terms of probability of occurrence, except that in this study the subjects were not 
instructed to make a response. Roth and Cannon found that N100 amplitude to T and 
T-1 was increased, compared to T+1 and T+2 in the control group, but not the group 
with schizophrenia. In Study 2 (Chapter 5), the auditory oddball paradigm required a 
motor response to the target stimulus (equivalent to the rare stimuli in Roth & 
Cannon's paradigm), using an ISI of 1.3 seconds with both chronic and FESz groups 
(both male and female). This Study similarly found N100 amplitude increased to 
target (compared with non-target) stimuli and increased to T-1 (compared with T+1) 
stimuli in the control group, but not in the schizophrenia group. 
In summary, both the Roth and Cannon (1972) and Brown et al. (2002) 
studies indicate that the N100 amplitude reduction to T+1 stimuli sequence effect, 
commonly found in normal controls, is not found in schizophrenia in an oddball 
paradigm where TT occurrences do not occur. The present Study attempts to clarify 
whether the reduction in N100 amplitude to T+1 is due to preparedness (probability 
/expectancy) or to response recovery processes. 
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6.1.5 Hypotheses:  
1. DR series 
There will be an increase in P300 amplitude and decrease in P300 latency and RT 
with repetitions in DR series (e.g. NNNNT>NNNT>NNT) in both the normal control 
and FESz groups. 
2. DA series 
P300 amplitude and latency and RT will increase with repetitions in DA series (e.g. 
NTNTNTT>NTNTT>NTT) in the normal group but not in the FESz group. 
3. Continuing (repeating) vs. discontinuing (alternating) short sequences 
P300 amplitude will be increased to discontinuing (TN, NT) compared with 
continuing (NN, TT) short sequences in both the normal control and FESz groups. 
4. N100 amplitude 
N100 amplitude to non-target T+1 (TN) will be reduced compared with N100 
amplitude to non-target T-1 (NN). 
6.2 MET HOD 
6.2.1 Participants  
6.2.1.1 Participants with FESz 
Eighteen participants with FESz were recruited from community and hospital 
settings through the Western Sydney First Episode Psychosis Project. Of these only 
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the data from fourteen participants (11 males, 3 females) between 13 yrs and 23 yrs 
(mean = 18.5 yrs; SD = 3.1 yrs) were able to be included in the analysis. Two 
participants were unable to complete the paradigm, while a further two were 
excluded from analysis due to a high error rate in their responses to targets. FESz 
participants were defined as those young people presenting for the first time to health 
services with psychotic symptoms that warranted a diagnosis of either schizophrenia 
or schizophreniform disorder. Diagnosis was made by means of a consensus 
conference (of at least three fully qualified psychiatrists) that drew upon the 
interview by the participating psychiatrist, information from family and case 
manager and the case notes. Diagnoses were made according to the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM—IV: American Psychiatric 
Association, 1994). Exclusion criteria were the same as for Studies 1 and 2 (Chapters 
3.2.1). The majority of participants were medicated with atypical antipsychotics 
alone, though a small number were also receiving antidepressant or anticholinergic 
medications 
6.2.1.2 Normal control participants 
Fourteen normal control participants (11 male, 3 female) between 14 yrs and 
24 yrs (mean = 19.7 yrs; SD = 3.4 yrs) were recruited from the community and were 
gender and age matched to within 2 years with the first episode participants 
exclusion criteria were the 
same as for Studies 1 and 2 (see Chapter 3.2.1) 
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6.3 DATA ACQUISITION 
This Study was approved by Western Sydney Area Health Service and 
University of Wollongong ethics' committees. Participants were seated in a reclining 
chair in a quiet, dimly lit laboratory, facing a video screen and wearing a pair of 
headphones. The paradigm used in this Study was an auditory oddball with target 
probability set at 0.5, 612 target (1500 Hz) tones and 612 non-target (1000 Hz) tones 
(with 10ms rise and fall). The tone intensity was 60 dBSPL and the fixed 
interstimulus interval (ISI) was 1.3 s. The design included at least 20 occurrences of 
each of the following sequences. 
Repetition series: TT TTT TTTT TTTTT TTTTTT 
Discontinuation of Repetition (DR) series: NT NNT NNNT 
T 
Alternation series: TNT NTNT TNTNT NTNTNT TNTNTNT 
Discontinuation alternations (DA) series: NTT TNTT NTNTT TNINTT 
NTNTNTT 
Participants were asked to look at a dot on the computer screen 60 cm in front 
of them, ignore the low non-target tones, and press two reaction time buttons with 
the index finger of each hand to target tones. Participants were required to respond 
with both hands to control for potential lateralized effects associated with unilateral 
motor activity. Task instructions emphasised speed and accuracy of response 
equally. EEGs were recorded on a DC based system (Synamps, equipped with a 16-
bit A/D converter) from 19 scalp sites according to the 10-20 International system 
(Bloom, 1982) in reference to linked-ear electrodes with an amplification of 200 a 
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band pass from 0 to 50 Hz and digitised at 250 Hz. Only data recorded at Fz Cz and 
Pz are reported here. Horizontal EOG was recorded via electrodes placed at the outer 
canthus of each eye and vertical EOG was recorded via two electrodes placed 1cm 
above and below the midline supraorbital and infraorbital regions of the left eye. Eye 
correction was carried out using a technique based on Gratton, Coles & Donchin 
(1983). ERPs were separately sorted and averaged for each level of DR and DA as 
defined above under Data Acquisition (6.3) 
For sub-averaged target and non-target stimuli, N100 and P300 peaks were 
measured relative to a pre-stimulus baseline of 200 ms by an automated system based 
on the detection of a consistent change in the direction of the gradient of the 
waveform (Haig, Gordon, Rogers & Anderson, 1995). Thus, a change from a 
consistently positive to a consistently negative gradient was identified as a positive 
peak, and vice versa for a negative peak, with the criteria that N100 occurred 
between 80 -140ms, and P300 occurred between 250-500 ms. Peaks thus identified 
were then verified through visual inspection. 
6.4 ANALYSIS AND RESULTS 
Amplitude, latency and RT measures were each subjected to ANOVA as 
described in greater detail below. 
6.4.1  ERPs  
In this Study ERPs were analysed in three stages: 
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(i) ERPs associated with targets following one or more repetitions of the 
non-target (NT, NNT, ..), termed discontinuation of repetition sequences 
or DR-series 
(ii) ERPs to targets that followed an alternation sequence, termed 
discontinuation of alternation or DA series 
(iii) ERPs to targets and non-targets reflecting all 4 possibilities of the 2nd 
order sequence effects, namely continuing (NN, TI) and discontinuing 
sequences (NT, TN) 
Each of these stages is discussed in order. As the P300 component was the 
primary interest, analyses were restricted to this component from the 3 midline 
sites for DR and DA sequences, and to P300 and N100 amplitudes for continuing 
vs. discontinuing sequences. Mean scores for N100 and P300 amplitudes at 
midline sites for all stages of the Study appear in a consolidated Table (See Table 
6.1). 
6.4.1.1  Discontinuation of repetition sequence for target stimuli (DR series) 
Grand average waveforms for DR sequences appear in Figure 6.1. P300 
amplitude and latency from the DR series were subjected to a 2 Groups X 5 
Sequences (DR levels) X 3 Sites (Fz, Cz, Pz) ANOVA with repeated measures on the 
last two factors. Linear and quadratic contrasts were examined for the sequence and 
site factors. 
P300 amplitude: No main or interaction effects were significant for group, however, 
there were significant linear, F(1,26) = 29.4, p<0.001, and quadratic, F(1,26) = 8.05, 
p<.01, contrasts for DR. P300 amplitude increased as longer strings of repetitions 
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were discontinued. This increase was more prominent in the first three levels, 
plateauing from level 3 for the control group and from level 4 for the FESz group 
(see Figure 6.2). There was a significant linear contrast for Site X DR, F(1.26) = 
13.88, p < 0.001, with sequence effects maximal at Pz. 
P300 latency: There were no significant effects evident for P300 latency. 
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Figure 6.2 P300 amplitude across midline sites (left) and at Pz (right) for DR 
sequences (DR1—NT; DR2=NNT; DR3=NNNT; DR4— ; DR5—NNNNNT 
6.4.1.2 Discontinuation of alternation sequence for target stimuli (DA series). 
Grand average waveforms appear in Figure 6.3. P300 amplitude and latency 
from the DA series were subjected to a 2 Groups X 3 Sequences (DA1, DA2, DA3)) 
X 3 Sites (Fz, Cz, Pz) ANOVA with repeated measures on the last two factors. 
Linear and quadratic contrasts were examined for sequence and site. 
P300 amplitude: No main or interaction effects for group, or linear and quadratic 
contrasts for DA series were significant for P300 amplitude. There was a significant 
linear contrast for site, F(1,26) = 38.77, p < 0.001, with P300 amplitude increased 
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from Fz to Pz. The quadratic, F(1,26) =15.69, p<.01, contrast arose as the increase 
from Fz to Cz was steeper than the increase from Cz to Pz. 
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effect was clearly apparent at Pz (see Figure 6.4), however, at Cz and Fz the 
prolongation occurred only from DA1 to DA2, giving rise to a significant DA X Site 
X Group quadratic, linear contrast F(1,26) = 11.37, p < 0.02. 
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Figure 6.4 P300 latency for the two groups as a function of DA series at Pz. 
(DA1=NTT, DA2= NTNTT, DA3 = NTNTNTT). 
6.4.1.3 Continuing (NN, TT) and discontinuing (TN, NT) series. 
P300 and N100 amplitudes were separately subjected to a 2 Groups X 2 
Sequences (continuation & discontinuation) X 2 Stimuli (target & non-target) X 3 
Sites (Fz, Cz, Pz) ANOVA with repeated measures for the last three factors. 
P300 amplitude: There were no significant main or interaction effects for group. The 
main effect for sequence was significant, F(1,26) = 20.73, p < 0.001, with larger 
P300 amplitudes for discontinuing sequences, as was the main effect for Site, with a 
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progressively increasing P300 amplitude from frontal to central and parietal sites. 
The main effect for stimulus was not significant, however there were significant 
Sequence X Stimulus, F(1,26) = 5.1, p < 0.05, and Stimulus X Site F(1.4, 36.27) = 
84.45, p <0.001, interactions. The Sequence X Stimuli interaction arose as P300 
amplitude differences between continuing vs. discontinuing sequences were more 
pronounced in non-target stimuli (NN vs TN) than in target stimuli (TT vs NT). The 
Site X Stimuli interaction arose as P300 amplitude increased from frontal to parietal 
sites for target stimuli, but decreased from frontal to parietal sites for non-target 
stimuli (see Figure 6.6). 
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Figure 6.5 Grand average ERPs to continuing and discontinuing sequences. 
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Figure 6.6 Sequence X Site and Sequence X Stimuli interactions for continuing and 
discontinuing sequences at Fz (top row) and Pz (bottom row) for P300 amplitude. 
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N100 amplitude: Mean N100 amplitudes were consistently lower for the 
schizophrenia group to TT, NT, NN and TN stimuli (see Table 6.1), however, the 
main effect for group did not reach significance F(1,26) = 3.06, p = .09, nor were 
there any significant interactions with group. Main effects for stimuli or sequence 
were not significant, however, the Sequence X Stimuli interaction approached 
significance, F(1,26) = 3.84, p = .06, as discontinuations produced increased N100 
amplitude to targets but not to non-targets. No significant difference was found 
between N100 amplitude to NN (T-1) and TN (T+1). There was a significant main 
effect for site, F(1.34, 34.7) = 40.27, p<0.001, as N100 amplitude increased from 
parietal to frontal sites. There were no significant site interactions. 
Table 6.1 Mean and standard deviation scores for P300 amplitude (amp) and latency (lat) and N100 components. 
Control FESz 
Fz Cz Pz Fz Cz Pz 
Mean SD mean SD mean SD mean SD mean SD mean SD 
DR1 P300 amp 0.46 4.80 5.80 3.60 7.72 3.41 2.07 6.18 5.53 4.75 5.88 4.29 
P300 lat 361.61 62.75 348.63 68.59 331.47 53.00 356.35 68.36 342.86 69.36 325.79 44.04 
DR2 P300 amp 3.24 5.24 8.06 4.78 10.13 3.81 4.06 4.56 7.83 5.36 9.59 6.02 
P300 lat 330.96 61.60 334.28 57.69 321.11 41.25 326.29 61.70 308.57 30.66 327.43 52.99 
DR3 P300 amp 2.60 4.69 9.255 4.027 11.93 4.17 3.86 4.27 9.20 5.19 10.49 6.09 
P3001at 334.39 78.24 345.62 66.94 328.00 46.06 311.66 50.24 340.45 60.59 347.43 65.82 
DR4 P300 amp 2.70 4.87 8.44 5.03 11.37 5.28 5.99 6.74 10.39 6.51 11.86 5.84 
P300 lat 353.90 90.25 332.09 64.08 347.93 44.91 316.32 40.53 316.32 32.33 325.41 32.61 
DR5 P300 amp 2.46 6.27 9.38 6.02 12.70 5.88 5.32 5.66 10.96 5.16 12.43 5.44 
P300 lat 362.00 76.67 320.86 39.45 329.43 45.60 305.42 37.90 317.43 52.66 313.71 46.69 
DA1 P300 amp .56 5.49 5.41 4.92 7.24 5.72 4.14 6.89 7.23 4.59 8.42 5.52 
P300 lat 343.05 68.52 351.65 64.46 332.29 40.82 413.37 63.46 394.76 72.49 368.38 64.13 
DA2 P300 amp 1.13 5.33 6.60 3.21 7.96 4.76 2.92 5.81 6.17 4.89 7.77 5.75 
P300 lat 378.89 65.97 384.53 68.07 358.30 54.42 331.71 60.81 376.28 65.13 376.29 65.13 
DA3 P300 amp 1.39 6.32 6.44 5.59 8.76 6.44 2.64 4.72 5.92 4.26 7.28 4.39 
P300 lat 341.73 49.94 373.14 62.77 380.01 60.05 348.28 63.27 369.43 76.32 376.85 73.16 
TT P300 amp 0.33 4.72 5.82 4.03 7.22 3.8024 1.66 5.86 5.22 3.84 5.70 3.72 
NT P300 amp 0.61 4.91 6.35 3.71 8.28 3.29 2.22 5.15 6.07 4.53 6.73 4.31 
NN P300 amp -2.52 6.17 3.02 5.72 1.39 3.39 3.33 5.64 2.46 3.73 1.88 1.98 
TN P300 amp 4.62 7.44 5.60 6.36 4.05 3.63 6.33 7.09 5.95 4.73 4.42 3.17 
TT N100 amp -5.33 2.95 -4.10 2.66 -2.75 2.17 -4.44 2.50 -2.91 1.99 -1.82 1.42 
NT N100 amp -6.09 2.18 -4.64 2.15 -2.93 1.97 -5.12 2.68 -3.86 2.45 -2.18 1.60 
NA,  N100 amp -5.78 2.51 -4.71 2.52 -3.75 1.84 -4.65 2.24 -3.49 1.73 -1.76 1.37 
TN N100 amp -5.72 3.04 -4.62 2.96 -3.38 2.39 -4.27 2.66 -2.70 2.01 1.85 1.05 
197 
198 
6.4.2 Response time (RT)  
The mean level of accuracy was 98% for the control group and 94% for the FESz 
group. Only correct responses were included in the analysis. RT data was subjected to a 2 
Groups X 5 Sequences (DR series) and a 2 Groups X 3 Sequences (DA series) ANOVA, 
with repeated measures for the DR and DA series, and linear and quadratic contrasts for 
the within-subjects factor. 
Mean RTs were consistently lower for the FESz group (see Table 6.2), however, 
main effects for group did not reach significance, for DR or DA series. The larger RT 
variance within the FESz group (see Table 6.2.) probably contributed to this lack of 
significance. No significant Group X Sequence interaction was found for either DR or DA 
series. There were no significant linear or quadratic effects for the DR series, however 
there were significant linear, F(1,26) =8.9 p<0.01, and quadratic, F(1,26) = 7.6 p<0.01, 
trends for the DA series, as RT increased (for both groups) from level 1 to 2 and then 
plateaued between level 2 and 3 (see Fig. 6.8.). 
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Figure 6.7 RT for DR and DA sequence levels. 
Table 6.2 Mean and standard deviation values for RT. 
Sequence type Mean 
Control 
SD 
First episode Sz 
Mean SD 
All stimuli 339.43 53.39 370.07 89.52 
DR1 338.64 61.70 373.78 102.56 
DR2 343.57 61.33 380.57 102.17 
DR3 319.21 50.42 365.36 106.79 
DR4 340.14 65.21 382.86 114.45 
DR5 331.86 57.48 370.71 91.00 
DA1 357.14 55.79 391.71 106.73 
DA2 386.79 76.87 435.07 101.53 
DA3 383.43 67.06 421.64 84.65 
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6.5 DISCUSSION 
The results from the current Study underline the relevance and importance of 
research on sequence effects. There has been limited research in this area in 
schizophrenia (see 6.1). Against the background of previous research, this Study draws 
attention to the fact that a large proportion of variance observed among single trials and 
washed out through conventional averaging of targets and non-targets (across sequence 
types) are due to systematic and reliable sequence effects. This Study reports results of an 
in-depth examination of specific sequence types that have theoretical and clinical 
significance. This is also the first time sequence effects on ERPs and RT have been 
investigated in FESz. 
6.5.1 DR sequences  
Both normal controls and the FESz group showed the same pattern of increasing 
P300 amplitude to DR series (NNNNNT> NNNNT>NNNT>NNT>NT). Previous studies 
in both control (Johnson & Donchin, 1980; Squires,Wickens, Squires, & Donchin,1976) 
and schizophrenia groups (Duncan-Johnson & Donchin, 1982) suggested a similar trend, 
but results were not examined statistically and were examined over shorter sequence 
lengths (usually a maximum length of 4-5 stimuli). Hence, this Study confirms and 
extends these results by demonstrating a significant linear contrast over the DR series for 
both control and FESz groups. This result is also consistent with findings in a chronic 
schizophrenia group (Gonsalvez et al., 1995). P300 amplitude changes at Pz arising from 
DR sequences varied dramatically (see Figures 7.1 & 7.2), suggesting that this sequence 
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type has a major effect on P300 amplitude in the auditory oddball paradigm. The change 
in target probability (0.5 vs. 0.15), made necessary in this Study by the sequence pattern 
requirements, are the most likely explanation for differences in P300 amplitudes between 
the two groups not reaching significance This is consistent with the results of previous 
studies indicating that patients with schizophrenia have significantly reduced P300 only 
to low probability stimuli, for example, 0.10, 0.20 and 0.30 and not to high probability 
stimuli, for example, 0.50 and 0.80 (Duncan, Perlstein, & Morihasa, 1987; Mathalon and 
Ford, 2002). The significant difference in P300 amplitude between the control and 
schizophrenia groups found in the Duncan-Johnson et al. sequence study, which also used 
a 0.50 probability, may be due to one, or a combination of variables, including task 
demands (simple vs. CRT), subject variables (first episode vs. chronic schizophrenia) or 
sequence structure (the current Study artificially increased certain types of sequences). 
There were no significant DR series effects for P300 latency consistent with 
Gonsalvez et al. (1999). The lack of significant findings for DR series effects on RT is 
consistent with the observed means for DR series shown in the sequence tree in the 
Duncan-Johnson et al. (1984) study; however it is in contrast to the decrease in RT over 
increasing numbers of preceding non-targets found in the Gonsalvez et al. (1995) study. 
It seems most likely that this difference would be explained by the differences in 
probability in the two studies — low (0.15) in the Gonsalvez et al. study and high (0.5) in 
the present Study and in the Duncan-Johnson et al. study. 
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The absence of a DR effect on RT and P300 latency, alongside a significant linear 
effect for DR on P300 amplitude, adds support to the results of other studies which argue 
against a common expectancy-violation explanation for P300 amplitude, but is in 
accordance with the TTI hypothesis. Gonsalvez and associates (Croft et al., 2003; 
Gonsalvez et al., 1999) have argued convincingly that the consistent increase in P300 
associated with increases in DR series is related to TTI and not to probability or number 
of non-target occurrences between targets. The fact that both the FESz and control groups 
showed similar DR sequence effects on P300 amplitude, would suggest that the temporal 
mechanisms underlying P300 variance associated with this sequence type are not 
impaired in this clinical group and is consistent with findings in chronic schizophrenia 
groups (Duncan-Johnson et al., 1984; Gonsalvez et al., 1995). 
6.5.2 DA sequences  
An important aim of this Study was the search for an ERP index of associative 
strength. The results of previous studies suggested that P300 amplitude associated with 
DA sequences might be a useful measure. The hypothesised linear trend for increased 
P300 amplitude over the DA sequence was not found in either the control group or the 
group with FESz. Thus the preliminary, but promising results of previous studies were 
not verified when this sequence type was examined over an extended range, and with an 
adequate signal:noise ratio. One possible explanation for the discrepancies between 
results may concern the magnitude of DA effects. DA effects with increasing runs of 
stimuli on P300 in previous studies were quite small and not tested statistically (see 
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6.1.1.1.). A visual inspection of the DA waveforms (see Figure 6.3) for the control group 
in this Study shows that DA effects on P300s were in the expected direction for the 
control group, but either the magnitude of the change was too small and/or the variance 
too great to reach statistical significance. The magnitude of DA effects did not increase, 
as expected, with extension of the DA series. In any event, the unfortunate outcome of 
these negative results is that the DA effects on P300 amplitude found in this Study could 
not be considered a useful index of associative strength, and thus it was not possible to 
verify if an impairment of associative strength was central to and could contribute to the 
widely replicated P300 deficit observed in schizophrenia. 
There was, however, as hypothesised, a significant linear DA series effect for 
controls on P300 latency, increasing with DA series length. As hypothesised this P300 
latency increase over the DA series was not found in the group with FESz (see Figure 
6.4). This effect has not been examined in previous research and is difficult to interpret 
with certainty. As these findings in the control group are in the same direction as the 
effects on RT, they will be discussed further after RT is examined 
The hypothesised DA series effect on RT for controls was found, with both linear 
and quadratic contrasts significant. While P300 latency showed a clear increase with each 
DA level, RT showed an increase from DA1 to DA2 before plateauing between DA2 and 
DA3. This indicates the possibility that different mechanisms may be responsible for 
P300 latency and RT effects. One possible explanation is that DA effects on P300 latency 
are more stimuli-related. They may be more sensitive to the preceding stimulus patterns 
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and reflect more automatic, non-conscious processes and priming. In contrast, RT could 
be seen as more response-related and more sensitive to conscious and controlled 
strategies (Maglliero, Bashore, Coles, & Donchin, 1984; McCarthey & Donchin, 1981; 
Smith, Mulder, Mulder, & Brands, 1992; Smulders, Kok, Kanemans, & Bashore, 1995; 
Verlager, 1997). This notion is consistent with previous investigations that have 
examined effects of practice (Somer et al., 1990) and manipulated expectancy (Matt et 
al., 1992) effects on RTs but not on ERPs. The hypothesised deficit in DA series effects 
on the schizophrenia group was not found. This finding provides further support for the 
hypothesis that DA sequence effects on P300 latency and RT may result from different 
mechanisms. The above suggestion would indicate that the schizophrenia group may 
have a deficit in automatic non-conscious mechanisms engaged by the stimulus sequence, 
but not in sequence effects on conscious and controlled response strategies. 
6.5.3 Continuing (matches) vs. discontinuting (mismatches) stimuli  
Both the FESz and the control groups showed increased P300 amplitude for 
discontinued sequence, when compared to continued sequence, for target (NT>TT) and 
non-target stimuli (TN>NN) in the shortened form of analysis. This is consistent with 
findings in healthy controls (Broderant & Polich, 1997) and in schizophrenia (Duncan-
Johnson et al., 1984). However, no between-group differences emerged. 
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6.5.4 Sequence paradigms in clinical settings:  
This Study also shed light on the applicability of sequence paradigms in clinical 
settings. The current paradigm was more difficult for this clinical population than the 
shorter oddball used in Studies 1 and 2. In the previous paradigm, data from all subjects 
was acceptable, whereas the longer paradigm used in the current Study had a 22% 
attrition rate for the clinical population, but not for the normal controls. Some FESz 
participants were unable to finish the task, falling asleep, while a further two were 
excluded because of high percentage of inaccurate responses. Polich and Broderant 
(1997) advocate the use of sequence effects as a sensitive means for assessing implicit 
cognitive information-processing capabilities in applied/clinical testing situations, and 
have proposed the use of an abbreviated format (McCarthy, Wood, Williamson, & 
Spence, 1989) which would be more easily tolerated by clinical patients than traditionally 
extended sequence paradigms. In this Study, although employing an extended paradigm, 
the analysis of short continuing and discontinuing series (NN, TN, TT, NT), as proposed 
by Polich and Broderant was also trialled. Consistent findings for sequence types 
emerged over group, but no between-group differences were observed. 
6.5.5 T+1 vs. T-1 sequence effects on N100 amplitude  
The reduced N100 amplitude for T+1 (vs T-1) found in Study 2 was not 
replicated in this Study. Hence, the hypothesis that this reduction in N100 amplitude 
could be related to post-target recovery mechanisms for the T+1 stimulus was not 
supported. This non-replication of reduced N100 amplitude when TT is a sequence 
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variant in the paradigm, is consistent with Polich and Broderant's (1997) findings and 
suggests an alternative explanation for the reduction in N100 to T+1, when TT is not a 
sequence variant in the paradigm (i.e. when every target is followed by a non-target). 
These findings support the possibility that mechanisms related to vigilance and 
preparedness may be a more likely explanation. The sequential pattern of auditory events 
is processed on an ongoing basis (Barry, de Pascalis, Hodder, Clarke, & Johnstone, 
2003). The brain prepares for the next event, in the case of the T+1 stimulus, by reducing 
thresholds of activation or allocating less attention, because the non-target status of this 
stimulus becomes known, resulting in reduced N100 amplitude. Thus, the failure of the 
schizophrenia group to demonstrate a reduced N100 to T+1 stimuli appears to be 
associated with an ability to modulate attentional resources to predictable occurrences of 
irrelevant (non-target) events, a dysfunction that has been hypothesised by several 
information processing models (See Chapter 2.2 for details). It could also be argued that 
this pattern of results is not inconsistent with the Gray-Hemsley proposal that people with 
schizophrenia fail to establish appropriate response biases, because they are unable to use 
stored memories of regularities based on their previous experience. However, in the past, 
N100 variations have been interpreted in terms of general or more specific attentional 
effects and the postulation that the N100 may reflect more specific mechanisms 
implicated in the Gray- Hemsley model may be considered tentative. Further examination 
of this is feasible if, within the same subjects, deficits in latent inhibition tasks are 
correlated with a similar pattern of ERP deficits observed in this Study. 
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7 SPECIFICITY OF TARGET AND NON-TARGET ERP DEFICITS IN FESz 
COMPARED WITH CLINICAL (ADHD) AND NORMAL CONTROLS 
7.1 INTRODUCTION AND RATIONALE 
The current thesis identified several notable target and non-target ERP deficits in 
schizophrenia; however, it is critical to determine whether these deficits are specific to 
the disorder. Attention Deficit Hyperactivity Disorder (ADHD) and schizophrenia have 
certain cognitive deficits in common: disturbed attention (Berger & Posner 2000; Satter 
1994) reduced working memory capacity (Oie, Sunde, & Rund, 1999; Karatekin & 
Asarnow, 1998; Ross, Harris, Olincy and Radant, 2000) and inhibitory dysfunction 
(Barkley 1997; Liddle & Morris, 1991). Dopamine dysfunction is also implicated in these 
cognitive deficits in both ADHD and schizophrenia (Nieoullon, 2002). Although ADHD 
is an early onset disorder, 60% of adolescents with ADHD maintain this diagnosis into 
adulthood (Biederman et al., 1996; Wender, 1995). Because of these shared deficits 
adolescents and young adults with ADHD, provide a useful psychiatric control group for 
exploring the specificity of ERP findings in a group with FESz. The reduced P300 
amplitude observed in both these disorders makes this comparison even more compelling. 
In studies investigating possible differences in the two disorders, smooth pursuit 
eye movement (SPEM) abnormalities (Jacobsen, Hong, Hommer et al., 1996; Ross, 
Olincy, Harris, Sullivan and Radant, 2000), failure to inhibit the P50 auditory ERP in a 
paired stimulus conditioning-testing paradigm (Olincy et al., 2000) and increased eye 
blinking (Jacobsen, et al., 1996), have been found to be present in schizophrenia, but not 
in patients with ADHD. Some studies have found that although both groups have 
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impaired performance on tasks measuring attention, working memory and inhibition, the 
pattern of deficits is different. On the continuous performance test (CPT), adult ADHD 
patients made more errors of omission (failure to detect the target stimulus) without 
increases in commission errors (incorrectly responding to a non-target) (Holdnack, 
Moberg Arnold, Gur, & Gur, 1995) while children with ADHD made significantly more 
errors of commission and omission than normal children. Patients with schizophrenia, on 
the other hand, have shown impaired ability to distinguish target (signal) from non-target 
(noise) information, as identified by the discrimination index (Cornblatt, Lenzenweger, & 
Erlenmeyer-Kimling, 1989). On the delayed oculomotor response task, used to study 
inhibitory and working memory function, both ADHD and schizophrenia patients showed 
disinhibition (an increased percentage of premature saccades), however, only the 
schizophrenia group demonstrated decreased spatial accuracy of the remembered 
saccade, purportedly a form of working memory (Ross et al., 2000). Some comparison 
studies have also reported deficits, which are sensitive, but not specific for ADHD and 
schizophrenia. For example, similar backward masking deficits have been found in both 
ADHD and schizophrenia patients (Rund, Oie, & Sundet, 1996). 
Reduced P300 amplitude in the auditory oddball paradigm has been a consistent 
and sensitive finding for schizophrenia (see Chapter 2) and is also found in ADHD 
(Frank, Seiden, & Napolitano, 1998; Holcomb, Ackerman, & Dykman, 1986; Johnstone 
& Barry, 1996; Jonkman et al., 1997; Loiselle, Stamm, Matinsky and Whipple, 1980; 
Overtoom et al., 1998 Robaey, Bretton, Dugas, & Renault, 1992; Satterfield, Schell, 
Nicholas, Satterfield and Freese, 1990). Although ERPs have been acquired in auditory 
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oddball paradigms for both groups, it has been difficult to compare these findings due to 
the difference in ages. Most schizophrenia studies have employed adults, while most 
studies with ADHD have employed children. Differences in paradigm variables, for 
example, stimuli, ISI and probability, and in data acquisition procedures, also add to the 
difficulty of making reliable inferences from such comparisons. The current Study has 
controlled for these variables, obtaining data with the same paradigm, with age and sex-
matched participants with FESz, ADHD, and normal controls. 
In common with trends in schizophrenia research, ADHD studies have focused on 
the P300 component elicited by target stimuli, although reduced N200 amplitude 
(Satterfield, Schell, Backs, & Hidaka, 1984; Satterfield et al., 1990; Satterfield, Schell, & 
Nicholas, 1994) and increased P200 amplitude (Holcomb et al., 1986; Satterfield et al., 
1994; Robaey et al.1992) to targets have also occasionally been reported in groups with 
ADHD. Findings for N100 amplitude to targets have been mixed, with some studies 
finding reduced N100 to targets (Loiselle et al., 1980; Satterfield et al., 1984; Satterfield 
et al., 1994), but not others (Johnstone & Barry, 1996; Lazzaro, Gordon, Whitmont, 
Meares, & Clarke, 2001). Barry, Johnstone & Clarke (2003) suggest an age-specific 
effect, in ADHD and control groups with N100 differentiation occurring between 7-9 
years and possibly also again at 12-14 and 16-18 years. 
Few studies have investigated ERPs to non-target stimuli. Johnstone and Barry 
(1996) and Winsberg, Javitt and Silipo (1997) found no significant deficits in people with 
ADHD with regard to N100 or P200 measures to non-target stimuli. If the N100 
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amplitude deficit pattern to target and non-target stimuli found in chronic and FESz 
groups in Study 2 is a non-specific attentional dysfunction, the ADHD group should 
display similar abnormalities. Given that the literature on cognitive deficits in ADHD 
does not suggest a failure to use context in information processing, the ADHD ERP 
findings discussed above, and the theoretical and empirical reasons, outlined in Chapter 
4, for expecting deficits to target and non-target stimuli in schizophrenia, it was important 
to determine whether the N100, P200 and P300 component deficits to target and non-
target stimuli (T-1 & T+1) found in Study 2 would also be present in the ADHD group. 
7.1.1 Hypotheses 
a) N100 and P200 components 
1. N100 amplitude will be increased to target compared with non-target stimuli in 
the clinical (ADHD) and normal controls, but not in the FESz group. 
2. N100 amplitude will be increased to T-1 compared with T+1 stimuli in the 
clinical (ADHD) and normal controls, but not in the FESz group. 
3. N100 latency will be delayed to non-target compared with target stimuli in the 
clinical (ADHD) and normal controls, but not in the FESz group. 
4. P200 amplitude will be increased and prolonged to non-target compared with 
target stimulus in the clinical (ADHD) and normal controls, but not in the FESz 
group. 
5. P200 amplitude will be increased and prolonged to T-1 compared with T+1 
stimuli in the clinical (ADHD) and normal controls, but not in the FESz group. 
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b) N200 and P300 component (target stimuli) 
1. N200 amplitude will be reduced in the FESz group compared to the clinical and 
normal controls. 
2. P300 amplitude will be reduced in the FESz group compared to the clinical and 
normal controls. 
3. P300 amplitude will be reduced in the clinical (ADHD) control group compared 
with the normal control group. 
7.2 METHOD 
7.2.1 Participants  
Participants with ADHD 
Twenty males diagnosed with ADHD aged between 13 and 26 years, with a mean 
age of 17 years (SD = 4.29 years), were referred by paediatricians, clinical psychologists 
and psychiatrists to participate in this Study. All patients were subsequently interviewed 
using a semi-structured interview based on DSM-IV criteria for ADHD (American 
Psychiatric Association, 1994). All participants had been free of stimulant treatment for a 
period of 2 weeks or longer prior to testing. Patients with a history of neurological 
disorder or substance abuse were excluded from the Study. 
Participants with FESz and normal controls 
A subset of twenty male participants from the FESz group, along with their 
matched pairs from the normal control group, was included in this Study. The selection of 
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this subset from the original sample of 40 subjects used in Study 2 (see Chapter 5.2.1) 
was based on age matching within two years to the ADHD participants. The FESz group 
aged between 14 and 28 had a mean age of 18.9 years (SD = 2.88years), and the normal 
controls aged between 14 and 29 had a mean age of 18.45 (SD = 3.87). 
7.2.2 Data Acquisition and Procedure  
Procedures for data acquisition were the same as Study 2 (Chapter 5.3). This 
Study was approved by the ethics' committees of the University of Wollongong and the 
Western Sydney Area Health Service. 
7.3 ANALYSIS 
7.3.1  Midline ERPS  
N100 and P200 amplitudes and latencies were submitted separately to 3-way 
ANOVAs. The design incorporated 3 groups (FESz, ADHD [clinical control] and normal 
controls) by 3 stimuli (T-1, T, T+1) by 3 electrode sites (Fz, Cz, Pz), with repeated 
measures for site and stimulus factors. For the group factor, two specific contrasts were 
conducted:(i) FESz vs. ADHD and normal controls, to determine if the FESz group was 
different from the 2 control groups, and (ii) ADHD vs. normal controls to determine if 
the clinical control group differed from the normal control group. For the stimulus factor, 
two specific planned contrasts were carried out: (i) target vs. non-targets (T vs. T-1/T+1) 
to examine whether the target status influenced ERP components and (ii) between non-
targets (T-1 vs. T+1) to examine whether the sequential position of the non-target 
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affected ERP components. For the site factor, linear and quadratic contrasts were 
examined, the linear contrast purporting to examine reduced amplitudes at parietal sites 
(Fz vs Pz) and the quadratic contrast purporting to test the frequently observed maximal 
amplitudes at central sites (Cz vs. Fz+Pz). 
N200 and P300 components were reliably observed only to the target stimulus 
and were therefore subjected to a group (FESz, ADHD, normal controls) by site (Fz, Cz, 
Pz) ANOVA repeated measures design. Similar linear and quadratic contrasts as 
described above were conducted for the site factor. The Statistical Package for Social 
Sciences 10.0 program (SPSS Inc., 1999) was used in all analyses. 
As a result of the above contrasts all comparisons were based on a single degree 
of freedom, obviating the need to employ statistical procedures to correct for alpha (e.g. 
Bonferroni) or sphericity effects (e.g., Greenhouse-Geisser). 
7.3.2 Discriminant function analysis  
The purpose of conducting a discriminant function (DA) analysis was to 
determine the accuracy with which the ERP measures could correctly classify persons 
with and without schizophrenia. Hence two groups were defined: the schizophrenia group 
and the non-schizophrenia group (the two control groups combined). Component 
amplitude and latency measures on which the clinical and control groups were 
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significantly different in ANOVA results were entered into three separate stepwise 
disciminant function analyses in the following manner: 
1. N100 and P200 component amplitude and latency for target, T-1 and T+1 stimuli. 
Where the number of significant differences exceeded the number of variables 
permissible under subject-to-variable ratio recommendations, and differences were 
observed at more than one site, then only the site at which the component has maximal 
between stimuli differences for amplitude/latency was entered (E.g., Cz for P200). 
2. All significant target N200 and P300 amplitude and latency at midline sites. 
3. Variables chosen from the stepwise Dfas described in 1 and 2 where then entered into 
a third stepwise Dfa 
7.4 RESULTS 
The same ERP waveforms are presented in Figure 7.1 to accentuate between-
group differences and in Figure7.2 to accentuate within group differences. Mean and 
standard deviation amplitude and latency values are presented in Tables 7.1 and 7.2 
respectively. A small percentage (2% for controls and 3% for FESz and ADHD) of ERP 
measures were identified as outliers (greater or less than one and a half the interquartile 
:Joevellikgatens -.••,.."$; 210em 
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-10(%".ZIac 
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Pz 
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range from the upper and lower quartile). All results below are based on data with 
outliers; however results remained significant following removal of outliers. All 
significant results appear in Tables 7.2 — 7.4 or are reported in text. Statistical values for 
non-significant results are not reported, but are attached (see Appendix 3, CD-Rom). 
—Control  —ADHD  —First  episode schizophrenia 
Figure 7.1 ERPs to T-1, Target and T+1 stimulus for normal control, ADHD and FESz 
groups 
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Figure7.2 ERP waveforms to T-1, Target and T+1 stimuli, superimposed to show within 
group differences, for control ADHD and FESz. 
Table 7.1 N100 and P200 mean and standard deviation amplitude and latency scores 
FESz 
Mean SD 
Normal control 
Mean SD 
ADHD 
Mean SD 
T-1 
N100 amplitude Fz -6.05 2.73 -7.39 4.21 -7.74 4.69 
Cz -5.14 2.41 -7.87 4.61 -6.48 4.72 
Pz -3.79 2.21 -5.42 3.28 -4.08 2.11 
N100 latency Fz 108.53 22.66 110.76 19.56 111.40 14.64 
Cz 103.74 21.99 105.48 13.57 99.60 10.37 
Pz 96.29 18.99 98.92 16.14 96.60 10.96 
P200 amplitude Fz 1.51 3.82 2.29 4.24 0.15 4.06 
Cz 4.07 3.89 5.70 4.98 4.97 4.09 
Pz 2.96 3.41 3.88 3.93 3.89 3.08 
P200 latency Fz 196.17 35.54 182.97 27.81 188.67 34.22 
Cz 199.03 32.99 178.57 25.28 183.71 32.00 
Pz 200.54 38.57 184.35 33.14 176.46 35.44 
Tar get 
N100 amplitude Fz -4.95 3.55 -10.93 4.56 -9.66 5.56 
Cz -4.47 2.34 -9.47 5.33 -8.29 6.55 
Pz -3.22 2.02 -4.88 3.34 -4.46 2.96 
N100 latency Fz 107.56 18.39 114.50 16.07 117.17 18.87 
Cz 95.31 18.04 106.28 11.52 103.96 17.23 
Pz 92.87 19.66 96.39 19.65 91.00 18.62 
P200 amplitude Fz 3.02 5.98 -1.66 5.31 -2.86 5.05 
Cz 4.33 5.37 1.63 7.57 2.98 6.08 
Pz 5.16 4.51 3.08 6.33 4.45 3.82 
P200 latency Fz 168.32 15.54 176.14 16.31 172.13 16.57 
Cz 161.55 17.38 171.56 17.47 170.05 19.83 
Pz 156.11 22.97 156.00 28.94 161.36 24.26 
N100 amplitude Fz -5.36 2.97 -4.74 3.74 -5.23 3.69 
Cz -3.91 2.38 -5.05 4.35 -4.82 4.66 
Pz -3.23 2.51 -4.33 4.04 -4.03 3.73 
N100 latency Fz 122.07 39.49 107.02 14.34 110.45 16.47 
Cz 104.27 16.06 101.66 14.86 95.88 12.20 
Pz 92.99 16.18 97.00 14.62 94.80 12.59 
P200 amplitude Fz 1.64 3.57 4.62 4.11 4.02 5.44 
Cz 3.26 3.61 6.97 4.42 7.52 4.28 
Pz 2.57 3.35 4.83 3.40 6.11 3.00 
P200 latency Fz 185.55 26.80 184.98 21.00 197.24 22.04 
Cz 180.28 28.73 185.40 20.77 198.39 24.15 
Pz 163.23 33.65 190.80 21.41 202.69 26.08 
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Table7.2 N100 and P200 mean and standard deviation amplitude and latency scores 
FESz 
Mean SD 
Normal control 
Mean SD 
ADH D 
Mean SD 
N200 amplitude Fz -5.4408 5.1813 -10.496 6.81705 -10.605 6.95912 
Cz -0.4826 6.30042 -3.8156 9.12753 -2.5057 7.90954 
Pz 1.28895 4.70631 0.66085 6.37969 1.78905 5.93713 
N200 latency Fz 222.659 21.9944 217.299 20.9499 216.96 17.5089 
Cz 214.915 18.7223 211.082 13.3428 215.091 18.3824 
Pz 203.918 34.9195 194.642 26.1287 202.477 23.742 
P300 amplitude Fz 9.82375 8.60497 9.8305 7.93304 4.0376 7.64664 
Cz 16.4389 8.86339 20.3025 9.87283 11.9716 9.54835 
Pz 20.8744 9.67486 27.8976 10.4392 19.969 9.93474 
P300 latency Fz 325.466 54.8732 320.179 29.1231 318.784 22.2235 
Cz 322.769 40.9583 317.4 29.4018 309.208 47.9957 
Pz 327.576 40.7367 325.393 24.945 316.51 40.3415 
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7.4.1 N100 Component 
7.4.1.1 Amplitude 
The results of the statistical analyses are summarised in Table 7.3 
FESz versus clinical (ADHD) and normal controls 
There was a significant main effect for group, with N100 amplitude reduced in 
the FESz group compared with the clinical (ADHD) and normal control groups. This 
main effect for group was further qualified by Group X Stimulus, Group X Site and 
Group X Stimulus X Site interactions as follows (see Table 7.3, values in blue & Figure 
7.3). With regard to the target vs. non-target comparisons, significant group differences 
were observed at frontal rather than parietal sites, so that the control and ADHD groups 
demonstrated reduced N100 amplitude to the non-target compared with target stimuli, 
while the FESz group demonstrated similarly reduced amplitudes to all stimuli. 
Additionally the ADHD and normal control group appeared to have reduced amplitude to 
T+1 compared with T-1, at the frontal rather than parietal sites, with the results 
approaching significance (p = .06), whereas the FESz group had similarly reduced 
amplitudes for both non-targets (see Figure 7.3). Hence, the reduction in N100 amplitude 
in the FESz group compared with normal and clinical controls was most prominent to 
target compared with non-target stimuli. 
Over group and site, targets produced larger amplitudes than non-targets and T+1 
produced larger amplitudes than T-1, with this effect being pronounced at the fronto- 
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central rather than parietal sites (see Table 7.3, values in green & Figure 7.3). As 
mentioned above, this effect was qualified by a group interaction with the results of the 
ADHD and normal control groups (but not the FESz group) contributing to these effects. 
The expected fronto-central maximum for N100 amplitude was also observed, 
with both linear and quadratic contrasts for site yielding significant results (see Table 7.3, 
values in red). 
Table 7.3 Summary of N100 Amplitude results 
FESz vs ADHD+NC 
41(1,58) 
ADHD vs NC 
df (1,38) 
Stimulus Site F p F p 
Group 5.91 .02 
Grp X Stim T vs NTs 9.96 .003 
T-1 vs T+1 
Grp X Site Cz vs Fz & Pz 4.33 .04 
Fz vs Pz 
Grp X Stim X T vs NTs Cz vs Fz & Pz 
Site Fz vs Pz 18.47 .000 
T-1 vs T+1 Cz vs Fz & Pz  
Fz vs Pz 3.46 .06 
Stimulus T vs NTs 5.31 .03 19.76 .0001 
T-1 vs T+1 13.07 .001 16.19 .0001 
Stim X Site T vs NTs Cz vs Fz & Pz 
Fz vs Pz 51.22 .0001 
T-1 vs T+1 Cz vs Fz & Pz 6.02 .02 4.76 .04 
Fz vs Pz 4.54 .04 9.80 .003 
Site Cz vs Fz & Pz 5.88 .02 10.85 .002 
Fz vs Pz 45.77 .0001 44.90 .0001 
-14 - -14 - ADHD Control 
-2 - 
Cz 0 
-2 - 
Fz Cz 0 
Site Site 
-14 - First episode schizophrenia 
-4 - 
-12 - 
-4 - 
-12 - 
-12 - 
-2 - 
Fz Cz Pz 0 
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Site 
T-1 —0— Target T+1 
Figure 7.3 N100 amplitude to target and non-target stimuli for all groups. 
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Clinical (ADHD) versus normal controls 
Neither main effects for group nor interaction effects were significant. Over group 
and site, targets produced larger amplitudes than non-targets and T+1 produced larger 
amplitudes than T-1, with this effect being pronounced at the fronto-central rather than 
parietal sites (see Table 7.3, values in green & Figure 7.3). This effect was qualified by a 
Stimulus X Site interaction with the target vs. non-target effect occurring at frontal 
compared with parietal sites, and the non-target effect, showing both linear and quadratic 
contrasts, being maximal at fronto-central compared with parietal sites. 
The expected fronto-central maximum for N100 amplitude was also observed, 
with both linear and quadratic contrasts for site yielding significant results (see Table 7.3, 
values in red). 
Summary: The results yielded an interesting pattern of deficits that appear to be specific 
to schizophrenia. Specifically, the FESz group did not differ in the way they responded 
between targets and non-targets, or between the two non-targets, while the normal 
control and ADHD groups demonstrated decreased N100 amplitude to non-targets 
compared with targets (maximal at fronto-central sites) and decreased N100 amplitude to 
T+1 compared with T-1 (maximal at fronto-central sites). 
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7.4.1.2 Latency 
FESz versus clinical (ADHD) and normal controls 
N100 latency effects were not significant for group, however, there was a 
significant Group X Stimulus interaction for the target vs. non-target contrast, F(1,58) = 
5.63, p < 0.05, as non-targets produced more prolonged latencies than targets in the 
clinical (ADHD) and normal control group, while the FESz group showed the opposite 
pattern. As a result, compared with the control groups, the FESz group showed delayed 
latency to target rather than non-target stimuli. 
Over groups there was a significant linear contrast for site, F(1,58) = 55.49, p < 
0.001, with N100 latency prolonged at frontal compared with parietal sites. 
Clinical controls (ADHD) versus normal control 
Effects were not significant for group or interactions with group for the ADHD 
vs. normal controls comparison. There was a Stimuli X Site interaction for the target vs. 
non-target comparison, F(1,38) = 4.41, p < 0.05, indicating prolonged N100 latency to 
target compared with non-target stimuli at frontal, rather than parietal sites. There was a 
main effect for site, with the significant linear contrast, F(1,38) = 50.4, p < 0.001, 
showing N100 latency prolonged at frontal compared with parietal sites. 
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Summary: Targets (vs. non-targets) produced a delayed N100 in the FESz group, but had 
the opposite effect for the two control groups who responded similarly, suggesting that 
this latency effect might be specific to schizophrenia. 
7.4.2 P200 component 
7.4.2.1 Amplitude 
The results of the statistical analyses are summarised in Table 7.4 
FESz versus clinical (ADHD) and normal controls 
Main effects for group were not significant, although Group X Stimuli, Group X 
Site and Group X Stimuli X Site interactions were significant. With regard to the target 
vs. non-target comparisons, the control and ADHD groups demonstrated reduced P200 
amplitude to the target compared with non-target stimuli, especially at the frontal site 
(vs. parietal) while the FESz group had similar amplitudes to both stimuli types (see 
Table 7.4, values in blue & Figures 7.4 and 7.5). Additionally the ADHD and normal 
control group showed enhanced amplitude to T+1 (vs. T-1) across sites, whereas the 
FESz group did not differ in the way that they responded to the two non-targets (see 
Table 7.4, values in blue & Figure 7.4). 
Over the three groups, the Stimulus X Site interactions (linear and quadratic) for 
the target vs. non-target comparison were significant, suggesting stimuli-based 
topographical shifts, with targets producing maximal amplitude parietally and non- 
225 
targets centrally(see Table 7.4, values in green & Figure 7.5). For the non-target 
comparison, a quadratic contrast indicated the reduced P200 amplitude to T-1 compared 
withT+1 stimulus was maximal at the vertex (see Table 7.4, values in green). 
Across groups and stimuli, the expected centro-parietal maximum for P200 
amplitude was also observed, with both linear and quadratic contrasts yielding significant 
results (see Table 7.4, values in red). 
Table 7.4 Summary of P200 amplitude results 
FESz vs ADHD+NC ADHD vs NC 
df(1,58) df (1,38) 
Stimulus Site 
Group 
Grp X Stim T vs NTs 11.18 .001 
T-1 vs T+1 5.71 .02 
Grp X Site Cz vs Fz & Pz 5.57 .02 
Fz vs Pz 
Grp X Stim X T vs NTs Cz vs Fz & Pz 
Site Fz vs Pz 4.30 .04 
T-1 vs T+1  Cz vs Fz & Pz 
Fz vs Pz 
Stimulus T vs NTs 14.44 .001 
T-1 vs T+1 14.23 .001 
Stimulus X T vs NTs Cz vs Fz & Pz 5.96 .02 
Site Fz vs Pz 11.08 .002 27.05 .0001 
T-1 vs T+1  Cz vs Fz & Pz 3.98 .05  
Fz vs Pz 4.62 0.04 
Site Cz vs Fz & Pz 45.71 .0001 51.64 .0001 
Fz vs Pz 24.36 .0001 26.62 .0001 
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Figure 7.4 P200 amplitude to target and non-target stimuli for all groups across midline 
sites. 
Clinical control (ADHD) versus normal control 
Effects were not significant for group nor were any interaction effects significant 
with group for the ADHD vs. normal controls comparison. 
Over groups, there was a significant main effect for stimulus for both the target 
vs. non-target contrast and the non-target contrast, T-1 vs.T+1, with target stimuli 
producing reduced amplitude compared with the non-target stimuli and T-1 producing 
reduced amplitude compared with T+1. Across groups, the expected centro-parietal 
maximum for P200 amplitude was also observed, with both linear and quadratic contrasts 
yielding significant results. 
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Summary: The reduced P200 amplitude found frontally, to target compared with non-
target stimuli, which was present in the ADHD and normal controls, was not found in the 
FESz group. Hence, these P200 amplitude deficits also appear to be specific to FESz. 
Site 
-6 - 
Figure 7.5 P200 amplitude to target and non-target stimuli (T-1 & T+1) for all groups. 
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7.4.2.2 Latency 
The results of the statistical analyses are summarised in Table 7.5. 
FESz versus clinical (ADHD) and normal controls 
Effects were not significant for group, however, Group X Stimulus and Group X 
Stimulus X Site interactions were significant as follows. With regard to the non-target 
comparisons, significant group differences were observed at parietal rather than frontal 
sites, so that the control and ADHD groups demonstrated earlier P200 latency to T-1 
compared with T+1 stimuli, while the FESz group showed the reverse pattern (see Table 
7.5 values, in blue & mean scores in Table 7.1). 
Across group, latency was earlier to targets than non-targets and this effect was 
maximal at Pz (see Table 7.5, values in green & mean scores in Table 7.1). The main 
effect for site was also significant; the significant linear contrast indicated latency was 
earliest at Pz. 
Clinical control (ADHD) versus normal control 
Effects were not significant for group nor were any interaction effects significant 
with group for the ADHD vs. normal controls comparison. 
Over group, there was a significant main effect for stimulus for both the target vs. 
non-target contrast and the non-target contrast, T-1 vs.T+1, with target stimuli producing 
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earlier latency compared with the non-target stimuli and T-1 producing earlier latency' 
compared with T+1. 
Table 7.5 Summary of P200 latency results 
FESz vs ADHD+NC ADHD vs NC 
df (1,58) df (1,38) 
Stimulus Site F p 
Group 
Grp X Stim T vs NTs 
T-1 vs T+1 16.13 .001 
Grp X Site Cz vs Fz & Pz 
Fz vs Pz 
Grp X Stim X  T vs NTs Cz vs Fz & Pz 
Site Fz vs Pz 
T-1 vs T+1  Cz vs Fz & Pz 
Fz vs Pz 11.32 .001 
Stimulus T vs NTs 53.17 .0001 33.70 .0001 
T-1 vs T+1 5.20 .03 
Stim X Site T vs NTs Cz vs Fz & Pz 
Fz vs Pz 6.68 .01 
T-1 vs T+1  Cz vs Fz & Pz 
Fz vs Pz 4.52 .04 
Site Cz vs Fz & Pz 
Fz vs Pz 9.61 .003 4.09 .056 
This effect for both contrasts was qualified by an interaction with site, indicating that the 
difference was maximal parietally (see Table 7.5, values in green). Across group, the 
expected centro-parietal maximum for P200 amplitude was also observed, with both 
linear and quadratic contrasts yielding significant results (see Table 7.5, red). 
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Summary: T+1 stimuli produced delayed latency in the two control groups, but not in the 
FESz group, an effect maximal at the parietal site. 
7.4.3 N200 component  
7.4.3.1 Amplitude 
FESz versus clinical (ADHD) and normal controls 
Main Effects were not significant for group. However, there was a Group X Site 
interaction with a significant linear contrast, F(1,58) = 6.94, p = 0.01, indicating that the 
FESz showed reduced frontal N200 amplitude compared with normal and clinical 
(ADHD) controls. Significant linear, F(1,58) = 95.01, p < .0001, and quadratic, F(1,58) 
= 7.94, p < .01, contrasts for site indicated that N200 amplitude was maximal frontally 
with marked reductions at centro-parietal sites. 
Clinical control (ADHD) versus normal control 
Effects were not significant for group or group X site interaction. Significant 
linear, F(1,38) = 99.64, p < 0.001, and quadratic, F(1,38) = 4.97 p < .05, contrasts for 
site indicated that N200 amplitude was maximal frontally. 
Summary: There was a frontal reduction in N200 amplitude specific to the FESz group. 
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7.4.3.2 Latency 
FESz versus clinical (ADHD) and normal controls 
Effects were not significant for group or Group X Site interaction. Significant 
linear, F(1,58) = 24.91, p < 0.001, and quadratic, F(1,58) = 4.36 p < .05, contrasts for 
site indicated that N200 latency was prolonged fronto-centrally. 
Clinical control (ADHD) versus normal control 
Effects were not significant for group or Group X Site interaction. Significant 
linear, F(1,58) = 25.13, p < 0.001, and quadratic, F(1,58) = 9.58 p < .01, contrasts for 
site indicated that N200 latency was prolonged fronto-centrally. 
7.4.4 P300 component 
7.4.4.1 Amplitude 
FESz versus clinical (ADHD) and normal controls 
The main effect for group was not significant, however, there was a main effect 
for site, with the expected parietal maximum for P300 amplitude being observed for the 
linear contrast, F(1,58) = 138.53, p < .001. This result was qualified by a significant 
Group X Site interaction with the linear contrast, F(1,58) = 6.23, p < 0.01, indicating that 
this pattern was maximal for the control (clinical + ADHD) group compared with the 
FESz group (see Figure 7.6). 
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Clinical (ADHD) versus normal controls 
There was a significant main effect for group, F(1,38) = 7.88, p < .01 with P300 
amplitude reduced in the ADHD group compared with normal controls (see Figure 7.6). 
Across group, the expected parietal maximum for P300 amplitude was also observed, 
with a significant linear contrast, F(1,38) = 145.57, p < .001, for site. 
Summary: Over sites, the ADHD group demonstrated reduced P300 amplitude compared 
with normal controls. The FESz group did not demonstrate a significantly reduced P300 
amplitude when compared to the combined (clinical + normal ) control group. The 
conventionally observed enhancement of P300 amplitude from frontal to parietal sites 
was more pronounced for the combined control groups when compared with the FESz 
group. 
Control —0— First episode Sz —A— ADHD 
Figure 7.6 P300 amplitude for all groups at midline sites. 
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7.4.4.2 Latency 
Effects for group, site and group by site interactions were not significant for P300 latency 
in either of the group comparisons. 
7.4.5 Discriminant function analysis (DA)  
The results of the three stepwise DAs are presented in Table 7.6 
Table 7.6 Results of stepwise discriminant function analyses 
% Correctly classified 
Variables entered FESz ADHD and Variables included by 
in stepwise DA normal controls stepwise DA * 
1. N100, P200 
T, T-1, T+1 
2. N200, P300 
T 
85% 82.5% 
Wilk's 43,58) = .555, 
X2  = 33.28, p<.001 
65% 55% 
Wilk's 41,58) = .869, 
x
2 
= 8.06, p<.01 
T+1 P200 latency (-0.71) 
T-1 P200 latency (0.43) 
T N100 amplitude (.67) 
T N200 amplitude (1.0) 
3.Combined 85% 82.5% T+1 P200 latency (-0.71) 
stepwise variables Wilk's 43,58) = .555, T-1 P200 latency (0.43) 
from 1 and 2 x2 = 33.28, p<.001 T N100 amplitude (.67) 
* standardised canonical discriminant function co-efficients in brackets 
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Entering the same target and non-target N100 and P200 components as those used 
in the DA in Study 2 (see 7.3.2) 17.5% of the clinical + normal control group, i.e. three 
normal controls and four ADHD controls, would have been incorrectly classified as 
belonging to the schizophrenia group (false positives), while 15%, 3 people with FESz, 
would have been inaccurately identified as belonging to the clinical and normal control 
group (false negatives). However, when only N200 and P300 components to target 
stimuli were used, the accuracy rate was dramatically reduced with 45% of the clinical + 
normal control group, (10 normal controls & 8 ADHD controls) being incorrectly 
classified. 
When the critical variables selected by the two stepwise analyses (i. N100, P200 
& ii. N200, P300) above were combined and entered into a stepwise DA the results were 
identical to the N100, P200 analysis. In other words, the later components (N200, P300) 
derived from the target stimuli failed to enhance the classification accuracy derived from 
the earlier components (N100, P200). 
7.5 DISCUSSION 
The results yielded several distinctive findings for both N100 and P200 amplitude 
and latency for the FESz group, compared to the clinical (ADHD) and normal control 
group, supporting the possibility that these results are specific to schizophrenia. In 
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contrast, reduced P300 amplitude was not found to be specific for the FESz group and 
also occurred in ADHD. 
Results supported the hypothesis that the pattern of N100 and P200 deficits found 
in schizophrenia compared with normal controls would not be found in the ADHD group. 
The ADHD patients showed a similar pattern of N100 amplitude differences as the 
normal controls for both the target vs. non-target comparison, with non-targets producing 
decreased N100 amplitude compared with targets. In addition, for the non-target, T-1 vs. 
T+1 comparison, T+1 produced reduced N100 amplitude compared with T-1 for both 
control groups. The patients with FESz, however, did not show this N100 amplitude 
differentiation, either between target and non-target stimuli, or between non-target, T-1 
and T+1, stimuli. N100 amplitude was reduced overall in the FESz group compared to 
the control and ADHD group. 
This difference in N100 amplitude findings between the first episode and ADHD 
groups would seem to indicate that the N100 amplitude deficits in FESz are not simply 
the result of non-specific attentional deficits, as one would expect to find the pattern of 
deficits in the ADHD group if this was so. The results of Study 3 (Chapter 6) suggest that 
the lack of differentiation between T-1 and T+1 stimulus in FESz is not simply the result 
of a disturbed recovery following the response to the target stimulus. Additionally, Study 
3 indicated that normal controls no longer produce differentiated N100 amplitude to T-1 
and T+1 stimuli, when T+1 stimuli are not predictable. In combination, these results 
suggest that the FESz group were not able to make use of past regularities, i.e. a target 
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will always be followed by a non-target to establish appropriate response biases, i.e. 
reduced allocation of attention to T+1 stimuli reflected in a reduction in N100 amplitude. 
The results could also suggest a heightened state that allows even predictable irrelevant 
stimuli, such as T+1, to capture attentional resources. 
Similarly, for P200 amplitude, the ADHD and normal control groups showed a 
differentiation between stimuli, with a P200 amplitude reduction to target, compared to 
non-target stimuli. This pattern was not found in the FESz group, as target stimuli 
produced increased P200 amplitude, compared to non-target stimuli. This increase in 
P200 amplitude to targets in the FESz group is intriguing as this is generally thought to 
be precluded by the effects of the overlapping N200 component elicited by target stimuli. 
While the ADHD group showed increased P200 amplitude to T+1 compared with T-1 
stimuli, the FESz group did not differentiate between non-target stimuli. The FESz group 
showed the same pattern of differentiation for P200 latency elicited to target vs. non-
target stimuli, (earlier to target) as the normal control and ADHD groups. In addition, the 
comparison between non-target stimuli produced opposing results between the first 
episode and control groups with P200 latency elicited by T+1 stimuli prolonged 
compared with T-1 stimuli in the control group, but earlier in the first episode group. 
P300 amplitude was reduced in FESz, compared to normal controls, in Study 2 
(Chapter 5), however, in the current Study, the FESz group did not demonstrate a 
significantly reduced P300 amplitude when compared to the combined (clinical + 
normal) control group. This is because, across topography, the ADHD group 
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demonstrated reduced P300 amplitude compared with normal controls, a finding 
consistent with previous studies (Frank et al., 1998; Holcombe et al., 1986; Johnstone & 
Barry, 1996; Jonkman et al., 1997; Loiselle et al 1980; Overtoom et al., Robaey et al., 
1992; Satterfield et al., 1990). These findings have a number of important implications. 
Firstly, they reinforce doubts about the utility of P300 amplitude as a marker for 
schizophrenia because of its problems with specificity. Secondly, it may have theoretical 
implications for the reduction in P300 amplitude found in schizophrenia. For example, it 
may be associated with a generic impairment common to many psychopathologies, such 
as a working memory deficit. Alternatively, it may be sensitive to several different 
mechanisms in different psychiatric groups, each resulting in diminished P300. As might 
be expected from these findings, results from the discriminant function analysis 
demonstrated that patients with FESz were not accurately classified using N200 and P300 
amplitude, when the control group included people with ADHD. As no left (compared 
withright) temporal deficit was found in the first episode group, it is unlikely that this 
would have increased the specificity of the P300 findings. The finding that P300 
amplitude reduction is not specific to schizophrenia, challenges its usefulness as a 
biological marker for schizophrenia. 
The discriminant analysis indicated that the P300 deficit is not specific for 
schizophrenia while deficits in N100, P200 components were specific for schizophrenia 
when compared with the combined group of controls and patients with ADHD. The most 
compelling evidence for this was that only the N100 and P200 variables were chosen in 
the stepwise DA which combined, the variables chosen in the individual stepwise 
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analyses for (i) N100 and P200 and (ii) N200 and P300. This finding highlights the 
possibility that N100 and P200 components to target and non-target stimuli may provide 
a more useful biological marker for genetic research than the traditional focus on P300 
amplitude. 
An obvious limitation of this Study was the lack of female participants. This was 
a consequence of the all-male ADHD group, as ADHD is much more common in males 
than females. It would be important to replicate these findings in a larger study, with 
equal female and male participants included. 
This Study has demonstrated the benefits of using non-target, in addition to target 
ERPs, and in further separating ERPs elicited by non-target stimuli into those occurring 
immediately before the target stimulus (T-1), and those occurring immediately after the 
target stimulus. It was the distinct pattern of ERP responses to N100 and P200 elicited by 
T-1, target and T+1 stimuli found in the FESz group compared to the control and ADHD 
groups, that allowed the accurate discrimination of patients with FESz from a 
combination of normal and psychiatric, (ADHD) control groups. 
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8 THESIS CONCLUSIONS AND IMPLICATIONS 
8.1 MAJOR FINDINGS AND IMPLICATIONS 
This thesis has emphatically demonstrated the importance of looking beyond the 
P300 component in schizophrenia research. This is in contrast to earlier ERP research 
which focussed on the P300, because of its assumed association with critical cognitive 
variables and the robustness of the P300 amplitude reduction finding in schizophrenia. 
The first major finding was that the early ERP components elicited by both non-
target and target stimuli were disturbed in schizophrenia. ERPs to non-target stimuli 
showed reduced N100 amplitude and delayed P200 latency, while ERPs to target stimuli 
showed reduced and earlier N100 and increased P200 amplitude. A related finding, also 
revolving around the N100 and P200 components was the lack of differentiation between 
early ERP responses elicited by target and non-target stimuli in schizophrenia. Study 1 
demonstrated that both of these deficits were reliably found in a large sample of patients 
with schizophrenia and their matched controls. In Study 2, these initial findings were 
extended with results indicating that the pattern of deficits also occurred among first 
episode schizophrenia participants. 
The presence of these early deficits in both FESz and chronic schizophrenia 
suggests that they are more likely to be trait deficits, rather than transient state markers 
associated with severity of psychopathology, or other effects of illness or 
institutionalisation. Although reduced N100 amplitude to non-target stimuli in 
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schizophrenia has been found in some previous studies, the current series of studies that 
has tested large numbers of patients, in early and later stages of schizophrenia, and has 
used normal and clinical control groups, constitutes the most most comprehensive and 
compelling data-set about early ERP deficits in schizophrenia known to be reported. 
These findings have important empirical implications for schizophrenia research. 
They indicate the importance of systematic analysis of N100 and P200 ERPs elicited by 
non-target stimuli. Secondly, they show that an examination of the relationship between 
these components elicited by non-target and target stimuli yields valuable information, 
and, therefore, should be included in the analysis. 
A third major finding was that differences in the ERP response to non-target 
stimuli which occur before and after the target stimuli (T-1 & T+1) evident in the normal 
controls, was notably absent in both the first episode and chronic schizophrenia groups. 
The N100 reduction to T+1 compared with T-1 stimuli found fronto-centrally in normal 
controls was not present in chronic schizophrenia and was minimal in FESz (Study 2, 
Chapter 5). The N100 amplitude reduction associated with T+1 and observed in normal 
controls is consistent with findings of other oddball studies in the literature (Hirata & 
Lehman, 1989; Starr, Sandroni, & Michalewski, 1995; Starr et al., 1997) in which the 
target stimuli is always followed by a non-target stimuli by design or by virtue of low 
probability. The reason for this finding among normal controls has remained unclear, 
with the results being consistent with either response recovery or stimulus predictability 
hypotheses. However, Study 3 demonstrated that the effect disappeared when the non- 
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target status of the stimulus was not predictable, thereby ruling out the recovery 
hypothesis. Thus these studies confirm the T+1 effect on N100 amplitude in normals and 
more convincingly link it to the predictable occurrence of a task-irrelevant (non-target) 
stimulus. 
The reduced N100 amplitude to T+1 stimuli finding has important empirical 
implications for ERP research for schizophrenia and as well as in normal and other 
clinical groups. From an empirical perspective, it demonstrates that it is important not to 
average ERPs to all non-target stimuli in the auditory oddball paradigm as certain non-
target stimuli may have different functional significance. Among other possible 
interpretations, these findings could be seen to support a deficit in associative learning in 
schizophrenia and can be seen as support for the cognitive model proposed by Gray, 
Hemsley and others (Gray et al., 1991; Gray, 1998; Hemsley, 1996), that people with 
schizophrenia fail to establish appropriate response biases because they are unable to use 
stored memories of regularities based on their previous experience. An alternative 
possibility is that patients with schizophrenia, like normal controls, are aware that T+1 
are non-target occurrences, but are unable to prevent these irrelevant stimuli from 
automatically capturing valuable attentional resources. 
A fourth, and perhaps the most important finding of this thesis, is the improved 
sensitivity and specificity of deficits in the N100 and P200 components elicited by target 
and non-target stimuli when compared to the N200 and P300 measures. These results 
were both robust and reliable and the superior classification associated with the earlier 
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components between schizophrenia and normal control subjects in Study 2 were 
replicated in Study 4 between FESz and both clinical (ADHD) and normal controls. 
In Study 4, N100 and P200 components elicited to target and non-target stimuli, 
utilising a stepwise DfA, enabled correct identification of 85% of the FESz subjects, and 
82.5% of the combined (clinical + normal) controls. On the other hand, the use of N200 
and P300 components to target stimuli in a stepwise DfA resulted in correctly classifying 
65% of the FESz group and 55% of the combined (clinical+normal) control group. These 
classification rates appear impressive. If replicated, they have important empirical 
implications for genetic studies searching for a psychophysiological endophenotype. 
Currently reduced P300 amplitude has been considered as a likely endophenotype or 
biological marker for genetic studies with schizophrenia. However the results of Study 4 
(Chapter 7) indicate that the N100, P200 components may be a superior biological 
marker than P300. 
This thesis also examined the relationship between symptom factors and ERP 
components elicited by target and non-target stimuli. The most robust relationship was 
the negative correlation between the magnitude of N100 amplitude and the 
disorganisation factor, which is seen as a core feature of schizophrenia. This correlation 
was maximal for N100 amplitude to non-target stimuli. This suggests the possibility that 
the N100 amplitude to non-target stimuli may be related to the unique pathology of 
schizophrenia. In contrast, no significant correlations were found between symptom 
factors and P300 amplitude in this Study, and the results of previous investigations have 
been mixed and difficult to replicate. 
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The finding that people experiencing their first episode of schizophrenia have 
psychophysiological disturbances of a similar severity to those who have experienced 
schizophrenia over a number of years also has treatment and theoretical implications. 
With regard to treatment this finding emphasizes the need for an early and 
comprehensive intervention in schizophrenia. One further advantage of having the 
chronic schizophrenia group in addition to the FESz group was that it allowed for an 
exploration of differential age effects on ERPs to target and non-target stimuli between 
the two groups. The schizophrenia group did not show an exacerbation of the normal age 
effects on ERP components, providing an additional argument against the notion that 
schizophrenia is a neurodegenerative disorder. 
Finally, preliminary evidence suggested that the P300 amplitude was sensitive to 
alternating sequences of stimuli within the oddball task, and systematically increased or 
decreased depending on whether these alternations discontinued or continued. Study 3 
examined the proposal that, in these circumstances, reliable P300 changes to DA series 
would be a reliable index of associative strength in normal controls and would be 
impaired in schizophrenia. The results failed to confirm that such a pattern occurred in 
normals, hence the hypothesis could not be confirmed in schizophrenia. In any case, the 
study examined DR and DA effects in a comprehensive way in first episode 
schizophrenia, thereby contributing to the very limited research in this area. The finding 
that manipulations of the DR series has comparable effects on both normal controls and 
schizophrenia groups, suggests that the temporal determinants (such as target-to-target 
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intervals) that underpin these amplitude changes in normals, are not critical to the 
impairment in schizophrenia. 
8.2 LIMITATIONS AND FUTURE DIRECTIONS 
There are a number of study limitations. The participants with FESz, had 
commenced medication at the time of testing, so that while they had not had an extended 
time on medication and while medication was a covariate in the statistical analysis, it 
would be preferable to have tested these participants drug naïve and to have withdrawn 
the chronic schizophrenia participants from medication. This is difficult to achieve 
because of the serious ramifications of withholding medication for people with 
schizophrenia. However one possible way to overcome this would be to have a laboratory 
on the psychiatric admission ward, with the EEG recording a standard part of the initial 
neuropsychiatric battery prior to medication. At any rate, previous research has indicated 
that ERP component deficits are not due to the effects of medication (see Chapter 2.4.1) 
and as all significant results remained unchanged even after co-varying for medication, it 
appears very unlikely that the results were due to medication effects. 
The thesis necessarily employed a cross-sectional rather than longitudinal design. 
Future investigation, following subjects from their first episode of schizophrenia in a 
longitudinal study, would provide important information on ERP deficits over the course 
of the illness. 
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Study 4 demonstrated the specifity of target and non-target N100, P200 deficits in 
first episode and chronic schizophrenia. However in addition to the need for replication 
of these findings, it would also be important to demonstrate that these deficits were 
present in people prior to the onset of their schizophrenia illness and more prevalent in 
family members, to be able to consider these deficits as biological markers. 
The ADHD group provided an appropriate clinical control group to examine 
initially the specificity of schizophrenia deficits as both groups have cognitive and P300 
reduction deficits in common. Future investigations might extend this research by 
including additional psychiatric control groups to provide a more detailed examination of 
the specificity of the findings. A further limitation to Study 4, was the lack of female 
participants, due to the constraints of an all male ADHD group, thus limiting 
generalisation of findings to a male population. Further investigation, with adequate 
numbers of female participants, is required. 
The ERP topographical analysis in Study 2 although providing a high temporal 
resolution of brain activity, is limited in its spatial resolution. The neural basis of deficits 
in schizophrenia could be further explored using neuroimaging techniques, such as event 
related (er) fMRI, allowing for much greater spatial resolution of cortical and sub-cortical 
areas. For example, an erfMRI study by Kiehl and Liddle (2001) has been able to 
demonstrate reduced activations, both in strength and extent, in right lateral frontal 
cortex, thalamus, bilateral anterior superior temporal gyrus, anterior and posterior 
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cingulate, associated with target processing in schizophrenia compared to normal 
controls. 
Study 4 clarified answers to competing hypotheses arising from the N100 
amplitude reduction to T+1 stimuli found in Study 2. However, probability differences in 
paradigms existed between the two studies - 0.5 in Study 3 and 0.3 in Study 2, which may 
have affected results. This difference arose, in part, from the constraints imposed by 
having the target stimuli followed equiprobably by target and non-target stimuli, and by 
by the sequence requirements of Study 3. However a previous study (Polich & 
Bondurant, 1997) did not find N100 amplitude non-target sequence effects in normal 
participants, when examining these effects in paradigms with 0.33 and the other with 0.67 
target probabilities. This suggests that the probability difference between the two studies 
is unlikely to have affected findings. 
8.3 CONCLUSION 
This thesis provides a thorough investigation of target and non-target N100 and P200 
components, in contrast to target N200 and P300 components, from the first onset of 
schizophrenia, through chronic duration, and in comparison with both healthy controls 
and ADHD. The results present compelling evidence that N100 and P200 components to 
target and non-target stimuli are impaired in both the early and chronic manifestations of 
schizophrenia and demonstrate the importance of investigating non-target in addition to 
target ERPs in schizophrenia. In contrast to reduced P300 amplitude, deficits in these 
early components to both target and non-target stimuli show superior sensitivity and 
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specificity for schizophrenia, and hence may serve as potentially useful biological 
markers for the disorder. 
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10 APPENDICES 
10.1 APPENDIX 1- CHLORPROMAZINE EQUIVALENT 
This table shows the dosage estimates used to calculate the Chlorpromazine equivalent 
medication levels in patients in this thesis (Lambert, 1998). 
ORAL MEDICATIONS 100 CHLORPROMAZINE 
EQUIVALENTS 
Haloperidol 2 
Trifluoperazine 5 
Pimozide 1.5 
Pericyazine 10 
Fluphenazine 2 
Thioridazine 100 
Respiridone 1.5 
Olanzapine 3 
Clozapine 75 
Thiothixene 4 
Depot Injections (2 Weekly) 300 Chlorpromazine 
Equivalents per Day 
Fluphenazine Decanoate 25 
Haloperidol Decanoate 50 
Zuclopenthixol Decanoate 200 
Flupenthixol Decanoate 40 
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Abstract 
Objectives: Event-related potential (ERP) abnormalities to target stimuli are reliably found in schizophrenia. However, as people with 
schizophrenia are thought to have difficulty discerning the relevance of incoming sensory stimuli it is also important to examine ERPs to non-
targets. To differentiate between potential trait markers of the disease and deficits that might be associated with the consequence of illness 
chronicity, this study investigated ERPs to both target and non-target stimuli in groups of people with either first episode or chronic 
schizophrenia (CSz). 
Methods: Using an auditory oddball paradigm, ERPs to target, non-target before target (Nt before) and non-target after target (Nt after) 
stimuli were analysed for 40 patients with CSz, 40 patients with first episode schizophrenia (FESz) and two groups of normal controls 
matched for age and sex with their patient counterparts. 
Results: The FESz group showed the same pattern of amplitude disturbance as the CSz group to both targets (reduced N100, N200, P300 
and increased P200) and non-targets (reduced N100) compared to controls. Both CSz and FESz groups also failed to show the changes to the 
P200—N200 component between targets and non-target stimuli that was exhibited by controls (smaller earlier P200 to targets vs. increased 
delayed P200 to non-targets) or the reduction in N100 amplitude of ERPs to the Nt after stimuli compared with ERPs to the Nt before stimuli. 
Previous literature has focussed on the sensitivity of P300 deficits in classifying persons into schizophrenia and non-schizophrenia groups. 
This study demonstrated improved accuracy in the classification of patients with schizophrenia from controls using discriminant analysis of 
target and non-target N100 and P200 components. 
Conclusions: The results suggest that ERP disturbances are evident at the time of first referral to mental health services and may be a 
potential trait (rather than secondary effect) of the illness. It is important to include both target and non-target stimuli processing, and their 
interrelationship in future research. Crown Copyright © 2002 Published by Elsevier Science Ireland Ltd. All rights reserved. 
Keywords: Schizophrenia; First episode schizophrenia; Event-related potential; Non-target 
1. Introduction
Numerous studies have found deficits in event-related
potentials (ERPs) of patients with schizophrenia, linked to 
target stimuli in an auditory oddball paradigm, most notably 
a reduction in P300 amplitudes (for reviews see Pfefferbaum 
et al., 1989; Pritchard, 1986; Ford et al., 1992; Jeon and 
Polich, 2000). Most of these studies have investigated 
ERPs in chronic patients, however, an important emerging 
issue is whether these deficits are trait-like and therefore 
present at the onset of illness (Salisbury et al., 1998; Ford, 
* Corresponding author. Tel.: +61-2-9845-6835; fax: +61-2-9635-7734.
E-mail address: kerrib@psych.usyd.edu.au (K.J. Brown).
1999; Frodl-Bauch et al., 1999; Mathalon et al., 2000; 
Blackwood, 2000). This is particularly important because 
ERP deficits observed in patients with chronic schizophre-
nia (CSz) may be secondary effects of chronic morbidity, 
neuroleptic medication or other changes associated with 
chronic mental illness (e.g. hospitalisation). If established 
as a trait, ERP deficits could be useful in identifying 'at risk' 
individuals and would provide potential for the implemen-
tation of preventative strategies. 
Although there is now some evidence that reduced P300 
amplitude is a stable trait marker in schizophrenia (Matha-
lon et al., 2000; Blackwood, 2000), with evidence for 
genetic association (Blackwood et al., 2001; Weisbrod et 
al., 1999), there have been studies which have not found 
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reduced P300 in the undiagnosed family members of people 
diagnosed with schizophrenia (Friedman et al., 1988) and in 
a study that looked at the predictive validity of the P300, 
Squires-Wheeler et al. (1993) did not find P300 amplitude 
reduction predictive of subsequent schizophrenic break-
downs. However, in the Squires-Wheeler et al. study 
(1993), as might be expected, because of the relatively 
low incidence of schizophrenia even among relatives of 
schizophrenics, there were no more than 6 subjects classi-
fied as having a schizophrenic breakdown and only one 
classified with schizophrenia disorder (this subject's P300 
amplitude was reduced one and a half standard deviations 
below the mean for the normal group). Hence, the reliability 
of these findings is questionable, and the importance of 
using alternative methods to determine whether ERP defi-
cits observed among chronic schizophrenics is trait-like is 
further highlighted. One such method comprises the 
comparison of ERP deficits early (first presentation) and 
late (CSL) in the developmental course of schizophrenia. 
Reduced mismatch negativity (MMN) amplitude has also 
been found in non-psychotic first degree relatives of patients 
with schizophrenia (lessen et al., 2001) suggesting that 
earlier components (N100 and P200) should also be inves-
tigated. There have been few studies investigating auditory 
oddball ERP deficits in people with first episode schizophre-
nia (FESz). Salisbury et al. (1998) and Hirayasu et al. (1998) 
have both found reduced P300 amplitude to target stimuli in 
this group. ERPs to non-target stimuli (and their relationship 
with target ERPs) remain unexplored in FESz. 
There are both theoretical and empirical indications for 
investigating possible ERP disturbances to non-target 
stimuli in addition to target stimuli in people with schizo-
phrenia. Current models of information processing deficits 
in schizophrenia (e.g. Frith, 1995; Gray, 1998; Hemsley, 
1996) suggest a disturbance at the 'comparator' level in 
the match/mismatch between incoming stimuli and stored 
memories of past regularities or similarly, a failure in the 
inhibitory effect of context (Servan-Schreiber et al., 1996). 
These models highlight the need to examine the processing 
of irrelevant or context information in addition to relevant 
information in people with schizophrenia. Houghton and 
Tipper's (1996) model of 'normal' selective attention 
proposes that, in addition to the excitatory feed back loop 
elicited by target stimuli, selective attention involves an 
inhibitory feedback loop elicited by non-target stimuli. 
There is evidence from negative priming tasks indicating 
a disturbance of this inhibitory process in schizophrenia 
(Beech et al., 1989, 1991). In the auditory oddball paradigm, 
where subjects are asked to respond to target and not to non-
target stimuli, ERPs to non-targets may provide insight into 
this inhibitory process, and should be investigated along 
with ERPs to targets. As the auditory oddball paradigm 
comprises target events that often follow a series of non-
target occurrences, a comparison of ERPs elicited by targets 
and those elicited by non-targets immediately preceding and 
following the target stimuli might capture the effects of  
cognitive processes during the putative comparator stage 
(P200—N200) and immediately before (N100) and after 
(P300) such processing. 
Further evidence of the significance of non-target stimuli 
for information processing emerges from studies, showing 
that the same stimuli are processed differently when they 
appear as a non-target in the auditory oddball task than 
when they are used in a passive listening condition 
(Garcia-Larrea et al., 1992; Yordanova et al., 2001). There 
is also evidence that ERPs to non-targets before (Nt before) 
and after (Nt after) the target stimuli, in normals, may 
involve different brain states (as indicated by different 
scalp topographical distributions for the two types of non-
targets) and should be averaged separately (Hirata and 
Lehmann, 1990). ERPs to Nt after stimuli may also provide 
insight into the possibility of a disturbance in temporal 
recovery (Roth and Cannon, 1972) or refractoriness in 
N100 (Shelley et al., 1999), which has been suggested in 
schizophrenia. Additionally, there is the possibility of an 
expectancy effect associated with the Nt after stimuli, as a 
target stimulus is always followed by a non-target stimulus 
in the oddball design used in this study. For these reasons, in 
our study, we have examined separately Nt before and Nt 
after the target stimuli. 
Reported findings in non-target ERPs in people with schi-
zophrenia include reduced N100 amplitude (Roth et al., 
1980; Pfefferbaum et al., 1989; Ogura et al., 1991; Boutros 
et al., 1997; Laurent et al., 1999; Brown et al., 2000); both 
increased (Pfefferbaum et al., 1989; Ogura et al., 1991) and 
reduced (Roth and Cannon, 1972; Roth et al., 1980; McCar-
ley et al., 1991) P200 amplitude; earlier P200 latency 
(Brown et al., 2000) and less difference between target 
and non-target N100/P200 components (Brown et al., 
2000). Studies by Brown et al. (2000) and Roth and Cannon 
(1972) indicate the importance of examining the group by 
stimuli interaction, as patterns of differences between ERPs 
to target and non-target stimuli found in normal controls 
may not be present in schizophrenia. There is also compli-
mentary evidence of a disturbance of target/non-target 
discrimination from single trial ERP analysis showing 
people with schizophrenia had fewer P300s to targets and 
more P300s to non-targets compared with controls (Roschke 
et al., 1996; Wagner et al., 2000). 
Previous literature has focussed on the sensitivity of the 
P300 component in schizophrenia. For example, Ford et al. 
(1992) established criterion P300 amplitude, above which 
one can rule out a diagnosis of schizophrenia. Boutros et al. 
(1997), however, found that non-target N100 and P200 
components were also sensitive measures and recently 
Ford et al. (2001) proposed that N100 amplitude reduction 
to targets and non-targets may have greater specificity for 
schizophrenia than P300 reduction (in that study while P300 
amplitude was sensitive to schizophrenia-like symptoms 
found both in schizophrenic and in epileptic patients, with 
interictal CSz-like features, only N100 was specific to those 
symptoms in schizophrenia alone). We investigated the 
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sensitivity of the N100 and P200 components elicited by 
non-targets and targets and compared this with the P300 
component to targets in discriminating CSz and FESz 
groups from their respective normal control groups. Follow-
ing Gray's (1998) model and our (Brown et al., 2000) 
previous finding that there is less difference between target 
and non-target N100 and P200 scores in a schizophrenia, we 
decided to also investigate the sensitivity of the within 
group differences for stimuli (where these differed between 
the groups) by subtracting target and non-target scores. 
2. Methods
2.1. Participants 
2.1.1. Participants with chronic schizophrenia 
Forty people (28 males, 12 females) with CSL, aged 
between 23 and 51 years of age, with a mean age of 36.0 
years (SD = 7.1 years) were recruited from hospital and 
community health centres. All participants had been diag-
nosed with schizophrenia for at least 4 years (range 4-34 
years) with a mean duration of illness of 14.3 years 
(SD = 7.0 years). All were medicated, with 20 subjects on 
typical antipsychotics (mostly depot preparations), 7 on 
atypical antipsychotics and 13 on clozapine. The mean 
dose of medication was 520 chlorpromazine equivalents 
(SD = 423). Diagnosis was made by concordance between 
the case file diagnosis and diagnosis based on Section G 
(schizophrenia and psychotic disorders) of the Composite 
International Diagnostic Interview (World Health Organisa-
tion, 1992), or by concordance between diagnosis made by 
two psychiatrists according to the Diagnostic and Statistical 
Manual of Mental Disorders (3rd edition revised) (DSM-III-
R) (American Psychiatric Association, 1987). Exclusion 
criteria were a recent history of substance abuse, past history 
of substance dependence, mental retardation, other neuro-
logical disorders including epilepsy and head injury 
(defined as an injury requiring hospital observation for at 
least 4 h or unconsciousness for more than 1 h). 
2.1.2. Participants with first episode schizophrenia 
Forty people (26 males, 14 females) with FESz aged 
between 14 and 26 years (mean = 19.6 years; 
SD = 3.2 years), were recruited from community and 
hospital settings through the Western Sydney First Episode 
Psychosis Project. FESz participants were defined as those 
young people presenting for the first time to health services 
with psychotic symptoms that warranted a diagnosis of 
either schizophrenia or schizophreniform disorder. Diagno-
sis was made by means of a consensus conference (of at 
least 3 fully qualified psychiatrists) that drew upon the inter-
view by the participating psychiatrist, information from 
family and case manager and the case notes. Diagnoses 
were made according to the Diagnostic and Statistical 
Manual of Mental Disorders (4th edition) (DSM-IV) (Amer- 
ican Psychiatric Association, 1994). Exclusions were the 
same as for the chronic group. The majority of participants 
were medicated with atypical antipsychotics alone 
(M = 250 chlorpromazine equivalents: SD = 202), though 
a small number were also receiving antidepressant or antic-
holinergic medications. Four participants were on no medi-
cation. 
2.1.3. Positive and negative symptom scale (PANSS) 
Schizophrenic symptoms were rated for both CSz and 
FESz groups using the Positive and Negative Syndrome 
Scale (PANSS, Kay and Opler, 1987). The CSz group had 
a mean total score of 78.5 (SD = 18.7) and the FESz group 
75.2 (SD = 15.1). Mean (SD) subscale scores for the CSz 
group were: positive, 20.3 (SD = 6.5); negative, 20.6 
(SD = 6.5); and general, 37.6 (SD = 8.3); and for the 
FESz group: positive, 17.2 (SD = 5.7); negative, 19.5 
(SD = 6.2); and general, 38.7 (SD = 6.9). 
2.1.4. Normal control participants 
Normal control participants for the two groups were 
recruited from the community and were gender and age 
matched to within 2 years for clinical subjects under the 
age of 25 years and to within 5 years for those over the 
age of 25 years. The rationale for closer age matching of 
the younger subjects derived from research indicating 
maturational changes in the electroencephalogram (EEG), 
occurred up to early adulthood (Neidermeyer, 1999). 
Control group 1 with a mean age of 36.7 years (SD = 7.6) 
was compared with the CSz group and control group 2 with 
a mean age of 19.65 years (SD = 3.86) was compared with 
the FESz group. Persons with a recent history of substance 
abuse, or past history of substance dependence, epilepsy, 
other neurological disorders, mental retardation or head 
injury were excluded from the sample. 
2.2. Data acquisition 
Participants were seated in a reclining chair in a quiet, 
dimly lit laboratory, facing a video screen and wearing a 
pair of headphones. A conventional auditory oddball para-
digm was employed, consisting of 40 target tones (1500 Hz 
with 15% probability and 247 background (1000 Hz) tones 
both lasting 50 ms (with 10 ms rise and fall). The tone inten-
sity was 60 dBSPL and the fixed interstimulus interval (ISI) 
was 1.3 s. Participants were asked to look at a dot on the 
computer screen 60 cm in front of them, ignore the low 
(background) non-target tones and press two reaction time 
buttons (with the index finger of each hand, to counterba-
lance motor activity) when they identified a task relevant 
target tone. Task instructions emphasised speed and accu-
racy of response equally. EEGs were recorded on a DC 
based system (Synamps, equipped with a 16 bit A/D conver-
ter) from 19 scalp sites according to the 10-20 International 
system (Bloom, 1982) in reference to linked-ear electrodes 
with an amplification of 200, a band pass from 0 to 50 Hz 
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Non-target before Non-target after 
chronic schizophrenia — control 1 — 
FESz — control 2 — 
Fig. 1. Grand average waveforms for all groups, to each stimuli at midline 
sites. Both chronic and first episode Sz groups show reduced N100, N200 
and P300 and increased P200 amplitude to targets compared with controls 
and decreased N100 amplitude with Nt before. Chronics showed delayed 
P200 latency to targets and earlier P200 latency to non-targets and delayed 
N200 latency to targets. 
and digitised at 250 Hz. Only data recorded at Fz, Cz and Pz 
are reported here. Horizontal electro-oculogram (EOG) was 
recorded via electrodes placed at the outer canthus of each 
eye and vertical EOG was recorded via two electrodes 
placed 1 cm above and below the midline supraorbital and 
infraorbital regions of the left eye. Eye correction was 
carried out using a technique based on Gratton et al. 
(1983). Within the block comprising target and non-target 
tones, in 33 instances, targets occurred both immediately 
before and after the target tone and the responses to these 
33 targets, 33 non-targets before (Nt before), and 33 non-
targets after (Nt after) were averaged separately (in 7 
instances the non-targets were immediately preceded by 
and followed by a target and hence were simultaneously 
both Nt before and Nt after, and so were excluded). For 
targets N100, P200, N200 and P300 peaks were measured 
relative to a prestimulus (200 ms) baseline by an automated 
system based on the detection of a consistent change in the 
direction of the gradient of the waveform (Haig et al., 1995). 
Thus a change from a consistently positive to a consistently 
negative gradient was identified as a positive peak, and vice 
versa for a negative peak (Haig et al., 1995). In addition, the 
criteria that N100 occurred between 80 and 140 ms, P200 
between 150 and 240 ms, N200 between 200 and 280 ms 
and P300 between 250 and 500 ms. Peaks thus identified 
were then verified through visual inspection. N100 and 
P200 peaks in averaged ERPs to non-targets before and 
after were ascertained according to the same method. 
2.3. Analysis 
2.3.1. Midline ERPs 
N100 and P200 amplitudes and latencies were submitted 
separately to a to a 3-way analysis of variance (ANOVA) 
repeated measures design, incorporating two groups (schi-
zophrenic vs. controls) X 3 electrode sites (Fz, Cz, Pz) X 3 
stimuli (Nt before, target and Nt after) with repeated 
measures for electrode and stimulus factors. When spheri-
city assumptions were violated, the Greenhouse—Geisser 
correction was employed and the degrees of freedom (df) 
values were appropriately adjusted. N200 and P300 compo-
nents were reliably observed only to the target stimulus and 
were therefore subjected to a group (schizophrenia vs. 
controls) X site (Fz, Cz, Pz) ANOVA repeated measures 
design. These analyses were done separately for the CSz 
group vs. control 1 group and FESz group vs. control 2 
group. The Statistical Package for Social Sciences 9.0 
program (SPSS Inc., 1999) was used in all analyses. Signif-
icant main and interaction effects based on multiple df were 
further analysed by post-hoc comparisons with Bonferroni 
adjusted alpha level. ERP components were also submitted 
to a 3-way ANOVA repeated measures for chronic vs. FESz 
groups and for control 1 vs. control 2 group. Medication and 
age (used when comparing FESz and CSz groups, because 
between groups, ages differed markedly in this analysis) 
were used as covariates. 
2.3.2. Discriminant function analysis (dfa) 
Dfa was performed in two stages. Stage 1 related to ampli-
tudes and latencies of components derived conventionally, and 
stage 2 related to N100 and P200 difference score amplitudes 
and latencies. Component amplitude and latency measures on 
which the clinical and control groups were significantly differ-
ent were entered into a stepwise dfa for the CSz and FESz 
groups and their controls separately in the following manner. 
2.3.2.1. Stage I. 
1. N100 and P200 component amplitudes and latencies for
target, Nt before and Nt after. Where the number of
significant differences exceeded the number of variables
permissible under subject-to-variable ratio
recommendations, and differences were observed at more
than one site, then only the site at which the component has
maximal amplitude/latency was entered (e.g. Cz for P200).
2. All target P300 amplitudes and latencies at midline sites.
3. Variables arrived at by the stepwise procedure above
combined with significant N200 differences. Fisher
classification functions from the CSz dfa were then
applied to the FESz group to test the robustness of the dfa
replicated in an independent sample.
2.3.2.2. Stage 2. Consistent with some current theories, 
critical dysfunctions in schizophrenia could relate to 
mechanisms that are called into play when switches from 
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bolt chronic Sz 
droll -15 first episode Sz 
-10 
— Target - Nt after 
Fig. 2. Superimposed grand average waveforms for ERPs to target, Nt 
before and Nt after stimuli for each group at Cz. Arrows on control graphs 
refer to N100 amplitude reduction and P200 amplitude and latency shift 
between targets and non-targets. These patterns are not found in the CSz 
group and only the P200 latency shift is found in the FESz group. 
one stimulus to another occur, such as when a target follows 
a non-target or vice versa. Such processes may be best 
captured by difference scores rather than by ERP peaks 
derived independently for target and non-target stimuli. 
Difference scores were computed and these values were 
entered into a dfa to determine whether these measures 
would be as sensitive as conventionally derived measures 
to predict group membership. 
2.3.3. Reaction time 
Reaction times for CSz vs. control, FESz vs. control, CSz 
vs. FESz, and control 1 vs. control 2 were compared by t test. 
3. Results
ERP waveforms are presented in Fig. 1(between group)
and Fig. 2 (within group) and amplitude and latency values 
in Table 1. A small percentage (between 1 and 2.5% in each 
group) of ERP measures were identified as outliers (greater 
or less than one and a half the interquartile range from the 
upper and lower quartile). All results subsequently are based 
on data with outliers; however, results remained significant 
following removal of outliers and covarying for medication 
(chlorpromazine equivalents). 
3.1. ERPs 
3.1.1. N100 
3.1.1.1. CSz vs. controls. There were significant main 
effects for group, F(1,78) = 25.33, P < 0.001, the CSz 
group showing reduced N100 amplitudes overall; stimulus 
F(2, 77) = 10.69, P < 0.001, larger N100 amplitude to target 
than non-target stimuli and site, F(1.63, 126.94) = 130.34, 
P < 0.001, with N100 amplitude maximal fronto-centrally. 
There was also a significant group X stimulus X site interac-
tion, F(2.83, 220.97) = 2.89, P < 0.05. The interaction arose 
because N100 amplitudes were significantly larger for target 
stimuli than for Nt after stimuli, for the control, but not the CSz 
group (site interactions can be seen in Tables 1 and 2). There 
was a significant stimuli X group interaction, 
F = (2, 77) = 4.38, P < 0.05, for N100 latency which 
arose because N100 amplitude for Nt after stimuli was signif-
icantly earlier than for target or Nt before stimuli in the control, 
but not the CSz group, and a main effect for site, 
F = (1.63)130.34, P < 0.001 with earliest latency at Pz. 
3.1.1.2. FESz vs. control. There were significant main 
effects for group, F(1,78) = 9.57, P < 0.01, the FESz 
group showing reduced N100 amplitudes overall; 
stimulus, F(1.82,142.34) = 15.83, P < 0.001, larger N100 
amplitude to target than non-target stimuli and site, 
F(1.39,108.73) = 76.42; P < 0.001, with N100 ampli-
tude maximal fronto-centrally. There was also a 
significant group X stimulus X site interaction F(2.75, \ 
215.09) = 15.376, P < 0.001. The interaction arose 
because there were N100 amplitude changes as a function 
of stimuli (target > Nt before > Nt after) in fronto-central 
sites for the control, but not the FESz group. 
3.1.2. P200 
3.1.2.1. CSz vs. control. There was a significant group X 
stimulus X site interaction F(3.32, 258.73) = 7.86, P
0.001 for P200 amplitude. The CSz group had significantly 
larger P200 amplitude for target stimuli than controls which 
explains the main effect for group, F(1,78) = 12.21, 
P = 0.001. The interaction arose because there was a stimu-
lus effect, significantly reduced P200 amplitude to target 
than to non-target stimuli, found in controls but not in the 
chronic group which explains the main effect for stimulus 
F(2,77) = 11.21, P < 0.001. Site interactions can be seen 
in Table 1. There was a significant stimulus X group inter-
action F(2, 77) = 119.75, P < 0.001 for P200 latency. The 
CSz group was delayed for target, but earlier for non-target 
stimuli when compared with controls. 
3.1.2.2. FESz vs. control. There was a group X stimulus 
interaction F(1.82,140.12) = 8.57, P G 0.001 and 
group X site interaction F(1.69, 129.97) = 3.86, P < 0.001 
for P200 amplitude. The FESz group had larger P200 
amplitude than controls for target stimuli and smaller 
P200 amplitude than controls for Nt after stimuli. The 
stimulus interaction arose from a stimuli effect found in 
controls but not in FESz, where P200 amplitude to target 
stimuli was smaller than P200 amplitude to non-target 
stimuli. Site effects can be seen in Table 1. 
3.1.3. N200/P300 
3.1.3.1. CSz vs. control. There were significant main effects 
for group for N200 amplitude, F(1, 78) = 16.35, P < 0.001, 
and latency, F(1, 78) = 31.88, P < 0.001, with amplitudes 
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Table 1 
N100 and P200 means (SDs) for CSz and controls (a), FESz and controls (b) and N200 and P300 values for all groups (Oa 
Target Non-target before Non-target after 
Control 1 CSz Control 1 CSz Control 1 CSz 
(a) N100 and P200 means for CSz and controls
N100 amp Fz -10.2(3.0) -7.5(3.7)* -9.1(2.6) -5.6(4.2)* -8.1(4.1) -6.2(4.5)
Cz -11.4(3.8) -7.1(3.6)* -10.2(3.4) -5.9(3.5)* -7.5(3.6) -5.9(3.2)1 
Pz -6.6(3.1) 4.2(2.4)* -6.2(2.7) -3.5(2.1)* -5.39(2.4) -4.3(2.5)
N100 Lat Fz 108.3(16.6) 106.6(14.9) 105.2(16.1) 104.9(12.6) 100.5(12.7) 105.7(16.8)
Cz 103.1(13.2) 101.1(11.0) 103.0(11.4) 104.5(11.2) 95.5(9.7) 104.0(15.6)*
Pz 101.0(12.6) 98.7(12.9) 101.8(12.1) 100.7(16.5) 98.6(13.0) 101.0(19.2)
P200 amp Fz 0.8(3.7) 3.5(4.6)* 3.2(3.1) 4.7(4.1)* 3.4(4.3) 3.9(3.6) 
Cz -0.4(4.7) 5.6(4.2)* 5.8(2.9) 6.1(3.2) 5.2(3.5) 5.2(3.4) 
Pz 1.5(3.3) 5.4(3.1)* 3.9(2.2) 5.4(2.9) 3.7(3.2) 3.5(2.7) 
P200 lat Fz 172.4(16.1) 178.5(15.3) 201.9(27.7) 185.9(21.4)* 199.7(26.4) 182.3(20.6)* 
Cz 161.7(18.6) 174.9(16.7)* 203.7(26.4) 182.6(19.0)* 200.5(23.4) 184.6(20.0)* 
Pz 163.2(17.4) 178.5(21.3)* 192.1(28.9) 187.1(27.5) 199.5(26.0) 181.1(21.9)* 
(b) N100 and P200 means for FESz and controls
Control 2 FESz Control 2 FESz Control 2 FESz 
N100 amp Fz -10.6(4.1) -5.9(3.6)* -7.5(4.0) -6.3(2.8) -5.5(3.5) -5.6(3.5)
Cz -9.3(4.5) -5.4(3.4)* -7.7(3.9) -5.5(2.8)* -5.4(3.8) -4.4(2.9)
Pz -4.8(2.7) -3.9(3.1) -5.2(2.7) -4.0(2.5)* -4.4(3.6) -3.5(3.1)
N100 lat Fz 110.4(16.7) 106.5(15.8) 110.7(20.3) 105.6(19.1) 106.9(17.5) 113.5(31.7)
Cz 104.5(12.2) 97.1(15.0) 106.1(16.6 ) 101.5(18.1) 101.9(19.3) 102.6(17.4)
Pz 96.2(96.2) 94.3(19.4) 101.2(19.0) 98.8(18.8) 100.1(16.4) 95.2(18.0)
P200 amp Fz -1.7(5.2) 2.3(4.7)* 1.5(3.9) 1.6(3.2) 3.3(3.9) 1.8(4.1) 
Cz 1.7(6.2) 4.0(4.5) 4.6(4.6) 3.8(3.4) 5.8(4.4) 3.0(3.9)* 
Pz 3.5(5.8) 4.5(3.8) 3.5(3.6) 3.2(3.0) 4.1(3.4) 2.2(3.0)1 
P200 lat Fz 171.9(17.3) 168.4(13.9) 186.2(37.2) 188.7(29.9) 185.4(20.3) 181.6(25.5) 
Cz 171.2(20.4) 165.8(16.6) 184.2(31.2) 192.8(28.0) 184.6(22.2) 179.1(26.7) 
Pz 160.8(31.7) 158.1(25.2) 185.8(34.6) 194.7(33.0) 184.6(23.2 ) 172.2(31.7) 
(c) N200 and P300 values for all groups
Target 
Control 1 CSz Control 2 FESz 
N2 Amp Fz -5.3 ± 3.6 -3.9 ± 4.4 -9.9 ± 5.6 -5.8 ± 4.6*
Cz -7.5 ± 5.9 -1.7 ±4.8* -3.2 ± 7.2 -0.9 ± 5.5
Pz -2.1 ± 4.3 0.7 ± 3.4* 1.1 ± 5.3 0.8 ± 4.4
N2 Lat Fz 209.8 ± 16.6 229.5 ± 21.6* 214.1 ± 18.9 222.5 ± 19.8
Cz 207.2 ± 13.1 220.6 ± 18.2* 209.3 ± 18.1 216.1 ± 21.6
Pz 203.8 ± 22.3 226.5 ± 17.1* 195.1 ± 29.9 204.9 ± 31.0
P3 Amp Fz 10.3 ± 6.3 5.7 ± 5.9* 10.4 ± 8.5 7.9 ± 7.7
Cz 11.9 ± 8.0 11.2 ± 7.0 18.9 ± 10.6 13.3 ± 8.2*
Pz 18.9 ± 6.6 15.1 ± 6.6* 25.2 ± 10.5 17.7 ± 9.7*
P3 lat Fz 316.3 ± 23.4 315.5 ± 27.8 315.9 ± 28.8 320.4 ± 45.1
Cz 316.8 ± 23.7 309.2 ± 32.6 316.0 ± 35.8 317.7 ± 38.5
Pz 328.0 ± 21.6 327.4 ± 35.5 318.1 ± 27.6 325.4 ± 39.3
a 1.P < 0.05, *P < 0.01, Bonferroni adjusted alpha level. 
for the CSz group being reduced and latencies being delayed. 
The reduction in N200 amplitude was prominent at both Cz 
and Pz but not at the Fz site as indicated by the group X site 
interactions, F(2, 77) = 10.15, P < 0.001. The CSz group 
showed an overall reduced P300 amplitude demonstrated by 
a significant main effect for group, F(1, 78) = 5.87, P < 0.05, 
with the reduction being prominent in both Fz and Pz sites but 
not at the Cz site as indicated by the site X group interaction 
effect, F(1.82, 141.83) = 5.19, P < 0.01. There was also a 
main effect for site, F(1.82, 141.83) = 105.60, P < 0.001, 
with P300 amplitude maximal at Pz. 
3.1.3.2. FESz vs. control. There was a significant 
group X site interaction for N200, F(1.73) = 6.76, 
P < 0.01, with the FESz group showing reduced N200 
amplitude at Pc. The FESz group showed an overall 
reduced P300 amplitude demonstrated by a significant 
main effect for group, F(1,78) = 7.51, P < 0.01, with the 
reduction being prominent at Cc and Pc sites as indicated by 
the group X site interaction F(1.53) = 6.05, P < 0.01. 
There was also a main effect for site, 
F(1.53, 119.00) = 140.21, P < 0.001, with P300 
amplitude maximal at Pz. 
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Table 2 
Significant within-group differences for target (T), non-target before (Nt-b) and non-target after (Nt-a) stimuli' 
Control 1 CSz Control 2 FESz 
N100 amp 
N100 tat 
P200 amp 
P200 lat 
Fz 
Cz 
Pz 
Fz 
Cz 
Pz 
Fz 
Cz 
Pz 
Fz 
Cz 
Pz 
T > Nt-a 
T > Nt-b > Nt-a 
T > Nt-at 
T > Nt-at 
T > Nt-a, Nt-b > Nt-a 
T < Nt-b, T < Nt-a 
T < Nt-b, T < Nt-a 
T < Nt-b, T < Nt-a 
T < Nt-b, T < Nt-a 
T < Nt-b, T < Nt-a 
T < Nt-b, T < Nt-a 
T>Nt-b1 
T > Nt-a 
T > Nt-b > Nt-after 
T > Nt-b > Nt-after 
T < Nt-b and Nt-a, Nt-b < Nt-a 
T < Nt-b1  and Nt-a 
T < Nt-a 
T Nt-al 
T < Nt-b and Nt-a 
T > Nt-a 
T < Nt-b and Nt-b
1 
 
T < Nt-a < Nt-b1 
T < Nt-b, Nt-a < Nt-b 
a P < 0.01 for all except for 1  indicates P < 0.05, Bonferroni adjusted alpha level. 
3.1.3.3. CSz vs. FESz. For target P300 amplitude, significant 
differences found between the two control groups (which 
did not remain significant after effects of age were 
partialled out) were not found between the CSz and FESz 
groups. Thus, not only did the group with FESz show 
reduced P300 amplitude when compared with their 
controls, but also the age related differences in P300 
amplitude that one might have expected to find when 
compared with the CSz group were not apparent. 
3.2. Discriminant function analysis 
3.2.1. Stage 1 
3.2.1.1. N100, P200. Stepwise discriminant analysis with 
significant between group target and non-target variables 
was able to accurately classify 85% of the CSz group and 
77.5% of their control group, Wilk's A(3,78) = 0.51, 
X2  = 51.52, P < 0.001, using only the following variables, 
with standardised canonical discriminant function coeffi-
cients in brackets: target P200 amplitude (0.50), Nt before 
N100 amplitude (0.63) and Nt before P200 latency (-0.54). 
For the FESz group this procedure accurately classified 
77.5% of the clinical group and 75% of their controls, 
Wilk's A(1,78) = 0.722, X2  = 25.30, P < 0.001, using 
only target N100 amplitude (1.00). 
3.2.1.2. P300. Stepwise discriminant analysis with all 
midline P300 components was able to correctly identify 
70% of the CSz group and 77.5% of their control group, 
Wilk's A(3, 78) = 0.72, X2  = 25.32, P < 0.001, using P300 
amplitude at Pc (1.03), Cc (-1.35) and Fz (1.01). Similarly, 
72.5% of the FESz group and 57.5% of their controls, 
Wilk's A(1,78) = 0.88, x2 = 10.235, P = 0.001, were 
able to be correctly identified using P300 amplitude at Pc 
(1.00). 
3.2.1.3. All components. Stepwise discriminant analysis 
using the variables from the analysis previously and 
adding significant between group N200 variables (again so 
as not to exceed the subject to variable ratio these were 
limited to the maximal N200 site Fz) was able to 
accurately classify 90% of the CSz group and 75% of 
their controls, Wilk's A(4, 78) = 0.48, X2  = 55.27, 
P < 0.001, using Nt before N100 amplitude (0.51), Nt 
before P200 latency (-0.50), target P300 amplitude 
(-0.33) and target P200 amplitude (0.53). For the FESz 
group 77.5% of the clinical group and 72.5% of their 
controls, Wilk's A(2, 78) = 0.67, X2  = 31.12, P < 0.001 
using target N100 amplitude (0.85) and target P300 
amplitude (-0.48). Discriminant analysis applying the 
Fisher classification functions of the CSz group stepwise 
analysis to the independent FESz group was not able to 
classify better than chance, however, accurately classified 
67.5% of the FESL but only 28% of their controls, Pearson 
X
2
( 1 , 7 9 ) = 0.17, P = 0.63. 
3.2.2. Stage 2 
3.2.2.1. N100, P200 difference scores. Stepwise discrimi-
nant analysis with difference scores based on within group 
analysis (Table 2) were able to correctly identify 77.5% of 
the CSz group and 70% of the controls, Wilk's 
A(2, 78) = 0.64, x2 = 34.66, P < 0.001, using Nt after 
minus target P200 amplitude (0.53) and Nt before minus 
target P200 latency (0.68). Similarly, 75% of the FESz 
group and 66.7% of their control group were able to be 
classified using the same two variables, Nt after minus target 
P200 amplitude (0.98) and Nt before minus target P200 
latency (-0.68). 
3.3. Reaction time 
Both the CSz group (mean = 0.41 s, SD = 0.11) and the 
FESz group (mean = 0.35 s, SD = 0.01), showed signifi-
candy slower reaction times (df = 78, P < 0.001 and 
df = 78, P < 0.01, respectively) than their normal controls 
(mean = 0.35 s, SD = 0.01; mean = 0.31 s, SD = 0.04). 
There were no significant differences between the CSz 
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and FESz groups, or the two control groups. Control groups 
averaged 99.8% (1) and 99.9% (2) accuracy, with the CSz 
group 93% and the FESz 96.2% accuracy. 
4. Discussion
These results suggest that abnormalities in ERPs to both
target and non-target stimuli are evident at the onset of schizo-
phrenia, trait-like and not due to secondary effects of chronic 
morbidity, neuroleptics or institutionalisation. For both the 
CSz and FESz groups the traditional averaged ERP to target 
stimuli showed decreased N100, N200 and P300 amplitudes 
and increased P200 amplitude when compared with their 
controls. The reduced N100, N200 and P300 amplitudes are 
consistent with the previous ERP studies with schizophrenia 
(Ogura et al., 1991; Boutros et al., 1997; Brown et al., 2000) 
and with the reduced P300 findings in the FESz studies (Salis-
bury et al., 1998; Hirayasu et al., 1998). Previous target P200 
amplitude findings have been mixed, however, our increased 
P200 amplitude finding replicates that of Ogura et al. (1991) in 
an unmedicated sample. P200 amplitude has been reported to 
reflect aspects of decision making or stimulus encoding 
(McCarley et al., 1991). 
There were some differences between the CSz and FESz 
groups and their respective controls. While amplitude 
disturbances were common to both groups, latency deficits 
were specific to the chronic group who showed delayed 
latencies for P200 and N200 components to targets and 
earlier P200 latency for non-targets, with the FESz group 
showing no significant difference in latency from their 
control group. One possible explanation for this pattern of 
results could be that the amplitude deficits observed mani-
fest consequences of the disease itself, whereas the course of 
illness may have effects on speed of processing specific 
types of information. Considering latency impairments 
seen in CSz were restricted to targets, this would suggest 
that processing delays affected stimulus changes (infrequent 
target stimuli) but not non-target stimuli. In addition, the 
reduced P200 amplitude to Nt after stimuli found in the 
FESz was not found in the CSz group. However, the degree 
of similarity between the CSz and FESz groups is empha-
sised by their direct comparison, where no significant differ-
ences in ERP components remained after covarying for age. 
Interestingly, the P300 decrement with age observed in 
comparisons between the Normal control groups was not 
observed in comparisons between CSz and FESz groups. 
Among other interpretive possibilities, this pattern of results 
may indicate that P300 amplitude deficits may be a more 
sensitive index early in the schizophrenic process, and such 
a pattern of results was observed in the dfa where the P300 
amplitude deficits was one of only two valuable discrimina-
tors for FESz, whereas it was significant, but did not rate 
that highly for the CSz group. 
The disturbance in information processing is also eluci-
dated by a comparison of within group analysis, where the  
controls have a pattern of significant differences between 
targets and non-targets (smaller earlier P200 to targets vs. 
increased delayed P200 to non-targets) while both CSz and 
FESz groups failed to show this pattern (see Fig. 2 and Table 
2). In the CSz group P200 amplitude and latency did not 
vary significantly between target and non-target stimuli and 
in the FESz, while they do show a shift in P200 latency 
between target and non-target stimuli, the P200 amplitude 
either does not vary significantly (Fz, Cz) or is increased 
(Pz) (i.e. varies in the opposite direction to the controls). It 
appears that the P200 amplitude and latency shift between 
targets and non-targets found in the controls results mainly 
from the overlap with the N200 components in ERPs to 
target stimuli. Thus the large P200 amplitude component 
normally elicited by non-target stimuli is foreshortened by 
the negative shift for the N200 component in ERPs elicited 
to target stimuli. It is possible that this does not occur to the 
same extent in the CSz and FESz groups because their N200 
and P300 components are reduced compared with controls 
and so the N200 overlap is not so prominent in the P200 
component which would contribute to the larger P200 
amplitude to targets found in the CSz group when compared 
with controls. We intend to use a new single trial method 
developed by our lab (Melkonian et al., 2001) to tease out 
the overlapping components to clarify this and investigate 
among other questions, whether any P200 differences 
remain when the effects of the overlap are removed. 
The N100 component is correlated with specific aspects 
of stimulus features (Pritchard, 1986; Naatanen and Picton, 
1987) but may also reflect attention, being generally larger 
with greater attentional requirements ( Maclean et al., 1975) 
and is also affected by non-specific arousal (Rockstroh et al., 
1994). We found that, in addition to the overall reduction of 
N100 amplitude in the CSz and FESz groups, they also 
failed to show the distinct pattern of Nt before > Nt after 
N100 amplitude found in the control groups. As the stimulus 
features of the Nt after and Nt before stimuli are identical, it 
is possible that the reduction in N100 amplitude to Nt after 
stimuli found in normal controls, but not in patient partici-
pants, could be due to temporal recovery (as the Nt after 
stimuli follow a target that requires a cognitive and motor 
response) or to a reduced attentional requirement for Nt 
after stimuli due to expectancy (the expectancy may occur 
because, in this paradigm, a target stimuli is always 
followed by a non-target). These two possibilities will be 
further explored by averaging blocks of trials across the 
paradigm and single trial analysis to see if the reduction 
in Nt after N100 is consistent across the paradigm which 
would indicate temporal recovery, or if decreases occur 
across the course of the paradigm indicating the develop-
ment of expectancy. 
The patient group's diminished discrimination between 
targets and non-targets (and also between Nt before and Nt 
after) suggests that they are less flexible in differentiating 
and processing target and inhibiting non-target information 
than controls. This pattern of findings is consistent with 
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Gray's (1998) model in which `misattributions' in the 
match/mismatching of target: non-target information is 
proposed to underlie the core positive symptoms in schizo-
phrenia. A failure to develop an expectancy that a non-target 
would follow a target could be further evidence of this 
dysfunction and may be viewed, among other possibilities, 
as a disturbance of implicit memory. 
Compared with the P300 component, which has been the 
focus of schizophrenia research, the N100, P200 components 
acquired in response to both targets and non-targets gave a 
more accurate classification for both the CSz group (improved 
from 70 to 85%) and the FESz group (improved from 72.5 to 
77.5%). Thus, the current study's emphasis on extending ERP 
investigations to components other than P300 is vindicated. 
The combination of N100 and P200 components derived from 
Nt before stimuli and P300 components derived from target 
stimuli produce the best classification rates for the CSz group, 
whereas the best classification rates for the FESz group 
involved the combination of N100 and P300 amplitudes 
both derived from target stimuli. 
Perceptual abnormalities are an early sign of the onset of 
psychosis (Chapman, 1966) and the development of an 
investigational means to assess this would be of great 
importance. With the current emphasis on first episode 
psychosis treatment on early identification and active treat-
ment of young people at risk (McGlashan, 2000; McGla-
shan, 2001), an investigational means to help highlight risk 
prior to a psychotic episode and track treatment progress is 
important. For these purposes and to avoid unnecessary use 
of antipsychotic medication it is imperative to be able to 
correctly differentiate FESz from normal and other non-
psychotic controls. Forty-two and a half percent of the 
controls would have been falsely classified as FESz using 
the P300 component vs. 25% using the N100 and P200 
components to both target and non-target stimuli. 
Some final caveats should be mentioned here. In this 
paper we limited our participants to those with a diagnosis 
of FESz (for comparison with the chronic group and speci-
ficity to schizophrenia), we still need to analyse data we 
have collected from first episode psychosis (FEP) patients 
who attracted diagnoses other than FESz to see if these 
findings are applicable across FEP. In addition, our data 
indicate that these disturbances are present at the time of 
the first episode, it is yet to be determined if they are present 
prior to the first episode and also if they are specific to 
psychosis when compared with other young clinical groups 
(e.g. attention deficit hyperactivity disorder — ADHD). 
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1 STUDY 1 
1.1 N100 amplitude 
 
               Contrasts Sz vs Control 
Df (1,78)   F p 
Group   30.83 0.000 
Group X Stimulus T vs NT  1.74 0.191 
Group X Site  Cz vs Fz & Pz 19.31 0.000 
  Fz vs Pz 0.53 0.468 
Group X Stimulus X Site T vs NT Cz vs Fz & Pz 1.29 0.259 
  Fz vs Pz 0.67 0.416 
     
Stimulus T vs NT  53.09 0.000 
Stimulus X Site T vs NT Cz vs Fz & Pz 25.02 0.000 
  Fz vs Pz 22.45 0.000 
Site  Cz vs Fz & Pz 259.51 0.000 
  Fz vs Pz 130.56 0.000 
 
 
 
1.2 N100 latency 
 
           Contrasts Sz vs Control 
Df (1,78)   F p 
Group   2.88772 0.093242 
Group X Stimulus T vs NT  9.761876 0.002502 
Group X Site  Cz vs Fz & Pz 0.087288 0.768439 
  Fz vs Pz 1.587763 0.211403 
Group X Stimulus X Site T vs NT Cz vs Fz & Pz 0.364497 0.547771 
  Fz vs Pz 0.002516 0.960123 
     
Stimulus T vs NT  2.90436 0.092321 
Stimulus X Site T vs NT Cz vs Fz & Pz 2.108543 0.150489 
  Fz vs Pz 16.19872 0.000131 
Site  Cz vs Fz & Pz 2.155114 0.146117 
  Fz vs Pz 3.160987 0.079315 
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1.3 P200 amplitude 
 
 Contrasts  Sz vs Control 
Df (1,78)   F p 
Group   5.25659 0.024559 
Group X Stimulus T vs NT  19.80 0.0000 
Group X Site  Cz vs Fz & Pz 10.00 0.0022 
  Fz vs Pz 0.83 0.3653 
Group X Stimulus X Site T vs NT Cz vs Fz & Pz 22.69 0.0000 
  Fz vs Pz 0.57 0.4529 
     
Stimulus T vs NT  16.13 0.0001 
Stimulus X Site T vs NT Cz vs Fz & Pz 39.01 0.0000 
  Fz vs Pz 9.96 0.0023 
Site  Cz vs Fz & Pz 34.37 0.0000 
  Fz vs Pz 2.52 0.1165 
 
 
 
 
1.4 P200 latency 
 
 Contrasts  Sz vs Control 
Df (1,78)   F p 
Group   5.16 0.026 
Group X Stimulus T vs NT  18.77 0.000 
Group X Site  Cz vs Fz & Pz 0.10 0.749 
  Fz vs Pz 0.42 0.521 
Group X Stimulus X Site T vs NT Cz vs Fz & Pz 3.32 0.072 
  Fz vs Pz 0.34 0.559 
     
Stimulus T vs NT  53.24 0.000 
Stimulus X Site T vs NT Cz vs Fz & Pz 1.69 0.197 
  Fz vs Pz 0.11 0.736 
Site  Cz vs Fz & Pz 2.15 0.146 
  Fz vs Pz 6.34 0.014 
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1.5 N200 amplitude 
 
  Sz vs Control 
Df (1,78) Contrasts F p 
Group  6.88 0.010 
Group X Site Cz vs Fz & Pz 18.97 0.000 
 Fz vs Pz 4.29 0.042 
Site Cz vs Fz & Pz 18.12 0.000 
 Fz vs Pz 39.52 0.000 
 
 
1.6 N200 Latency 
 
  Sz vs Control 
Df (1,78) Contrasts F p 
Group  7.18 0.009 
Group X Site Cz vs Fz & Pz 0.01 0.919 
 Fz vs Pz 1.82 0.181 
Site Cz vs Fz & Pz 0.11 0.742 
 Fz vs Pz 7.55 0.007 
 
1.7 P300 amplitude 
 
  Sz vs Control 
Df (1,77) Contrasts F p 
Group  4.44 0.038 
Group X Site Cz vs Fz & Pz 13.03 0.001 
 Fz vs Pz 2.64 0.108 
Site Cz vs Fz & Pz 7.87 0.006 
 Fz vs Pz 119.41 0.000 
 
1.8 P300 latency 
 
  Sz vs Control 
Df (1,77) Contrasts F p 
Group  1.83 0.181 
Group X Site Cz vs Fz & Pz 0.88 0.351 
 Fz vs Pz 2.75 0.101 
Site Cz vs Fz & Pz 5.68 0.020 
 Fz vs Pz 11.68 0.001 
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2 STUDY 2 
2.1 Midline Site 
2.1.1 N100 amplitude 
 Contrasts  Csz vs controls FESz vs controls 
Df (1,76) Stimulus Site F p F p 
Group    30.08 0.000 6.45 0.013 
Group X Stimulus  T vs NTs  1.33 0.253 9.61 0.003 
 T-1 vs T+1  6.14 0.015 1.95 0.167 
Group X Site   Cz vs Fz & Pz 15.22 0.000 10.98 0.001 
  Fz vs Pz 1.57 0.214 3.93 0.051 
Group X Stimulus X Site  T vs NTs Cz vs Fz & Pz 12.76 0.001 3.27 0.074 
  Fz vs Pz 0.72 0.398 31.32 0.000 
 T-1 vs T+1 Cz vs Fz & Pz 11.44 0.001 1.11 0.295 
  Fz vs Pz 0.01 0.905 0.90 0.345 
       Stimulus  T vs NTs  15.78 0.000 15.37 0.000 
 T-1 vs T+1  1.60 0.210 8.96 0.004 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 24.37 0.000 13.04 0.001 
  Fz vs Pz 9.84 0.002 19.72 0.000 
 T-1 vs T+1 Cz vs Fz & Pz 37.20 0.000 13.37 0.000 
  Fz vs Pz 0.29 0.595 2.18 0.144 
       Site   Cz vs Fz & Pz 140.28 0.000 25.86 0.000 
  Fz vs Pz 123.65 0.000 74.71 0.000 
       Gender    5.57 0.021 3.90 0.052 
Group X Gender    2.78 0.100 0.73 0.396 
Group X Gender X Stimulus  T vs NTs  0.07 0.792 0.11 0.743 
 T-1 vs T+1  0.31 0.578 0.01 0.915 
Group X Gender X Site   Cz vs Fz & Pz 0.10 0.749 0.01 0.930 
  Fz vs Pz 0.07 0.787 1.32 0.254 
Grp X Gender X Stim X Site  T vs NTs Cz vs Fz & Pz 0.00 0.967 3.12 0.081 
  Fz vs Pz 0.02 0.886 0.31 0.579 
 T-1 vs T+1 Cz vs Fz & Pz 0.09 0.762 0.00 0.948 
  Fz vs Pz 0.31 0.579 0.01 0.932 
Gender X Stimulus  T vs NTs  1.07 0.305 0.22 0.643 
 T-1 vs T+1  0.43 0.515 1.47 0.230 
Gender X Stimulus X Site  T vs NTs Cz vs Fz & Pz 1.17 0.283 1.09 0.299 
  Fz vs Pz 0.00 0.970 1.62 0.208 
 T-1 vs T+1 Cz vs Fz & Pz 8.57 0.005 0.18 0.673 
  Fz vs Pz 0.07 0.787 0.00 0.999 
Gender X Site   Cz vs Fz & Pz 0.00 0.957 0.08 0.776 
  Fz vs Pz 2.34 0.130 0.06 0.814 
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2.1.2 N100 amplitude/age correlation 
 control  Schizophrenia 
 r p r p 
T-1 N100 amplitude -0.336 0.002 -0.114 0.316 
     
T  N100 amplitude -0.287 0.010 -0.337 0.002 
     
T+1  N100 amplitude -0.238 0.034 -0.200 0.076 
 
2.1.3 N100 amplitude? Symptom correlation 
  CSz  FESz  
  r p r p 
T-1CzN100 amplitute Reality distortion 0.12 0.47 0.26 0.14 
 Psychomotor poverty 0.07 0.7 0.29 0.09 
 Disorganisation 0.42 0.01 0.4 0.02 
TCzN100 amplitute Reality distortion 0.24 0.16 0.02 0.91 
 Psychomotor poverty 0.07 0.68 0.13 0.46 
 Disorganisation 0.36 0.03 0.22 0.22 
T+1CzN100 amplitute Reality distortion 0.17 0.3 -0.11 0.53 
 Psychomotor poverty 0.16 0.36 0.15 0.4 
 Disorganisation 0.36 0.03 0.32 0.06 
 
2.1.4 N100 latency 
 
                    Contrasts CSz vs control FESz vs control 
 Df (1,76) Stimulus Site F Sig. F Sig. 
Group   0.38 0.542 1.86 0.18 
Group X Stimulus  T vs NTs  2.79 0.099 0.17 0.68 
 T-1 vs T+1  2.65 0.108 0.65 0.42 
Group X Site   Cz vs Fz & Pz 5.27 0.025 0.47 0.49 
  Fz vs Pz 0.26 0.610 0.09 0.77 
Group X Stimulus X Site  T vs NTs Cz vs Fz & Pz 4.05 0.048 0.10 0.75 
  Fz vs Pz 0.21 0.651 3.01 0.09 
 T-1 vs T+1 Cz vs Fz & Pz 0.55 0.459 0.78 0.38 
  Fz vs Pz 0.42 0.519 0.18 0.67 
       
Stimulus  T vs NTs  0.01 0.937 0.03 0.86 
 T-1 vs T+1  2.89 0.093 2.26 0.14 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 1.47 0.229 0.15 0.70 
  Fz vs Pz 2.18 0.144 0.70 0.41 
 T-1 vs T+1 Cz vs Fz & Pz 1.82 0.181 0.81 0.37 
  Fz vs Pz 0.16 0.691 1.17 0.28 
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Site   Cz vs Fz & Pz 1.05 0.310 0.91 0.34 
  Fz vs Pz 16.95 0.000 26.76 0.0000 
       
Gender    5.39 0.023 0.55 0.46 
Group X Gender   0.02 0.885 0.46 0.50 
Group X Gender X Stimulus  T vs NTs  0.83 0.365 0.80 0.37 
 T-1 vs T+1  0.23 0.634 0.46 0.50 
Group X Gender X Site   Cz vs Fz & Pz 3.02 0.086 0.72 0.40 
  Fz vs Pz 0.11 0.739 0.48 0.49 
Group X Gender X Stimulus X Site T vs NTs Cz vs Fz & Pz 0.03 0.859 0.02 0.88 
  Fz vs Pz 0.12 0.732 1.70 0.20 
 T-1 vs T+1 Cz vs Fz & Pz 0.19 0.661 0.14 0.71 
  Fz vs Pz 1.51 0.223 0.01 0.90 
Gender X Stimulus  T vs NTs  7.46 0.008 0.55 0.46 
 T-1 vs T+1  0.09 0.766 1.36 0.25 
Gender X Stimulus X Site T vs NTs Cz vs Fz & Pz 4.05 0.048 1.15 0.29 
  Fz vs Pz 0.90 0.345 0.00 0.98 
 T-1 vs T+1 Cz vs Fz & Pz 0.47 0.497 0.23 0.63 
  Fz vs Pz 4.96 0.029 0.00 0.98 
Gender X Site   Cz vs Fz & Pz 3.15 0.080 0.48 0.49 
  Fz vs Pz 1.25 0.268 0.72 0.40 
2.1.5 N100 latency/age correlations 
  control   Schizophrenia 
 r p r p 
T-1 N100 latency -0.08 0.5 0.07 0.51 
     
T  N100 latency 0.07 0.56 0.18 0.11 
     
T+1  N100 latency -0.16 0.16 0.1 0.37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 9 
2.1.6 N100 latency/symptom correlations 
  CSz  FESz  
  r p r p 
T-1CzN100 latency Reality distortion 0.01 0.96 -0.13 0.48 
 Psychomotor poverty 0.02 0.89 0.08 0.66 
 Disorganisation 0.12 0.49 0.13 0.46 
TCzN100 latency Reality distortion 0.01 0.93 0.15 0.4 
 Psychomotor poverty -0.06 0.73 0.01 0.94 
 Disorganisation 0.05 0.76 0.28 0.12 
T+1CzN100 latency Reality distortion -0.01 0.96 -0.19 0.28 
 Psychomotor poverty -0.1 0.57 -0.01 0.94 
 Disorganisation -0.09 0.6 -0.12 0.49 
 
2.1.7 P200 amplitude 
 
                  Contrasts CSz vs. control FESz vs. control 
Df (1,76)  Stimulus Site F p F p 
Group    12.21 0.001 0.18 0.675 
Group X Stimulus  T vs NTs  24.98 0.000 5.45 0.022 
 T-1 vs T+1  0.48 0.489 3.90 0.052 
Group X Site   Cz vs Fz & Pz 3.62 0.061 2.62 0.109 
  Fz vs Pz 0.36 0.548 4.36 0.040 
Group X Stimulus X Site  T vs NTs Cz vs Fz & Pz 18.87 0.000 0.67 0.415 
  Fz vs Pz 3.60 0.062 3.98 0.050 
 T-1 vs T+1 Cz vs Fz & Pz 0.42 0.519 0.97 0.328 
  Fz vs Pz 0.57 0.452 0.01 0.935 
       
Stimulus  T vs NTs  12.35 0.001 0.88 0.352 
 T-1 vs T+1  2.26 0.137 0.48 0.493 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 25.17 0.000 3.81 0.055 
  Fz vs Pz 7.54 0.008 12.78 0.001 
 T-1 vs T+1 Cz vs Fz & Pz 3.62 0.061 0.53 0.471 
  Fz vs Pz 0.16 0.693 5.51 0.022 
       
Site   Cz vs Fz & Pz 57.16 0.000 47.79 0.000 
  Fz vs Pz 4.11 0.046 33.63 0.000 
       
Gender    1.94 0.168 0.50 0.481 
Group X Gender    0.19 0.666 0.79 0.376 
Group X Gender X Stimulus  T vs NTs  0.63 0.431 3.10 0.082 
 T-1 vs T+1  0.27 0.605 0.45 0.503 
Group X Gender X Stimulus X Site  T vs NTs Cz vs Fz & Pz 1.06 0.307 0.02 0.883 
  Fz vs Pz 2.12 0.149 0.01 0.934 
 T-1 vs T+1 Cz vs Fz & Pz 0.55 0.459 0.04 0.836 
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  Fz vs Pz 2.18 0.144 0.00 0.949 
Group X Gender X Site   Cz vs Fz & Pz 0.38 0.537 0.03 0.868 
  Fz vs Pz 1.43 0.235 0.46 0.498 
Stimulus X Gender  T vs NTs  8.83 0.004 1.06 0.306 
 T-1 vs T+1  0.90 0.346 0.00 0.982 
Gender X Stimulus X Site  T vs NTs Cz vs Fz & Pz 4.73 0.033 1.65 0.203 
  Fz vs Pz 0.11 0.736 0.10 0.753 
 T-1 vs T+1 Cz vs Fz & Pz 8.32 0.005 0.53 0.469 
  Fz vs Pz 0.12 0.726 0.07 0.798 
Gender X Site   Cz vs Fz & Pz 1.91 0.171 0.06 0.805 
  Fz vs Pz 3.54 0.064 0.07 0.788 
 
2.1.8 P200 amplitude/age correlations 
  control   Schizophrenia 
 r p r p 
T-1 P200 amplitude 0.11 0.33 0.22 0.05 
     
T  P200 amplitude -0.16 0.16 0.14 0.2 
     
T+1  P200 amplitude 0.07 0.56 0.24 0.03 
 
2.1.9 P200 amplitude/ symptom correlations 
  CSz  FESz  
  r p r p 
T-1CzP200 amplitute Reality distortion -0.14 0.42 0.01 0.96 
 Psychomotor poverty -0.21 0.2 0.09 0.59 
 Disorganisation -0.02 0.91 0.06 0.74 
TCzP200 amplitute Reality distortion 0.14 0.39 -0.02 0.93 
 Psychomotor poverty 0.17 0.31 -0.1 0.58 
 Disorganisation 0.2 0.23 -0.03 0.86 
T+1CzP200 amplitute Reality distortion 0.09 0.6 -0.15 0.39 
 Psychomotor poverty 0.25 0.14 -0.29 0.09 
 Disorganisation 0.05 0.77 -0.12 0.5 
 
2.1.10 P200 latency 
 
             Contrasts CSz vs control FESz vs control 
Df(1,76) Stimulus Site F Sig. F Sig. 
Group    5.62 0.020 0.00 0.994 
Group X Stimulus  T vs NTs  40.50 0.000 3.72 0.058 
 T-1 vs T+1  0.02 0.886 0.73 0.395 
Group X Site   Cz vs Fz & Pz 0.04 0.845 0.29 0.590 
  Fz vs Pz 0.74 0.394 0.03 0.871 
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Group X Stimulus X Site  T vs NTs Cz vs Fz & Pz 3.88 0.053 0.02 0.881 
  Fz vs Pz 0.36 0.548 1.00 0.321 
 T-1 vs T+1 Cz vs Fz & Pz 0.90 0.345 0.01 0.936 
  Fz vs Pz 2.09 0.153 0.18 0.677 
       
Stimulus  T vs NTs  65.18 0.000 32.95 0.000 
 T-1 vs T+1  0.01 0.926 1.76 0.189 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 15.51 0.000 2.28 0.135 
  Fz vs Pz 0.09 0.762 4.30 0.042 
 T-1 vs T+1 Cz vs Fz & Pz 0.08 0.784 0.00 0.959 
  Fz vs Pz 3.43 0.068 1.43 0.236 
       
Site   Cz vs Fz & Pz 0.02 0.892 0.62 0.433 
  Fz vs Pz 4.37 0.040 2.45 0.121 
       
Gender    0.50 0.482 2.45 0.121 
Group X Gender    0.14 0.707 0.81 0.372 
Group X Gender X Stimulus  T vs NTs  4.67 0.034 0.30 0.586 
 T-1 vs T+1  0.54 0.465 0.10 0.755 
Group X Gender X Stimulus X Site  T vs NTs Cz vs Fz & Pz 5.54 0.021 5.22 0.025 
  Fz vs Pz 2.55 0.114 2.24 0.139 
 T-1 vs T+1 Cz vs Fz & Pz 2.42 0.124 0.21 0.646 
  Fz vs Pz 1.81 0.183 1.56 0.216 
Group X Gender X Site   Cz vs Fz & Pz 3.64 0.060 0.06 0.806 
  Fz vs Pz 4.32 0.041 0.46 0.498 
Stimulus X Gender  T vs NTs  0.42 0.517 1.74 0.191 
 T-1 vs T+1  0.04 0.847 4.15 0.045 
Gender X Stimulus X Site T vs NTs Cz vs Fz & Pz 0.00 0.960 0.17 0.679 
  Fz vs Pz 0.04 0.848 0.22 0.638 
 T-1 vs T+1 Cz vs Fz & Pz 0.05 0.820 0.84 0.362 
  Fz vs Pz 0.94 0.336 0.94 0.336 
Gender X Site  Cz vs Fz & Pz 1.03 0.314 0.66 0.419 
  Fz vs Pz 1.13 0.291 1.04 0.312 
 
 
 
2.1.11 P200 latency/age correlation 
 
  control   Schizophrenia 
 r p r p 
T-1 P200 latency 0.32 0 -0.15 0.17 
     
T  P200 latency -0.07 0.53 0.23 0.04 
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T+1  P200 latency 0.27 0.01 0.12 0.31 
 
 
 
 
2.1.12 P200 latency/symptom correlation 
 
 
  CSz  FESz  
  r p r p 
T-1CzN100 
latency 
Reality distortion -0.33 0.05 -0.26 0.14 
 Psychomotor 
poverty 
-0.2 0.23 0.09 0.61 
 Disorganisation -0.17 0.32 0.02 0.91 
TCzN100 latency Reality distortion -0.1 0.55 0.12 0.5 
 Psychomotor 
poverty 
-0.13 0.44 0.14 0.45 
 Disorganisation -0.13 0.43 0.1 0.59 
T+1CzN100 
latency 
Reality distortion 0.08 0.66 0.02 0.89 
 Psychomotor 
poverty 
-0.12 0.49 0 0.99 
 Disorganisation 0.15 0.37 0.02 0.9 
 
 
2.1.13 N200 amplitude 
 
  CSz vs control FESz vs control 
Df (1,76)CSz, (1,75) FESz Contrasts F Sig. F Sig. 
Group  17.98 0.0001 2.52 0.1170 
Group X Site Cz vs Fz & Pz 19.80 0.0000 0.32 0.5742 
 Fz vs Pz 0.86 0.3576 10.58 0.0017 
      
Site Cz vs Fz & Pz 20.90 0.0000 10.73 0.0016 
 Fz vs Pz 60.71 0.0000 132.95 0.0000 
      
Gender  7.60 0.0073 0.00 0.9531 
Group X Gender  0.49 0.4859 0.14 0.7135 
Group X Gender X Site Cz vs Fz & Pz 0.06 0.8149 0.39 0.5350 
 Fz vs Pz 4.39 0.0396 0.71 0.4026 
Gender X Site Cz vs Fz & Pz 0.42 0.5184 0.06 0.8101 
 Fz vs Pz 2.33 0.1309 1.07 0.3033 
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2.1.14  N200 amplitude/ age correlations 
 
2.1.15 N200 amplitude/ symptom correlations 
 
2.1.16 N200 latency 
 
 
 Contrasts CSz vs. controls FESz vs. controls 
Df (1,76)CSz, (1,75)FESz  F Sig. F Sig. 
Group  5.25 0.0248 2.49 0.1191 
Group X Site Cz vs Fz & Pz 11.89 0.0009 0.10 0.7575 
 Fz vs Pz 0.01 0.9355 0.00 0.9956 
      
Site Cz vs Fz & Pz 4.52 0.0368 2.11 0.1504 
 Fz vs Pz 152.75 0.0000 24.20 0.0000 
      
Gender  2.78 0.0997 1.03 0.3136 
Group X Gender  0.07 0.7878 0.20 0.6556 
Group X Gender X Site Cz vs Fz & Pz 0.40 0.5301 0.47 0.4949 
 Fz vs Pz 2.90 0.0927 0.23 0.6357 
Gender X Site Cz vs Fz & Pz 0.29 0.5895 1.44 0.2337 
 Fz vs Pz 0.00 0.9609 0.08 0.7817 
 
 
 
 
 
2.1.17 P300 amplitude 
 
  CSz vs control FESz vs control 
DF (1,76) Contrasts F p F p 
Group  5.25 0.0248 5.31 0.0240 
Group X Site Cz vs Fz & Pz 11.89 0.0009 0.47 0.4941 
 Fz vs Pz 0.01 0.9355 4.38 0.0396 
      
Site Cz vs Fz & Pz 4.52 0.0368 1.83 0.1801 
 Fz vs Pz 152.75 0.0000 148.54 0.0000 
      
Gender  2.78 0.0997 0.04 0.8451 
Group X Gender  0.07 0.7878 0.20 0.6550 
Group X Gender X 
Site 
Cz vs Fz & Pz 0.40 0.5301 0.01 0.9035 
 Fz vs Pz 2.90 0.0927 1.15 0.2868 
Gender X Site Cz vs Fz & Pz 0.29 0.5895 0.01 0.9285 
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 Fz vs Pz 0.00 0.9609 0.92 0.3403 
 
 
2.1.18 P300 latency 
 
  CSz vs control FESz vs control 
DF (1,76) Contrasts     
Group  0.18 0.6705 0.41 0.526 
Group X Site Cz vs Fz & Pz 3.18 0.0786 1.72 0.194 
 Fz vs Pz 0.05 0.8317 0.76 0.387 
      
Site Cz vs Fz & Pz 14.71 0.0003 1.24 0.269 
 Fz vs Pz 10.15 0.0021 1.25 0.268 
      
Gender  0.61 0.4367 0.01 0.936 
Group X Gender  0.27 0.6100 0.02 0.883 
Group X Gender X Site Cz vs Fz & Pz 1.15 0.2875 1.71 0.194 
 Fz vs Pz 0.90 0.3447 1.93 0.169 
Gender X Site Cz vs Fz & Pz 0.08 0.7738 0.01 0.915 
 Fz vs Pz 0.48 0.4922 0.49 0.487 
 
 
 
 
 
2.1.19 Age/ERP correlations 
 
  Combined control 
groups 
Combined 
Schizophrenia 
groups 
  AGE AGE 
T-1CzN100 amplitude Pearson Correlation -0.34 -0.11 
 Sig. (2-tailed 0.00 0.32 
T-1CzN100 latency Pearson Correlation -0.08 0.07 
 Sig. (2-tailed 0.50 0.51 
T-1CzP200 amplitude Pearson Correlation 0.11 0.22 
 Sig. (2-tailed 0.33 0.05 
T-1CzP200 latency Pearson Correlation 0.32 -0.15 
 Sig. (2-tailed 0.00 0.17 
TCzN100 amplitude Pearson Correlation -0.29 -0.34 
 Sig. (2-tailed 0.01 0.00 
TCzN100 latency Pearson Correlation 0.07 0.18 
 Sig. (2-tailed 0.56 0.11 
TCzP200 amplitude Pearson Correlation -0.16 0.14 
 Sig. (2-tailed 0.16 0.20 
TCzP200 latency Pearson Correlation -0.07 0.23 
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 Sig. (2-tailed 0.53 0.04 
TFzN200 amplitude Pearson Correlation 0.44 0.21 
 Sig. (2-tailed 0.00 0.06 
TFzN200 latency Pearson Correlation 0.01 0.18 
 Sig. (2-tailed 0.91 0.10 
TPzP300 amplitude Pearson Correlation -0.39 -0.22 
 Sig. (2-tailed 0.00 0.05 
TPzP300 latency Pearson Correlation 0.20 0.02 
 Sig. (2-tailed 0.07 0.86 
T+1CzN100 amplitude Pearson Correlation -0.24 -0.20 
 Sig. (2-tailed 0.03 0.08 
T+1CzN100 latency Pearson Correlation -0.16 0.10 
 Sig. (2-tailed 0.16 0.37 
T+1CzP200 amplitude Pearson Correlation 0.07 0.24 
 Sig. (2-tailed 0.56 0.03 
T+1CzP200 latency Pearson Correlation 0.27 0.12 
 Sig. (2-tailed 0.01 0.31 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.20 Symptom/ERP correlations 
 
 
  chronic schizophrenia first episode schizophrenia 
  RD PP D RD PP D 
T-1CzN100 amplitute Pearson Correlation 0.12 0.07 0.42 0.26 0.29 0.40 
 Sig. (2-tailed) 0.47 0.70 0.01 0.14 0.09 0.02 
T-1CzN100 latency Pearson Correlation 0.01 0.02 0.12 -0.13 0.08 0.13 
 Sig. (2-tailed) 0.96 0.89 0.49 0.48 0.66 0.46 
T-1CzP200 amplitude Pearson Correlation -0.14 -0.21 -0.02 0.01 0.09 0.06 
 Sig. (2-tailed) 0.42 0.20 0.91 0.96 0.59 0.74 
T-1CzP200 latency Pearson Correlation -0.33 -0.20 -0.17 -0.26 0.09 0.02 
 Sig. (2-tailed) 0.05 0.23 0.32 0.14 0.61 0.91 
TCzN100 amplitute Pearson Correlation 0.24 0.07 0.36 0.02 0.13 0.22 
 Sig. (2-tailed) 0.16 0.68 0.03 0.91 0.46 0.22 
TCzN100 latency Pearson Correlation 0.01 -0.06 0.05 0.15 0.01 0.28 
 Sig. (2-tailed) 0.93 0.73 0.76 0.40 0.94 0.12 
TCzP200 amplitude Pearson Correlation 0.14 0.17 0.20 -0.02 -0.10 -0.03 
 Sig. (2-tailed) 0.39 0.31 0.23 0.93 0.58 0.86 
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TCzP200 latency Pearson Correlation -0.10 -0.13 -0.13 0.12 0.14 0.10 
 Sig. (2-tailed) 0.55 0.44 0.43 0.50 0.45 0.59 
TFzN200 amplitude Pearson Correlation 0.22 -0.08 -0.11 -0.07 -0.03 -0.02 
 Sig. (2-tailed) 0.20 0.64 0.52 0.69 0.84 0.92 
TFzN200 latency Pearson Correlation 0.03 -0.01 0.19 -0.03 0.00 0.07 
 Sig. (2-tailed) 0.86 0.97 0.25 0.88 0.98 0.68 
TPzP300 amplitude Pearson Correlation 0.19 0.07 0.15 -0.16 -0.20 -0.26 
 Sig. (2-tailed) 0.25 0.66 0.37 0.37 0.26 0.14 
TPzP300 latency Pearson Correlation -0.09 -0.12 0.05 -0.07 -0.10 0.01 
 Sig. (2-tailed) 0.58 0.47 0.77 0.70 0.56 0.95 
T+1CzN100 amplitute Pearson Correlation 0.17 0.16 0.36 -0.11 0.15 0.32 
 Sig. (2-tailed) 0.30 0.36 0.03 0.53 0.40 0.06 
T+1CzN100 latency Pearson Correlation -0.01 -0.10 -0.09 -0.19 -0.01 -0.12 
 Sig. (2-tailed) 0.96 0.57 0.60 0.28 0.94 0.49 
T+1CzP200 amplitude Pearson Correlation 0.09 0.25 0.05 -0.15 -0.29 -0.12 
 Sig. (2-tailed) 0.60 0.14 0.77 0.39 0.09 0.50 
T+1CzP200 latency Pearson Correlation 0.08 -0.12 0.15 0.02 0.00 0.02 
 Sig. (2-tailed) 0.66 0.49 0.37 0.89 0.99 0.90 
 
 
 
 
 
 
 
 
 
2.2 Topography 
 
2.2.1 N100 amplitude  
 
2.2.1.1 Hemisphere (left/right)  
 
   Chronic Sz FESz  
Df (1,60) CSz, (1,59) FESz  Stimulus Hemisphere F p F p 
Group   21.101 0.000 12.970 0.001 
Group X Hemisphere  L vs R 1.696 0.198 0.812 0.371 
Group X Stimulus T vs NTs  0.687 0.411 17.313 0.000 
 T-1 vs T+1  1.098 0.299 0.992 0.323 
Group X Hem X Stim T vs NTs L vs R 2.346 0.131 0.021 0.886 
 T-1 vs T+1 L vs R 0.014 0.905 0.169 0.683 
       
Hemisphere  L vs R 0.768 0.384 0.106 0.746 
Stimulus T vs NTs  28.356 0.000 12.157 0.001 
 T-1 vs T+1  7.554 0.008 15.695 0.000 
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Hemisphere X Stimulus T vs NTs L vs R 0.000 0.986 3.383 0.071 
 T-1 vs T+1 L vs R 10.506 0.002 0.532 0.469 
 
 
 
 
2.2.1.2 Region (anterior/posterior) 
 
 
   Chronic Sz FESz  
Df (1,60) C&FESz Stimulus Region F Sig. F Sig. 
Group   22.330 0.000 11.500 0.001 
Group X Region  A vs P 2.047 0.158 5.108 0.027 
Group X Stimulus T vs NTs  0.873 0.354 12.448 0.001 
 T-1 vs T+1  0.775 0.382 0.529 0.470 
Grp X Reg X Stim T vs NTs A vs P 1.050 0.310 19.612 0.000 
 T-1 vs T+1 A vs P 1.239 0.270 1.077 0.303 
       
Region  A vs P 97.062 0.000 100.750 0.000 
Stimulus T vs NTs  16.762 0.000 7.611 0.008 
 T-1 vs T+1  4.438 0.039 5.659 0.021 
Region X Stim T vs NTs A vs P 7.185 0.009 28.445 0.000 
 T-1 vs T+1 A vs P 0.040 0.843 0.118 0.732 
 
2.2.2 N100 latency 
 
2.2.2.1 Hemisphere (left/right)  
 
   CSz FESz 
Df (1,60) CSz, (1,59) FESz STIMULI HEM F p F p. 
Group 1,60  0.824 0.368 4.552 0.037 
Group X Hemisphere  L vs R 0.413 0.523 1.275 0.263 
Group X Stimulus T vs NTs  1.289 0.261 1.347 0.250 
 T-1 vs T+1  0.376 0.542 0.200 0.657 
Group X Hem X Stim T vs NTs L vs R 0.819 0.369 1.139 0.290 
 T-1 vs T+1 L vs R 0.040 0.843 0.001 0.974 
       
Hemisphere  L vs R 3.752 0.057 0.245 0.622 
Stimulus T vs NTs  4.573 0.037 0.103 0.749 
 T-1 vs T+1  4.254 0.044 4.637 0.035 
Hemisphere X Stimulus T vs NTs L vs R 0.081 0.777 0.592 0.445 
 T-1 vs T+1 L vs R 2.329 0.132 1.814 0.183 
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2.2.2.2 Region (anterior/posterior) 
 
Df (1,60) C & FESz Stimulus Region F Sig. F Sig. 
Group   0.461 0.500 2.941 0.092 
Group X Region  A vs P 2.538 0.116 0.009 0.924 
Group X Stimulus T vs NTs  1.442 0.235 0.143 0.707 
 T-1 vs T+1  0.176 0.676 1.544 0.219 
Grp X Reg X Stim T vs NTs A vs P 0.122 0.728 2.031 0.159 
 T-1 vs T+1 A vs P 1.290 0.261 1.107 0.297 
       
Region  A vs P 9.768 0.003 34.976 0.000 
Stimulus T vs NTs  4.921 0.030 4.706 0.034 
 T-1 vs T+1  1.012 0.319 1.038 0.312 
Region X Stim T vs NTs A vs P 11.511 0.001 2.448 0.123 
 T-1 vs T+1 A vs P 0.948 0.334 5.777 0.019 
 
 
 
 
 
 
 
2.2.3 P200 amplitude 
2.2.3.1 Hemisphere (left/right) 
 
 
Df (1,59)CSz, (1,56) FESz Contrasts  CSz vs control FESz vs control 
 Stimulus Hemisphere F    p F     p 
Group   9.34 0.003 0.84 0.363 
Group X Hemisphere  L vs R 0.00 0.947 0.75 0.390 
Group X Stimulus T vs NTs  1.34 0.251 3.35 0.072 
 T-1 vs T+1  1.11 0.297 3.50 0.067 
Group X Hem X Stim T vs NTs L vs R 0.00 0.971 0.22 0.643 
 T-1 vs T+1 L vs R 0.09 0.759 0.05 0.828 
       
Hemisphere  L vs R 0.05 0.818 2.04 0.159 
Stimulus T vs NTs  25.87 0.000 3.13 0.082 
 T-1 vs T+1  0.31 0.580 0.91 0.343 
Hemisphere X Stimulus T vs NTs L vs R 3.16 0.081 0.00 0.949 
 T-1 vs T+1 L vs R 10.70 0.002 5.47 0.023 
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2.2.3.2  Region (anterior/posterior) 
 
Df (1,59) C & FESz              Contrast CSz vs control FESz vs control 
1,59 Stimulus Region F p F p 
Group   8.82 0.004 0.437 0.511167 
Group X Region  A vs P 0.01 0.927 3.10 0.083 
Group X Stimulus T vs NT A vs P 0.30 0.588 3.50 0.066 
 T-1 vs T+1 A vs P 0.10 0.755 2.12 0.151 
Grp X Region X Stimulus T vs NT  0.25 0.618 0.38 0.542 
 T-1 vs T+1  1.08 0.303 0.60 0.443 
       
Region  A vs P 5.68 0.020 35.49 0.000 
Stimulus T vs NT A vs P 2.86 0.096 0.05 0.830 
 T-1 vs T+1 A vs P 3.47 0.067 0.12 0.735 
Region X Stim T vs NT A vs P 12.01 0.001 4.62 0.036 
 T-1 vs T+1 A vs P 0.21 0.648 0.78 0.380 
 
 
 
 
 
 
 
 
 
 
2.2.4 P200 latency 
2.2.4.1 Hemisphere 
 
Df (1,59)CSz, (1,56) FESz                Contrasts CSz vs control FESz vs control 
 Stimulus Hemisphere F Sig. F p 
Group   8.701195 0.004554 2.61 0.112 
Group X Hemisphere  L vs R 4.67 0.035 0.99 0.325 
Group X Stimulus T vs NT  20.27 0.000 2.79 0.100 
 T-1 vs T+1  2.89 0.094 4.65 0.035 
Group X Hemisphere X Stimulus T vs NT L vs R 0.57 0.454 0.60 0.441 
 T-1 vs T+1 L vs R 0.35 0.555 0.32 0.575 
       
Hemisphere  L vs R 0.28 0.599 4.30 0.043 
Stimulus T vs NT  45.89 0.000 10.16 0.002 
 T-1 vs T+1  2.01 0.161 29.15 0.000 
Hemisphere X Stimulus T vs NT L vs R 3.38 0.071 3.86 0.055 
 T-1 vs T+1 L vs R 0.03 0.865 0.42 0.518 
 
 
2.2.4.2 Region 
 
Df(1,59) C & FESz           Contrasts CSz vs control FESz vs control 
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 Stimulus Region F p F p 
Group   7.77 0.007 3.17 0.080 
Group X Region  A vs P 0.82 0.370 1.47 0.230 
Group X Stimulus T vs NTs  17.38 0.000 2.48 0.121 
 T-1 vs T+1  2.13 0.150 4.13 0.047 
Group X Region X Stimulus T vs NTs A vs P 6.49 0.013 3.82 0.055 
 T-1 vs T+1 A vs P 1.68 0.201 0.08 0.775 
       
Region  A vs P 10.36 0.002 10.86 0.002 
Region X Stimulus T vs NTs A vs P 3.41 0.070 4.45 0.039 
 T-1 vs T+1 A vs P 0.01 0.904 0.62 0.435 
Stimulus T vs NTs  46.14 0.000 25.21 0.000 
 T-1 vs T+1  2.27 0.137 11.45 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.5 N200 and P300 components 
 
2.2.5.1 Hemisphere (left/right) and region (anterior/posterior) 
 
   Csz vs control FESz vs control 
 Source Contrast df F p df F p 
N200  Hemisphere L vs R 1,70 0.01 0.906 1,59 4.33 0.042 
anplitude Group   0.15 0.700  1.44 0.235 
 Hemisphere X Group L vs R  0.74 0.393  0.10 0.755 
 Region A vs P 1,70 23.44 0.000 1,60 88.80 0.000 
 Group   0.05 0.821  0.80 0.314 
 Region X Group A vs P  11.59 0.001  4.36 0.041 
N200 latency Hemisphere L vs R 1,70 1.69 0.198 1,59 0.00 0.979 
 Group   21.89 0.000  5.32 0.025 
 Hemisphere X Group L vs R  0.02 0.895  5.38 0.024 
 Region A vs P 1,70 12.07 0.001 1,60 88.80 0.000 
 Region X Group A vs P  0.05 0.822  4.36 0.041 
P300  Hemisphere L vs R 1,70 0.04 0.844 1,63 0.39 0.535 
amplitude Group   12.24 0.001  2.5 0.117 
 Hemisphere X Group L vs R  1.31 0.257  0.04 0.843 
 Region A vs P 1,70 153.28 0.000 1,63 160.18 0.000 
 Region X Group A vs P  0.45 0.506  4.97 0.029 
P300 latency Hemisphere L vs R 1,70 1.76 0.189 1,63 1.47 0.230 
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 Group   0.35 0.553  4.53 0.037 
 Hemisphere X Group L vs R  1.22 0.274  3.43 0.069 
 Region A vs P 1,70 11.66 0.001 1,63 0.85 0.360 
 Region X Group A vs P  3.74 0.057  0.40 0.530 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 STUDY 3 
3.1 DR 
3.1.1 P300 Amplitude 
 
Df(1,26) Contrasts  FESz vs controls 
 DR Site F p 
Group   0.16 0.690 
Group X DR Linear  2.13 0.156 
 Quadratic  0.08 0.780 
Group X Site  Linear 2.93 0.099 
  Quadratic 0.06 0.816 
Group X DR X Site Linear Linear 0.04 0.838 
  Quadratic 1.10 0.304 
 Quadratic Linear 0.50 0.485 
  Quadratic 0.47 0.500 
     
DR Linear  29.40 0.000 
 Quadratic  8.05 0.009 
DR X Site Linear Linear 13.90 0.001 
  Quadratic 0.26 0.614 
 Quadratic Linear 0.16 0.692 
  Quadratic 0.02 0.889 
Site  Linear 82.73 0.000 
  Quadratic 20.47 0.000 
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3.1.2 P300 latency 
Df(1,26) Contrasts  FESz vs controls 
 DR Site F Sig. 
Group   1.10 0.303 
DR Linear  2.18 0.152 
 Quadratic  0.33 0.573 
Group X DR Linear  1.70 0.204 
 Quadratic  0.26 0.612 
Group X Site  Linear 1.13 0.298 
  Quadratic 0.12 0.735 
Group X DR X Site Linear Linear 2.52 0.125 
  Quadratic 5.83 0.023 
 Quadratic Linear 0.20 0.658 
  Quadratic 3.63 0.068 
DR X Site Linear Linear 2.41 0.133 
  Quadratic 1.55 0.224 
 Quadratic Linear 11.50 0.002 
  Quadratic 0.97 0.333 
Site  Linear 0.36 0.555 
  Quadratic 0.19 0.666 
 
 
3.1.3 RT 
 
Df(1,26) Contrasts F p 
Group  0.21 0.061 
DR Linear 0.36 0.552 
 Quadratic 0.19 0.664 
DR X Group Linear 0.14 0.708 
 Quadratic 0.59 0.448 
 
 
 
 
 
 
3.2 DA 
3.2.1 P300 amplitude 
 
Df(1,26) Contrasts  FESz vs controls 
 DR Site F Sig. 
Group   0.26 0.613 
DA Linear  0.01 0.917 
 Quadratic  0.00 0.958 
Group X DA Linear  1.82 0.189 
 Quadratic  0.29 0.597 
Group X Site  Linear 1.63 0.213 
  Quadratic 1.42 0.245 
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Group X DA X 
Site 
Linear Linear 0.03 0.859 
  Quadratic 0.02 0.888 
 Quadratic Linear 0.13 0.726 
  Quadratic 1.14 0.296 
DA X Site Linear Linear 0.32 0.574 
  Quadratic 0.02 0.884 
 Quadratic Linear 0.01 0.905 
  Quadratic 0.48 0.493 
Site  Linear 38.60 0.000 
  Quadratic 17.22 0.000 
 
 
 
 
 
 
 
 
 
 
 
3.2.2 P300 Latency 
 
Df(1,26) Contrasts  FESz vs control 
 DA Site F p 
Group   0.12 0.732 
DA Linear  1.00 0.326 
 Quadratic  0.30 0.591 
Group X DA Linear  2.41 0.133 
 Quadratic  3.91 0.059 
Group X Site  Linear 0.19 0.669 
  Quadratic 1.31 0.262 
Group X DA X 
Site 
Linear Linear 0.30 0.591 
  Quadratic 0.14 0.715 
 Quadratic Linear 10.28 0.004 
  Quadratic 0.03 0.870 
DA X Site Linear Linear 6.67 0.016 
  Quadratic 0.01 0.915 
 Quadratic Linear 0.46 0.504 
  Quadratic 0.14 0.711 
Site  Linear 0.51 0.480 
  Quadratic 2.96 0.097 
 
 
3.2.3 RT 
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  FESz vs control 
Df (1,26) Contrasts F p 
GROUP  1.83 0.188 
DA Linear 8.89 0.006 
 Quadratic 7.59 0.011 
Group X DA Linear 0.04 0.848 
 Quadratic 0.53 0.472 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Continuing (NN, TT) and discontinuing (TN, NT) series. 
 
3.3.1 P300 amplitude 
 Contrasts   FESz vs Controls 
Df (1,26) Sequence Stimulus Site         F         p 
Group    3.06 0.092 
Sequence cont vs discont   1.21 0.282 
Stimulus  T vs N  0.07 0.793 
      
Group X Sequence cont vs discont   0.00 0.983 
Group X Stimulus  T vs N  3.83 0.061 
Group X Site   Linear 0.06 0.808 
   Quadratic 0.07 0.788 
Group X Sequence X Stimulus cont vs discont T vs N  0.17 0.686 
Group X Sequence X Site cont vs discont  Linear 1.22 0.280 
   Quadratic 2.37 0.136 
Group X Stimulus X Site  T vs N Linear 2.13 0.157 
   Quadratic 0.11 0.742 
Group X Sequence X Stimulus X Site cont vs discont T vs N Linear 0.26 0.615 
   Quadratic 4.12 0.053 
      
Sequence X Stimuli cont vs discont T vs N  3.63 0.068 
Sequence X Site cont vs discont  Linear 0.57 0.456 
   Quadratic 0.00 0.980 
Sequence X Stimulus X Site cont vs discont T vs N Linear 1.12 0.300 
   Quadratic 3.47 0.074 
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Stimulus X Site  T vs N Linear 4.54 0.043 
   Quadratic 0.47 0.498 
Site   Linear 47.41 0.000 
   Quadratic 0.01 0.916 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 N100 amplitude 
 
 Contrasts   FESz vs Controls 
Df (1,26) SEQ STIM SITE F Sig. 
Group    3.06 0.092 
Sequence cont vs discont   1.21 0.282 
Stimulus  T vs N  0.07 0.793 
      
Group X Sequence cont vs discont   0.00 0.983 
Group X Stimulus  T vs N  3.83 0.061 
Group X Site   Linear 0.06 0.808 
   Quadratic 0.07 0.788 
Group X Sequence X Stimulus cont vs discont T vs N  0.17 0.686 
Group X Sequence X Site cont vs discont  Linear 1.22 0.280 
   Quadratic 2.37 0.136 
Group X Stimulus X Site  T vs N Linear 2.13 0.157 
   Quadratic 0.11 0.742 
Group X Sequence X Stimulus X Site cont vs discont T vs N Linear 0.26 0.615 
   Quadratic 4.12 0.053 
      
Sequence X Stimuli cont vs discont T vs N  3.63 0.068 
Sequence X Site cont vs discont  Linear 0.57 0.456 
   Quadratic 0.00 0.980 
Sequence X Stimulus X Site cont vs discont T vs N Linear 1.12 0.300 
   Quadratic 3.47 0.074 
Stimulus X Site  T vs N Linear 4.54 0.043 
   Quadratic 0.47 0.498 
Site   Linear 47.41 0.000 
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   Quadratic 0.01 0.916 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 STUDY 4 
 
 
4.1.1 N100 amplitude 
 
 
   FESz vs ADHD+NC ADHD vs NC 
   df (1,58)  df (1,38)  
 Stimulus Site F p F p 
Group    5.91 0.02 0.30 0.589 
Grp X Stim T vs NTs  9.96 0.003 0.27 0.605 
 T-1 vs T+1  1.79 0.187 0.77 0.385 
Grp X Site   Cz vs Fz & Pz 4.33 0.042 0.86 0.360 
  Fz vs Pz 1.89 0.174 0.35 0.558 
Grp X Stim X Site  T vs NTs Cz vs Fz & Pz 0.16 0.691 0.12 0.729 
  Fz vs Pz 18.47 0.000 3.85 0.057 
 T-1 vs T+1 Cz vs Fz & Pz 0.01 0.904 0.87 0.357 
  Fz vs Pz 3.46 0.068 0.51 0.480 
       
Stimulus  T vs NTs  5.31 0.025 19.76 0.000 
 T-1 vs T+1  13.07 0.001 16.19 0.000 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 3.58 0.064 3.20 0.082 
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  Fz vs Pz 3.46 0.068 51.22 0.000 
 T-1 vs T+1 Cz vs Fz & Pz 0.01 0.904 4.76 0.035 
  Fz vs Pz 3.46 0.068 9.80 0.003 
       
Site   Cz vs Fz & Pz 5.88 0.018 10.85 0.002 
  Fz vs Pz 45.77 0.000 44.90 0.000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.2 N100 Latency 
 
 
   FESz vs ADHD+NC ADHD vs NC 
   df (1,58)  df (1,38)  
 Stimulus Site     
Group    0.06 0.81 0.48 0.49 
Grp X Stim T vs NTs  5.63 0.0210 0.01 0.9247 
 T-1 vs T+1  2.71 0.1050 0.08 0.7768 
Grp X Site   Cz vs Fz & Pz 0.06 0.8074 2.92 0.0957 
  Fz vs Pz 0.30 0.5839 1.50 0.2289 
Grp X Stim X Site  T vs NTs Cz vs Fz & Pz 1.92 0.1708 0.69 0.4125 
  Fz vs Pz 3.28 0.0754 0.19 0.6653 
 T-1 vs T+1 Cz vs Fz & Pz 0.47 0.4965 0.13 0.7202 
  Fz vs Pz 3.65 0.0611 0.12 0.7264 
       
Stimulus  T vs NTs  1.04 0.3120 1.85 0.1822 
 T-1 vs T+1  0.06 0.8073 2.28 0.1393 
 28 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 0.03 0.8631 1.14 0.2932 
  Fz vs Pz 0.14 0.7121 4.41 0.0425 
 T-1 vs T+1 Cz vs Fz & Pz 6.02 0.017 0.81 0.3752 
  Fz vs Pz 4.54 0.037 0.02 0.8989 
       
Site   Cz vs Fz & Pz 2.74 0.1032 1.96 0.1694 
  Fz vs Pz 55.49 0.0000 50.40 0.0000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3 P200 amplitude 
 
   FESz vs ADHD+NC ADHD vs NC 
   df (1,58)  df (1,38)  
 Stimulus Site     
Group    0.18 0.67 0.00 0.99 
Grp X Stim T vs NTs  11.18 0.0015 0.20 0.657 
 T-1 vs T+1 5.71 0.0201 1.37 0.249 
Grp X Site   Cz vs Fz & Pz 5.57 0.0216 0.95 0.3353 
  Fz vs Pz 3.34 0.0728 3.00 0.0912 
Grp X Stim X Site  T vs NTs Cz vs Fz & Pz 0.06 0.8050 0.65 0.4239 
  Fz vs Pz 4.30 0.0426 0.12 0.7274 
 T-1 vs T+1 Cz vs Fz & Pz 0.20 0.6535 0.04 0.8457 
  Fz vs Pz 0.57 0.4549 0.03 0.8529 
       
Stimulus  T vs NTs  1.58 0.2144 14.44 0.0005 
 T-1 vs T+1 2.97 0.0904 14.23 0.0006 
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Stimulus X Site  T vs NTs Cz vs Fz & Pz 5.96 0.0177 2.80 0.1022 
  Fz vs Pz 11.08 0.0015 27.05 0.0000 
 T-1 vs T+1 Cz vs Fz & Pz 3.98 0.0508 1.83 0.1837 
  Fz vs Pz 2.32 0.1335 4.62 0.0381 
       
Site   Cz vs Fz & Pz 45.71 0.0000 51.64 0.0000 
  Fz vs Pz 24.36 0.0000 26.62 0.0000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.4 P200 Latency 
 
   FESz vs ADHD+NC ADHD vs NC 
   df (1,58)  df (1,38)  
 Stimulus Site     
Group    0.29 0.59 0.97 0.330 
Grp X Stim T vs NTs  0.78 0.3820 1.45 0.236 
 T-1 vs T+1 16.13 0.0002 0.00 0.9711 
Grp X Site   Cz vs Fz & Pz 0.37 0.5444 0.24624 0.622593 
  Fz vs Pz 1.04 0.3122 0.087545 0.768933 
Grp X Stim X Site  T vs NTs Cz vs Fz & Pz 3.72 0.0586 0.76 0.387 
  Fz vs Pz 1.45 0.2337 1.84 0.182 
 T-1 vs 
T+1 
Cz vs Fz & Pz 0.55 0.4627 0.55 0.465 
  Fz vs Pz 11.32 0.0014 1.62 0.211 
       
Stimulus  T vs NTs  53.17 0.0000 33.70 0.000 
 T-1 vs T+1 1.93 0.1697 5.20 0.028 
Stimulus X Site  T vs NTs Cz vs Fz & Pz 0.21 0.6483 3.78 0.059 
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  Fz vs Pz 3.37 0.0716 6.68 0.014 
 T-1 vs 
T+1 
Cz vs Fz & Pz 0.52 0.4728 0.00 0.987 
  Fz vs Pz 1.94 0.1685 4.52 0.040 
       
Site   Cz vs Fz & Pz 0.48 0.4897 0.01 0.939 
  Fz vs Pz 9.61 0.0030 3.89 0.056 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.5 N200 amplitude 
 
  FESz vs ADHD+NC ADHD vs NC 
  df (1,58)  df (1,38)  
 Site F p F p 
Group  2.79 0.10 0.15 0.6982 
Group X Site Cz vs Fz & Pz 0.01 0.9340 0.35 0.5560 
 Fz vs Pz 6.94 0.0108 0.28 0.6029 
      
Site Cz vs Fz & Pz 7.95 0.0066 4.97 0.0318 
 Fz vs Pz 93.34 0.0000 99.64 0.0000 
 
 
4.1.6 N200 latency 
 
  FESz vs ADHD+NC ADHD vs NC 
  df (1,58)  df (1,38)  
 Site F p F p 
Group  0.69 0.41 0.50 0.48 
Group X Site Cz vs Fz & Pz 1.21 0.2763 0.01 0.9390 
 Fz vs Pz 0.00 0.9818 1.12 0.2966 
      
Site Cz vs Fz & Pz 4.36 0.0412 9.58 0.0037 
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 Fz vs Pz 24.91 0.0000 23.13 0.0000 
 
4.1.7 P300 amplitude 
 
  FESz vs ADHD+NC ADHD vs NC 
  df (1,58)  df (1,38)  
N2amp Site F p F p 
Group  0.00 0.99 7.88 0.0078 
Group X Site Cz vs Fz & Pz 0.10 0.7486 1.07 0.3082 
 Fz vs Pz 6.23 0.0154 0.57 0.4532 
      
Site Cz vs Fz & Pz 2.23 0.1406 0.98 0.3293 
 Fz vs Pz 138.53 0.0000 145.57 0.0000 
 
 
 
 
 
 
 
 
 
 
 
4.1.8 P300 latency 
 
  FESz vs ADHD+NC ADHD vs NC 
  df (1,58)  df (1,38)  
N2amp Site F p F p 
Group  0.53 0.4728 0.71 0.4043 
Group X Site Cz vs Fz & Pz 0.10 0.7575 0.17 0.6815 
 Fz vs Pz 0.49 0.4895 0.00 0.9514 
      
Site Cz vs Fz & Pz 1.98 0.1671 1.94 0.1692 
 Fz vs Pz 0.08 0.7855 0.12 0.7332 
 
 
 
